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Total Hip Replacement (THR) and Total Knee Replacement (TKR) are effective surgical
interventions, which alleviate pain and improve Health-Related Quality of Life (HRQoL)
in patients with hip or knee joint degeneration.[1] National joint replacement registries
show good long-term results regarding the probability of revision surgery, which is lower
than 10% at 10 years follow-up, both for THR and TKR.[2, 3] Compared to non-operative
treatment, both THR and TKR have been shown to be cost-effective interventions.[4–7]
Epidemiology Annually, 25,000 THR and 20,000 TKR are performed in the
Netherlands.[8] These numbers are projected to rise substantially, due to demographical
changes, the rising incidence of overweight and obesity, improved long-term outcomes
of joint replacements, more active lifestyle of the elderly and the increasing number of
orthopaedic surgeons.[9] The annual numbers of THR and TKR performed are expected
to increase to approximately 50,000 and 60,000 in 2030.[9]
In the Netherlands, the majority (80%) of THR are performed for osteoarthritis (OA).[8]
Less frequent indications for joint replacement include a displaced femoral neck fracture,
osteonecrosis, secondary posttraumatic OA, rheumatoid arthritis, OA due to Legg-
Calvé-Perthes disease and the treatment of a neoplasm.[8] The mean age at joint
replacement is 70 years, two-thirds of the patients are females.[8] The majority (96%) of
TKR are also performed for OA.[8] Less frequent indications for joint replacement include
rheumatoid arthritis, secondary posttraumatic OA, osteonecrosis and the treatment of a
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neoplasm.[8] The mean age at joint replacement is 68 years, two-thirds of the patients
are females.[8]
Implants Currently, a wide variety of Total Hip Implants is available to orthopaedic
surgeons worldwide. The probability of revision surgery varies considerably between
different implants.[10] In order to prevent unnecessary harm and limit secondary health
care costs, it is imperative to choose an implant with a low probability of revision surgery,
when performing primary THR.
Patient and Surgeon Factors Although joint replacements are highly effective in
improving HRQoL and joint specific functioning at the group level,[1] this is not the
case for each individual patient. Persistent pain is reported in 9% of THR patients and
20% of TKR patients at long term follow-up.[11] Additionally, up to 30% of patients are
dissatisfied with the results after surgery.[12–20]
The therapeutic options for patients with an unfavourable outcome after THR or TKR
are limited. The outcome of revision surgery performed without a specific mechanical or
physiological indication is highly unpredictable. Predicting which patient groups are at
increased risk of an unfavourable outcome after joint replacement may provide additional
insights in the mechanisms involved and offer the possibility of intervention in order to
optimise the outcome.[21] At the very least, it allows patients to be well informed of their
specific risks and expected gains before surgery.
In this thesis, we have investigated the role of two potential predictors, which are
inexpensive to measure and easily available in clinical practice. Firstly, we studied
whether the patients’ Socio-Economic Position was associated with the improvement in
Health-Related Quality of Life and patient satisfaction after THR and TKR. Secondly, we
studied whether the preoperative radiographic severity of OA was associated with the
improvement in Health-Related Quality of Life and patient satisfaction after THR and
TKR.
Research Methodology
Competing Risks: The probability of revision surgery at a specific point in time (given
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CHAPTER 1: INTRODUCTION
that revision surgery has not occurred up to that point in time) is of special interest.
The Kaplan-Meier estimator is often used to estimate this probability.[22] This method
assumes independence of the time to event and the censoring distribution. In the
presence of competing events, this assumption is violated.
Clinimetrics: Health-Related Quality of Life can be studied at multiple levels. Minimal
Clinically Important Differences (MCIDs), Clinically Important Differences (CIDs) and
Patient Acceptable Symptom States (PASS) are closely related concepts, which could
provide more insight into the patients outcome at the individual level. MCIDs are defined
as the minimal improvement in a specific outcome measure, which is perceived by
patients as beneficial or harmful. The CID constitutes a larger, more clinically relevant
improvement. In PASS, the focus is shifted from the improvement to the actual outcome
achieved.
Questionnaire Mode Preference: Electronic forms of data collection have gained
interest in recent years.[23] Expected advantages include more complete data
capturing, immediate availability of results and less costs in administrating and entering
data.[23, 24] However, electronic questionnaires might induce selection bias, as some
patients could be less inclined to participate in a study which exclusively uses electronic
questionnaires.
The Paprika Study In order to study predictors of clinical outcome in THR and
TKR, we set up the Paprika Study: “Patients Prospectively Recruited in Knee and
Hip Arthroplasty” (CCMO-Nr: NL29018.058.09; MEC-Nr: P09.189; Netherlands Trial
Register: NTR2190). Patients who previously participated in the Trigger Study or the
TOMaat Study, both multicenter randomised controlled trials, were eligible for inclusion
in the Paprika Study. The Trigger Study compared the effect of a restrictive blood
transfusion policy compared to standard care on the red blood cell transfusion rate
after THR and TKR.[25, 26] The TOMaat Study compared the effect of different blood
management modalities on the red blood cell transfusion rate during and after THR and
TKR (Netherlands Trial Register: NTR303). Patients who were willing to participate in
the Paprika Study, were sent a questionnaire and a saliva DNA collection kit.
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In this thesis, we focussed on the improvement in Health-Related Quality of Life after
primary THR and TKR. Therefore, only patients who previously participated in the
TOMaat Study were available for analyses, as Health-Related Quality of Life was not
measured before joint replacement in the Trigger Study. A comprehensive overview of
the study population of each paper, in which data from the Paprika Study was used, is
presented in figure 1.1 on the facing page.
Thesis Overview In chapter 2 (p. 9), we have systematically searched and appraised
the literature to compare the probability of revision surgery at 10 years follow-up for
each THI to the National Institute for Clinical Excellence (NICE) benchmarks. Based on
this systematic review of the literature, we can recommend a number of THI for primary
THR, which outperform NICE benchmarks.
Using data from the Paprika Study, we investigated whether the patients Socio-Economic
Position affects the improvement in HRQoL and satisfaction with the surgical results
in chapter 3 (p. 37). In chapter 4 (p. 55), we investigated whether the preoperative
radiographic severity of OA affects the improvement in HRQoL and satisfaction with the
surgical results, using data from the Paprika Study.
In chapter 5 (p. 71), we assessed how much bias is introduced by the Kaplan-Meier
estimator in a long-term cohort study.
In chapter 6 (p. 81), we performed a systematic review to find studies reporting MCIDs
in HRQoL after primary or revision THR and TKR. In chapter 7 (p. 93), we determined
CIDs in HRQoL after primary THR and TKR, using data from the Paprika Study. In
chapter 8 (p. 105), we determined PASS in joint specific functioning scores after primary
THR and TKR, using data from the Paprika Study.
In chapter 9 (p. 119), we assessed which questionnaire mode THR and TKR patients
preferred in the Paprika Study.
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Background Many total hip implants are currently available on the market worldwide.
We aimed to estimate the probability of revision surgery at ten years for each individual
total hip implant and to compare these estimates with the National Institute for Health
and Care Excellence (NICE) benchmark.
Methods We performed a meta-analysis of cohort studies. The methodological quality
was assessed with use of the Assessment of Quality in Lower Limb Arthroplasty
(AQUILA) checklist. We searched PubMed, EMBASE, Web of Science and the
Cochrane Library. Additionally, National Joint Registries that were full members of
the International Society of Arthroplasty Registers (ISAR) were hand searched. Studies
in which the authors reported the survival probability for either the acetabular or the
femoral component of primary total hip replacements, with at least 100 implants at
baseline, and in which at least 60% of the patients had primary osteoarthritis were
eligible for inclusion.
Results The search strategy revealed 5513 papers describing survival probabilities for
thirty-four types of acetabular components and thirty-two types of femoral components.
Eight types of acetabular cups and fifteen types of femoral stems performed better than
the NICE benchmark.
Conclusions We recommend the surgeons performing a primary total hip replacement
use an implant that outperforms the NICE benchmarks.
Introduction
Total Hip Replacement (THR) is an effective surgical intervention to alleviate pain,
restore functionality of the hip and improve the quality of life of patients with end-stage
degeneration of the hip joint.[1, 21, 27, 28]. Currently, a wide variety of Total Hip
Implants (THI) is available to orthopaedic surgeons worldwide.[29] Many factors, such
as the cost of the implant, familiarity with the design and instruments and ease of use,
influence the choice for a particular THI. Arguably, from both a patient and a societal
perspective, the most important factor is the clinical performance of the total hip implant
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and the probability of revision surgery during a given period of time. Revision hip
arthroplasty is technically challenging with a higher complication rate, a longer hospital
stay, and a higher cost than primary total hip replacement and can lead to disability and
death.[30–34] Clearly, choosing a total hip implant that is associated with the lowest rate
of revision surgery can prevent harm and reduce long-term health-care costs. Recently,
the National Institute for Health and Care Excellence (NICE) suggested a ten-year
revision rate of ≤10% as an acceptable benchmark performance of a primary total hip
implant, which was loosely based on an earlier report by Murray et al.[29, 35]
The objective of our study was to systematically search and appraise the literature
to estimate the probability of revision surgery at ten years for each individual type of
total hip implant. Additionally, we sought to compare the estimates of the probability of
revision surgery for each total hip implant to with NICE benchmark.
Materials and Methods
Protocol and registration This systematic review and meta-analysis was performed
from March 2011 to February 2013, with use of the guidelines of the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-Analyses) Statement for development
of the study protocol and reporting the results of our study.[36]
Eligibility criteria The NICE Technology Appraisal Guidance states: “The evidence
used in support of any prosthesis . . . should relate to data on 10 or more years follow up
from a number of centers, obtained via adequately sized, well conducted observational
studies (preferably with consecutive patients from non-selected populations) or
randomised controlled trials. Such evidence should have been published or be available
for peer review”.[35] Studies in which the authors reported the survival probability (i.e.
the Kaplan-Meier estimate) for either the acetabular or the femoral component of a
primary total hip replacement with use of revision for any reason or for aseptic loosening
at ten years as the end point were eligible for inclusion. We considered studies to be of
adequate size when there were at least 100 implants at baseline, and we defined a study
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population as representative of the general population at large when at least 60% of the
patients had primary osteoarthritis. Studies with fewer than 100 implants at baseline
and in which <60% of the patients had primary osteoarthritis were excluded. Studies
were also excluded when the authors described the outcomes of multiple (sub)types of
implants without reporting the outcomes for each (sub)type separately. Articles written
in any language other than English, Dutch, German, French, Spanish or Italian were not
eligible for inclusion. In order to limit the extent of publication bias, no publication status
restrictions were imposed.
Information sources On March 22, 2011, an experienced independent information
specialist (JWS) searched four electronic databases: PubMed, EMBASE, Web of
Science and the Cochrane Library. We also performed implant-specific PubMed
searches for all primary total hip implants registered in the first annual report of the Dutch
Arthroplasty Register (Landelijke Registratie Orthopaedische Implantaten [LROI]).[8]
Finally, National Joint Registries that were full members of the International Society of
Arthroplasty Registers (ISAR, www.isarhome.org) were hand searched.
Search strategy The following search terms were applied to Pubmed and adapted
for all other databases:
(tha[tw] OR “total hip” OR “total hips” OR ((“total joint” OR “total joints”) AND (hips
OR hip)) OR (total hip AND (prosthesis OR prosthetic OR endoprosthesis OR
endoprostheses OR endoprosthetic OR arthroplasty OR arthroplasties OR replacement
[tiab])) OR (Hip Replacement Arthroplasty AND total [tiab]) OR Hip Replacement
Arthroplasty OR hip arthroplasty OR hip replacement OR Hip Prosthesis) AND
(Osteoarthritis OR Osteoarthritides OR osteoarthriti* OR Osteoarthrosis[tiab] OR
Osteoartroses OR athrosis[tw] OR arthroses OR “Degenerative Arthritis”) NOT (early[tw]
OR initial[tw] OR preliminary[tw] OR “short follow-up”[tw] OR “Letter”[Publication type]
OR “Case Reports”[Publication Type])
Study Selection Two authors (JFM & SDM) independently screened the titles and
abstracts of the search results using pre-specified eligibility criteria, as stated above.
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Two other authors (JCK & FRvT) screened the full text of the remaining articles using the
same eligibility criteria. Disagreements between authors were resolved by consensus.
Data collection process and data items Data collection was performed by two
authors (JCK & FRvT) independently using predefined data extraction sheets.
Inconsistencies between the two authors were resolved by consensus. When data
were not reported numerically, but were presented graphically in Kaplan-Meier curves,
the estimated observations of both authors were averaged. The brand name and
manufacturer of the implant, the Kaplan-Meier estimate at ten years, and its standard
error and 95% confidence interval were extracted from each included study.
Risk of bias in individual studies The methodological quality of all included studies
was assessed using the Assessment of Quality in Lower Limb Arthroplasty (AQUILA)
checklist, a tool specifically designed to appraise the quality of observational studies
concerning total hip replacement and total knee replacement.[37] Two authors (JCK
& FrvT) independently assessed the quality of all included studies, using predefined
data extraction sheets. Inconsistencies between the two authors were resolved by
consensus.
Summary measures and Synthesis of results The principal summary measure was
the survival probability for each implant at 10 years with use of revision for any reason
as the end point. The secondary summary measure was the survival probability for each
implant at 10 years with use of revision for aseptic loosening as the end point. Estimates
of the survival probability in different studies on the same implant were pooled with use
of inverse variance weighting. When no estimate of the variance or standard error of the
survival probability at 10 years was presented, we deduced the missing standard error
from the confidence interval of the survival probability. When the study did not provide
an estimate of the variance or standard error, or a confidence interval, we imputed
the missing standard error from the mean standard error of all other studies.[38, 39]
When >50% of all standard errors were missing, we imputed the missing standard
errors with single imputation on the basis of the survival estimate and the number of
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implants at baseline. We chose this approach instead of a more elaborate modelling
approach[40–42] for two reasons. First, we were interested in the survival probability at
only one specific point in time. Second, the majority of studies that did not provide the
standard error also did not give enough information to allow modelling of the survival
probability.
In order to test whether each implant performed better than the NICE benchmark, we
calculated the confidence interval for each implant survival estimate. The 10-year
revision rate of 10% for a total hip implant corresponds with a survival probability of
90% for a THI. Therefore, the survival probability of a cup or stem should exceed 90%.
Assuming independence of the survival probability for either the cup or the stem, we
can summarise the minimal survival probability with the formula: pcup ∗ pstem ≥ 0.9.
When it is assumed that pcup = pstem, then the minimal survival probability for the cup
is p2cup = 0.9, leading to a minimal cup survival probability of
√
0.9, which is rounded to
95%. Therefore, the survival probability of either the cup or the stem should exceed
95%. When both the survival estimate and the lower limit of the confidence interval
were >95%, we concluded that that particular implant performed significantly better
than the NICE benchmark. When both the survival estimate and the upper limit of the
confidence interval were <95%, we concluded that that particular implant performed
significantly worse than the NICE benchmark. In all other cases, we concluded that
there was insufficient evidence to suggest that the particular implant performs better or
worse than the NICE benchmark.
All analyses were performed with use of R, version 2.15.2.[43]
Source of funding This study was funded by a grant from the Dutch Arthritis
Association (Grant number LLP-13), which had no role in the study design, data
collection, data analysis, data interpretation, or writing of the report. The corresponding
author had full access to all of the data in the study. All authors had final responsibility
for the decision to submit for publication.
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Figure 2.1: Flow-chart of study inclusion.
Results
Study selection Our search strategy revealed 8731 hits: the main search strategy
yielded 7773 hits and the implant-specific search yielded an additional 958 hits (Fig. 2.1).
After removal of duplicate entries, 5513 unique papers remained, and their titles and
abstracts were screened. 4970 papers were excluded, leaving 543 papers eligible
for inclusion. Further assessment of eligibility based on the full-text papers led to the
exclusion of 481 papers: 259 papers did not report the survival probability of a cup or
stem at ten years, and 222 papers did not provide separate results for cups or stems.
Of all national joint registries that were full members of ISAR, only the Swedish Hip
Arthroplasty Register reported separate results for cups and stems at ten years with
revision for any reason as the end point.[44] This left 63 papers for further analysis.
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Study characteristics and Risk of bias Tables 2.1 (p. 22) and 2.2 (p. 23) provide
an overview of the characteristics of all included studies in which the end point was
revision for any reason, and tables 2.3 (p. 24) and 2.4 (p. 25) provide such an overview
for the studies in which the end point was revision for aseptic loosening. The
methodological quality of the studies in which revision for any reason was the end
point is shown in tables 2.5 (p. 26) and 2.6 (p. 27), and the methodological quality
of the studies in which the end point was revision for aseptic loosening is shown in
tables 2.7 (p. 28) and 2.8 (p. 29). We found 41 cohorts for which the ten-year survival
probability of an acetabular cup was described with revision for any reason as the
end point. These studies included a total of 34 different acetabular implants: ABG
1,[45, 46] ABG 2 HA,[44] ACS Triloc+,[47] Arthopor,[47] ATLAS II,[48] ATLAS III,[48]
Charnley,[44, 49] Charnley Elite,[44] CLS Spotorno,[44] Conserve Plus,[50] Exeter All-
Polyethylene,[51] Exeter Duration,[44] Fitmore,[52] Harris Design 2,[53] Harris-Galante
I,[54] Harris-Galante II,[45] Hofer-Imhof,[55] JRI Threaded Cup,[56] Lubinus,[44] Lubinus
Eccentric,[57] Mallory-Head Cementless,[45, 58] Miami Orthopaedic Surgical Clinic:
All Polyethylene,[49] Miami Orthopaedic Surgical Clinic: Metal Backed,[49] Morscher
Press Fit,[59, 60] Mueller,[49] Novae,[61] PCA Pegged,[45] Plasmacup,[62] RM,[63]
Romanus,[45] T28,[49, 64] Trilogy HA,[44] Universal,[45, 65] Zweymuller-Alloclassic
Screw Cup.[66, 67]
42 papers described the ten-year survival probability of 32 different femoral
stem implants with revision for any reason as the end point: ABG 1,[44–
46] Anatomic Mesh,[45] Bicontact,[68] Bi-Metric,[45, 69, 70] Charnley,[44, 71]
CLS Spotorno,[44, 45] Conserve Plus,[50] Corail,[72] Exeter Polished,[44] Exeter
Universal,[73] Freeman Cementless,[74] Furlong,[56] Harvard Femoral Stem,[75]
Heritage,[76] Iowa polished,[76] Lord Madreporique,[45, 77] Lubinus IP,[57, 78]
Lubinus SP,[57, 78] Lubinus SPII,[44] Mallory Head Cemented,[79] Mallory Head
Cementless,[58, 80] MS-30,[59] Omnifit Cemented,[71] Osteonics Cementless,[81]
PCA,[45] Profile Porous,[45] R-B Interlok,[71] SBG,[82] Stanmore Custom Made,[83]
Taperloc,[84] Triumph,[76] Zweymuller SL.[66]
16
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39 papers described the ten-year survival probability of 31 different acetabular cup
implants with revision for aseptic loosening as the end point: ABG 1,[45] ACS Triloc+,[47]
Arthopor,[47] Brunswik,[85] Charnley,[49, 85–87] Charnley All-Polyethylene,[88]
Conserve Plus,[50] Elite Ogee,[73] Exeter,[87] Exeter All-Polyethylene,[51] Fitmore,[52]
Harris Design-2 All-Polyethylene,[89] Harris-Galante II,[45] Hofer-Imhof,[55, 90] JRI
Threaded Cup,[56] Link,[87] Lord Threaded,[77] Mallory-Head Cementless,[45] Miami
Orthopaedic Surgical Clinic: All Polyethylene,[49] Miami Orthopaedic Surgical
Clinic: Metal Backed,[49] Morscher Press Fit,[59, 60] Mueller,[49] PCA Pegged,[45]
Romanus,[45] Spectron,[87] T-28,[49, 64] Titan,[87] Trabecular Metal Monoblock
Acetabular Component System,[91] Universal,[45, 65] Weber Hemispheric,[92]
Zweymuller-Alloclassic Screw Cup.[93, 94]
Finally, we found 52 cohorts in which the ten-year survival probability of 37 different
femoral stem implants was assessed with revision for aseptic loosening as the end
point: ABG 1,[45, 46] Anatomic Mesh,[45] Bi-Metric,[45, 69, 70] Charnley,[71, 87, 95]
Charnley Elite-Plus,[96, 97] Charnley Flat-back,[97] CLS Spotorno,[45] Corail,[72]
Exeter,[87] Exeter Matt,[97] Exeter Universal,[73, 97, 98] Freeman Cemented,[99, 100]
Freeman Cementless,[74, 101] Furlong,[56] Harris Design 2,[89] Harvard Femoral
Stem,[75] Interlok,[97] ITH,[87] Lord Madreporique,[45, 77] Lubinus IP,[97] Lubinus
SP II,[97] Mallory Head Cementless,[58, 80] MS-30,[59] Muller Straight Protasul-10
Cobalt-Nickel-Chromium,[97, 102, 103] Muller Straight Protasul-100 Titanium,[104]
Muller Style Titanium,[105] Omnifit Cemented,[71] Osteonics Cemented,[106] Osteonics
Cementless,[81] PCA,[45] Profile Porous,[45] R-B Interlok,[71] SBG,[82] Stanmore
Custom Made,[83] Taperloc,[65, 84] Titan,[87] Zweymuller Alloclassic.[94]
Synthesis of results An overview of the survival probability for the different implants
is presented in figures 2 through 5. With use of revision for any reason as the end point,
the following acetabular cups performed better than the NICE benchmark: JRI Threaded
Cup, Conserve Plus, Zweymuller-Alloclassic Screw Cup, Charnley Elite, Lubinus, Exeter
Duration, Charnley, T28 (fig. 2.2 (p. 30)). With use of revision for any reason as the
end point, the following femoral stems performed better than the NICE benchmark:
17
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Stanmore Custom Made, MS-30, Iowa Polished, RB Interlok, Taperloc, Corail, Furlong,
SBG, Zweymuller SL, CLS Spotorno, Mallory-Head Cementless, Osteonics Cementless,
Lubinus SPII, ABG 1, Exeter Polished (fig. 2.3 (p. 31)). With use of revision for
aseptic loosening as the end point, the following acetabular cups performed better
than the NICE benchmark: Weber Hemispheric, Trabecular Metal Monoblock Acetabular
Component System, JRI Threaded Cup, Fitmore, Conserve Plus, Morscher Press Fit,
Zweymuller-Alloclassic Screw Cup, Arthropor, ACS Trilok+, Charnley, Titan, Spectron,
Charnley All-polyethylene, Exeter (fig. 2.4 (p. 32)). With use of revision for aseptic
loosening as the end point, the following femoral stems performed better than the
NICE benchmark: ABG 1, Osteonics Cementless, RB Interlok, Zweymuller Alloclassic,
Freeman Cementless, Stanmore Custom Made, MS-30, Corail, Profile Porous, Bimetric,
Mallory-Head Cementless, Taperloc, Omnifit Cemented, Furlong, CLS Spotorno, Harris
Design II, Exeter, Exeter Universal, Titan, Osteonics Cemented, Freeman Cemented,
Charnley, Muller Straight Protasul-10 Cobalt-Nickle-Chromium (fig. 2.5 (p. 33)).
Discussion
In this systematic review and meta-analysis, we estimated the probability of revision
surgery at ten years for 34 types of acetabular cups and 32 types of femoral stems that
were available on the market with published results. Of these implants, 8 acetabular
cups and 15 femoral stems performed better than the NICE benchmark.
Most studies were of low methodological quality: the majority of studies consisted
of non-consecutive cohorts, with more than 5% of the hips lost to follow-up and no
worst-case analysis.
In the past decades, numerous efforts have been made to improve the survival
probability of primary total hip implants. Some efforts, such as the addition of antibiotics
to bone cement,[107] have led to an improvement in survival probability. Others, such
as the introduction of Boneloc R© cement or the 3M Capital Hip System have led to
unprecedented failures, which could have been prevented by phased introduction of
new implants and techniques.[108, 109] Despite subsequent calls for stricter regulation
18
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of new total hip implants,[29, 110] few actions were taken, facilitating the recent disaster
with the ASR hip prosthesis.[111] In providing an overview of all implants that perform
better or worse than the NICE benchmark, we aid practising orthopaedic surgeons
in choosing safe, time-proven implants for primary total hip replacement. Additionally,
our study documents that an astonishing limited number of publications are currently
available.
There are a number of limitations to this study. The description of the type of implant
used in a specific total hip replacement cohort was often limited to the specific brand
name. Some studies, such as the well described one by Franklin et al,[112] included the
results of multiple subtypes of implants, which had undergone major changes in design,
summarized in one survival estimate at 10 years. We excluded studies which did not
specify separate survival estimates for subtypes with substantial changes in design. In
all other papers, we assumed that a single subtype of implant was used for all patients.
Additionally, the NICE benchmarks were poorly defined, leaving much room for
interpretation.[35] The recommendation to use a ten-year revision rate of 10% as
a threshold does not specify a particular end point — e.g. aseptic loosening or revision
for any reason. Additionally, it is unclear whether this revision rate should include the
acetabular or femoral component or both implants. Furthermore, no guidance is given
regarding the statistical methods to use for outlier detection. Finally, the guidelines do
not define “adequately sized” or “well conducted” studies. In order to err on the side of
caution, we chose revision for any reason instead of revision for aseptic loosening as the
primary outcome measure. Aseptic loosening is considered the principal mechanism
of failure at the time of long-term follow-up, is slowly progressive and causes disabling
pain.[113] Especially in the case of focal osteolysis, an implant might appear solidly fixed
at revision surgery, despite moving up to 1 mm relative to the surrounding bone.[114] In
order to minimise the risk of misclassification bias (e.g. misclassifying cases of aseptic
loosening as cases revised for persistent pain after joint replacement), we chose to
use revision for any reason as the principal outcome measure.[115] On the basis of our
clinical judgement, we defined the revision rate of 10% as referring to the combination of
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both implants and defined “adequately sized” as a minimum of 100 implants at baseline.
No competing risk analyses were performed in any of the included cohorts. It is highly
unlikely that no competing events, such as the death of a patient, have taken place
within 10 years after primary THR. Disregarding these competing events leads to
an underestimation of the survival probability.[116] Therefore, some implants might
outperform the NICE benchmark in reality but not appear to do so on the basis of their
survival estimates because of unrealistic statistical assumptions.
In our analyses, we assumed that the case mix of all studies was similar. Regarding one
of the most important characteristics— namely, the indication for joint replacement— this
was certainly the case, as this was one of the inclusion criteria. Other characteristics,
such as age, sex, physical activity, and number of co-morbidities were not recorded and
might have differed among the cohorts. Some patient characteristics, such as age and
sex, are easily identified in most studies. Others, such as physical activity and number
of co-morbidities are not uniformly measured if they are measured at all. Because there
is no current consensus on relevant case-mix variables,[37] we decided to omit these
variables from this systematic review.
Finally, the majority of the survival estimates were based on a single study, performed
in a single center. This raises the question of whether the survival rates presented in
this meta-analysis represent the actual survival rates of these implants. In the unlikely
case of extreme publication bias, an implant might appear to outperform the NICE
benchmark in the only published study, while performing worse in the unpublished reality.
Extreme negative publication bias is also theoretically possible. Surgeons who notice
poor results using a certain prosthesis might be more inclined to report their results,
as a general warning, than are surgeons who notice acceptable results. In the case
of extreme negative publication bias, an implant might appear to perform worse than
the NICE in the only published study, while performing better in the unpublished reality.
It is difficult to study the effect of publication bias in this meta-analysis. Conventional
methods such as funnel plots would fail in this case, as it would be pointless to make a
funnel plot for an implant for which there was only one estimate and therefore only one
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point. A sensible approach is to interpret estimates based on the experience at a single
center with more caution, especially if those centers were involved in the design of the
implant.[117]
A wide variety of implants is available to orthopaedic surgeons worldwide, but there
is a very limited amount of evidence for some of these implants. In the European
Union, there is a single organisation for the approval of drugs— the European Medicines
Agency, which demands evidence of safety and efficacy in controlled trials. In contrast,
for medical devices such as an orthopaedic implant, it is only necessary to obtain
a European Conformity (Conformité Européenne (CE)) mark, which requires limited
or no evidence of clinical efficacy.[118] Since the introduction of Charnley’s total hip
replacement in the late 1950s, new successful total hip replacement implants have been
designed, lowering the probability of revision surgery. However, recent problems with
several hip prostheses have illustrated that patient safety can be at risk when new total
hip replacement implants are developed.[119, 120] We encourage the development of
new implants but not at the cost of patient safety.[121] Therefore, the development of
new implants should take place in the setting of comparative clinical studies. Ideally,
results of experimental implants should be compared with results of implants that
outperform the NICE benchmark. To provide access to innovative treatments while
ensuring evidence is collected, health-care funders need to implement a payment-with-
evidence-development approach.[122]
The use of optimally performing total hip implants is possible despite older and more
recent disasters with certain hip implants. It is the surgeon who has to decide which
implant will provide the best quality for his or her specific patient. The current study
underscores that there is evidence in the literature, but that evidence has to be used.
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ABG 1 [45] Howmedica Finland 108
ABG 1 [46] Howmedica Wales 100
ABG II HA [44] n.s. Sweden 213
ACS Triloc+ [47] DePuy USA 394
Arthopor [47] Joint Medical Products USA 433
ATLAS II [48] n.s. France 171
ATLAS III [48] n.s. France 126
Charnley [49] Thackrey USA 238
Charnley [44] n.s. Sweden 23272
Charnley Elite [44] n.s. Sweden 9456
CLS Spotorno [44] n.s. Sweden 1169
Conserve Plus [50] Wright Medical Technology USA 100
Exeter All-Polyethylene [51] Stryker UK 263
Exeter Duration [44] n.s. Sweden 11712
Fitmore [52] Sulzer UK 119
Harris Design 2 [53] Howmedica Sweden 126
Harris-Galante I [54] Zimmer Denmark 324
Harris-Galante II [45] Zimmer Finland 277
Hofer-Imhof [55] n.s. Austria 678
JRI Threaded Cup [56] JRI UK 112
Lubinus [44] n.s. Sweden 76047
Lubinus Eccentric [57] Waldemar-Link Finland 444
Mallory-Head Cementless [45] Biomet Finland 110
Mallory-Head Cementless [58] Biomet Canada 307
MOSC1: All Polyethylene [49] Biomet USA 100
MOSC1: Metal Backed [49] Biomet USA 134
Morscher Press Fit [59] Zimmer Switzerland 124
Morscher Press Fit [60] Sulzer New Zealand 125
Mueller [49] Depuy International Ltd USA 141
Novae [61] SERF France 135
PCA Pegged [45] Howmedica Finland 122
Plasmacup [62] B Braun Ltd UK 318
RM [63] Mathys Netherlands 630
Romanus [45] Biomet Finland 114
T28 [49] Zimmer USA 559
T28 [64] Zimmer USA 132
Trilogy HA [44] n.s. Sweden 1196
Universal [45] Biomet Finland 898
Universal [65] Biomet USA 114
ZA2 Screw Cup [66] Sulzer Germany 320
ZA2 Screw Cup [67] Sulzer Germany 139
Table 2.1: Study Characteristics of all included Studies, describing the Survival
Probability of Acetabular Cups for Revision Any Reason. n.s.: not specified.
1: Miami Orthopaedic Surgical Clinic. 2: Zweymuller-Alloclassic.
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ABG 1 [45] Stryker Finland 390
ABG 1 [46] Howmedica UK 100
ABG 1 [44] n.s. Sweden 370
Anatomic Mesh [45] Zimmer Finland 135
Bicontact [68] B.Braun-Aesculap Germany 250
Bi-Metric [69] Biomet Sweden 115
Bi-Metric [45] Biomet Finland 1982
Bi-Metric [70] Biomet USA 129
Charnley [71] Johnson & Johnson USA 160
Charnley [44] n.s. Sweden 23272
CLS Spotorno [45] Sulzer-medica Finland 108
CLS Spotorno [44] n.s. Sweden 1169
Conserve Plus [50] Wright Medical Technology USA 100
Corail [72] DePuy France 120
Exeter Polished [44] n.s. Sweden 11712
Exeter Universal [73] Howmedica UK 230
Freeman Cementless [74] Finsbury Instruments UK 100
Furlong [56] JRI UK 134
Harvard Femoral Stem [75] Harvard Health Care UK 269
Heritage [76] Zimmer USA 283
Iowa polished [76] Zimmer USA 120
Lord Madreporique [45] Benoist Girard Finland 286
Lord Madreporique [77] Benoist Girard Norway 116
Lubinus IP [78] Waldemar Link Finland 280
Lubinus IP [57] Waldemar Link Finland 257
Lubinus SP [78] Waldemar Link Finland 263
Lubinus SP [57] Waldemar Link Finland 185
Lubinus SPII [44] n.s. Sweden 76047
Mallory Head Cemented [79] Biomet USA 102
Mallory Head Cementless [80] Biomet USA 2000
Mallory Head Cementless [58] Biomet Canada 307
MS-30 [59] Zimmer Switzerland 124
Omnifit Cemented [71] Osteonics USA 305
Osteonics Cementless [81] Stryker USA 226
PCA [45] Howmedica Finland 111
Profile Porous [45] Depuy Finland 115
R-B Interlok [71] Biomet USA 235
SBG [82] Plus Orthopaedics Austria 230
Stanmore Custom Made [83] Depuy Italy 129
Taperloc [84] Biomet USA 129
Triumph [76] Zimmer USA 148
Zweymuller SL [66] Zimmer Germany 320
Table 2.2: Study Characteristics of all included Studies, describing the Survival
Probability of Femoral Stems for Revision Any Reason. n.s.: not specified.
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ABG 1 [45] Howmedica Finland 108
ACS Triloc+ [47] DePuy USA 394
Arthopor [47] Joint Medical Products USA 433
Brunswik [85] n.s. Sweden 151
Charnley [86] DePuy Norway 9186
Charnley [85] n.s. Sweden 204
Charnley [87] n.s. Norway 14842
Charnley [49] Thackrey USA 238
Charnley All-Polyethylene [88] Zimmer USA 193
Conserve Plus [50] Wright Medical Technology USA 100
Elite Ogee [73] DePuy UK 218
Exeter [87] n.s. Norway 3934
Exeter All-Polyethylene [51] Stryker UK 263
Fitmore [52] Sulzer UK 119
Harris Design-2
All-Polyethylene
[89] Howmedica Canada 195
Harris-Galante II [45] Zimmer Finland 277
Hofer-Imhof [90] Smith and Nephew Austria 100
Hofer-Imhof [55] n.s. Austria 678
JRI Threaded Cup [56] JRI UK 134
Link [87] n.s. Norway 413
Lord Threaded [77] Benoist Girard Norway 116
Mallory-Head Cementless [45] Biomet Finland 110
MOSC1: All Polyethylene [49] Biomet USA 100
MOSC1: Metal Backed [49] Biomet USA 134
Morscher Press Fit [59] Zimmer Switzerland 124
Morscher Press Fit [60] Sulzer New Zealand 125
Mueller [49] Depuy USA 141
PCA Pegged [45] Howmedica Finland 122
Romanus [45] Biomet Finland 114
Spectron [87] n.s. Norway 2019
T-28 [64] Zimmer USA 132
T-28 [49] Zimmer USA 559
Titan [87] n.s. Norway 3205
Trabecular Metal Monoblock
ACS2
[91] Zimmer Greece 156
Universal [45] Biomet Finland 898
Universal [65] Biomet USA 123
Weber Hemispheric [92] Hoechst Netherlands 315
ZA3 Screw Cup [93] Zimmer Netherlands 135
ZA3 Screw Cup [94] Sulzer France 200
Table 2.3: Study Characteristics of all included Studies, describing the Survival
Probability of Acetabular Cups for Revision Aseptic Loosening. n.s.: not specified.
1: Miami Orthopaedic Surgical Clinic. 2: Acetabular Component System. 3: Zweymuller-
Alloclassic.
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ABG 1 [45] Stryker Finland 390
ABG 1 [46] Howmedica UK 100
Anatomic Mesh [45] Zimmer Finland 135
Bimetric [69] Biomet Sweden 104
Bimetric [45] Biomet Finland 1982
Bimetric [70] Biomet USA 105
Charnley [95] Thackray Japan 405
Charnley [87] n.s. Norway 14842
Charnley [71] Johnson & Johnson USA 160
Charnley Elite-Plus [96] Depuy Sweden 114
Charnley Elite-Plus [97] Johnson & Johnson Finland 885
Charnley Flat-back [97] Johnson & Johnson Finland 925
CLS Spotorno [45] Sulzer-medica Finland 108
Corail [72] DePuy, France France 120
Exeter [87] n.s. Norway 3934
Exeter Matt [97] Stryker Finland 876
Exeter Universal [97] Stryker Finland 10620
Exeter Universal [73] Howmedica UK 230
Exeter Universal [98] Howmedica UK 142
Freeman Cemented [99] Finsbury Instruments UK 92
Freeman Cemented [99] Finsbury Instruments UK 97
Freeman Cemented [100] Finsbury Instruments Australia 202
Freeman Cementless [101] Finsbury Instruments UK 100
Freeman Cementless [74] Finsbury Instruments UK 100
Furlong [56] JRI UK 134
Harris Design 2 [89] Howmedica Canada 195
Harvard Femoral Stem [75] Harvard Health Care UK 269
Interlok [97] Biomet Finland 581
ITH [87] n.s. Norway 2019
Lord Madreporique [45] Benoist Girard Finland 286
Lord Madreporique [77] Benoist Girard Norway 116
Lubinus IP [97] Link Finland 5790
Lubinus SP II [97] Link Finland 10634
Mallory Head Cementless [80] Biomet USA 2000
Mallory Head Cementless [58] Biomet Canada 307
MS-30 [59] Zimmer Switzerland 124
Muller S PCNC1 [97] Zimmer Finland 2309
Muller S PCNC1 [102] Protek Switzerland 112
Muller S PCNC1 [103] n.s. Switzerland 161
Muller S T2 [104] Protek Germany 203
Muller Style Titanium [105] Lima Slovenia 170
Omnifit Cemented [71] Osteonics USA 305
Osteonics Cemented [106] Osteonics USA 215
Osteonics Cementless [81] Stryker USA 262
PCA [45] Howmedica Finland 111
Profile Porous [45] Depuy Finland 115
R-B Interlok [71] Biomet USA 235
SBG [82] Plus Orthopaedics Austria 230
Stanmore Custom Made [83] Depuy Italy 129
Taperloc [65] Biomet USA 123
Taperloc [84] Biomet USA 129
Titan [87] n.s. Norway 3205
Zweymuller Alloclassic [94] Sulzer-medica France 200
Table 2.4: Study Characteristics of all included Studies, describing the Survival
Probability of Femoral Stems for Revision Aseptic Loosening. n.s.: not specified.



















ABG 1 [45] Yes NC U U ≥20 No
ABG 1 [46] Yes U FC P <20 Yes
ABG II HA [44] Yes NC U P ≥20 No
ACS Triloc+ [47] Yes NC U U ≥20 No
Arthopor [47] Yes NC U U ≥20 No
ATLAS II [48] Yes NC >5% lost U U No
ATLAS III [48] Yes NC >5% lost U U No
Charnley [49] Yes NC U U ≥20 No
Charnley [44] Yes NC U P ≥20 No
Charnley Elite [44] Yes NC U P ≥20 No
CLS Spotorno [44] Yes NC U P ≥20 No
Conserve Plus [50] No NC 5% lost P ≥20 No
Exeter All-Poly1 [51] Yes U ≤5% lost P ≥20 Yes
Exeter Duration [44] Yes NC U P ≥20 No
Fitmore [52] Yes NC ≤5% lost NP ≥20 No
Harris Design 2 [53] Yes C >5% lost P ≥20 No
Harris-Galante I [54] Yes NC ≤5% lost U ≥20 No
Harris-Galante II [45] Yes NC U U ≥20 No
Hofer-Imhof [55] Yes U >5% lost P ≥20 No
JRI Threaded Cup [56] Yes C >5% lost P ≥20 Yes
Lubinus [44] Yes NC U P ≥20 No
Lubinus
Eccentric
[57] Yes U FC NP ≥20 No
Mallory-Head2 [45] Yes NC U U ≥20 No
Mallory-Head2 [58] Yes NC ≤5% lost P ≥20 No
MOSC: All Poly3 [49] Yes NC U U ≥20 No
MOSC: MB4 [49] Yes NC U U ≥20 No
Morscher Press Fit [59] No NC FC P ≥20 No
Morscher Press Fit [60] Yes NC ≤5% lost P ≥20 No
Mueller [49] Yes NC U U ≥20 No
Novae [61] Yes NC ≤5% lost U ≥20 No
PCA Pegged [45] Yes NC U U ≥20 No
Plasmacup [62] Yes NC >5% lost NP ≥20 No
RM [63] Yes U ≤5% lost U U Yes
Romanus [45] Yes NC U U ≥20 No
T28 [49] Yes NC U U ≥20 No
T28 [64] Yes NC ≤5% lost P ≥20 No
Trilogy HA [44] Yes NC U P ≥20 No
Universal [45] Yes NC U U ≥20 No
Universal [65] Yes NC ≤5% lost P ≥20 No
ZA Screw Cup5 [66] Yes NC >5% lost NP ≥20 No
ZA Screw Cup5 [67] No U ≤5% lost U ≥20 No
Table 2.5: Study Quality of all included Studies, describing the Survival
Probability of Acetabular Cups for Revision Any Reason. U: Unknown. C:
Consecutively, NC: Non-Consecutively. FC: Fully Completed. P: Predefined, NP:
Non-Predefined.
1: Exeter All-Polyethylene; 2: Mallory-Head Cementless; 3: Miami Orthopaedic
Surgical Clinic, All Polyethylene; 4: Miami Orthopaedic Surgical Clinic, Metal Backed; 5:
Zweymuller-Alloclassic Screw Cup.
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ABG 1 [45] Yes NC U NP ≥20 No
ABG 1 [46] Yes U FC P <20 Yes
ABG 1 [44] Yes NC U P ≥20 No
Anatomic Mesh [45] Yes NC U NP ≥20 No
Bicontact [68] Yes U ≤5% lost NP ≥20 No
Bi-Metric [69] Yes U ≤5% lost NP ≥20 No
Bi-Metric [45] Yes NC U NP ≥20 No
Bi-Metric [70] Yes U ≤5% lost P ≥20 Yes
Charnley [71] Yes C >5% lost NP ≥20 Yes
Charnley [44] Yes NC U P ≥20 No
CLS Spotorno [45] Yes NC U NP ≥20 No
CLS Spotorno [44] Yes NC U P ≥20 No
Conserve Plus [50] Yes NC ≤5% lost P ≥20 No
Corail [72] Yes U ≤5% lost NP ≥20 No
Exeter Polished [44] Yes NC U P ≥20 No
Exeter Universal [73] Yes U ≤5% lost P ≥20 Yes
Freeman
Cementless
[74] Yes U >5% lost P ≥20 Yes
Furlong [56] Yes C ≤5% lost P ≥20 Yes
Harvard Femoral
Stem
[75] Yes U ≤5% lost NP ≥20 No
Heritage [76] Yes NC U P ≥20 No
Iowa polished [76] Yes NC U P ≥20 No
Lord Madreporique [45] Yes NC U NP ≥20 No
Lord Madreporique [77] Yes C ≤5% lost NP ≥20 No
Lubinus IP [78] Yes NC ≤5% lost P ≥20 No
Lubinus IP [57] Yes NC FC NP ≥20 No
Lubinus SP [78] Yes NC >5% lost P ≥20 No
Lubinus SP [57] Yes NC FC NP ≥20 No
Lubinus SPII [44] Yes NC U P ≥20 No
Mallory Head
Cemented
[79] Yes NC ≤5% lost NP ≥20 No
Mallory Head
Cementless
[80] Yes U >5% lost NP ≥20 No
Mallory Head
Cementless
[58] Yes NC ≤5% lost P ≥20 No
MS-30 [59] Yes U FC P ≥20 No
Omnifit Cemented [71] Yes NC >5% lost NP ≥20 Yes
Osteonics
Cementless
[81] Yes U U NP ≥20 No
PCA [45] Yes NC U NP ≥20 No
Profile Porous [45] Yes NC U NP ≥20 No
R-B Interlok [71] Yes NC >5% lost NP ≥20 Yes
SBG [82] Yes U >5% lost NP ≥20 No
Stanmore
Custom Made
[83] Yes NC FC P ≥20 No
Taperloc [84] Yes U ≤5% lost P ≥20 Yes
Triumph [76] Yes NC U P ≥20 No
Zweymuller SL [66] Yes NC >5% lost NP ≥20 No
Table 2.6: Study Quality of all included Studies, describing the Survival
Probability of Femoral Stems for Revision Any Reason. U: Unknown. C:




















ABG 1 [45] Yes NC U U ≥20 No
ACS Triloc+ [47] Yes NC U U ≥20 No
Arthopor [47] Yes NC U U ≥20 No
Brunswik [85] Yes NC FC NP ≥20 No
Charnley [86] No C ≤5% lost NP ≥20 No
Charnley [85] Yes NC FC NP ≥20 No
Charnley [87] Yes NC ≤5% lost NP ≥20 No
Charnley [49] Yes NC U U ≥20 No
Charnley All-Poly [88] No NC >5% lost U ≥20 No
Conserve Plus [50] No NC ≤5% lost P ≥20 No
Elite Ogee [73] No NC ≤5% lost U U Yes
Exeter [87] Yes NC ≤5% lost NP ≥20 No
Exeter All-Poly [51] Yes U ≤5% lost P ≥20 Yes
Fitmore [52] Yes NC ≤5% lost NP ≥20 No
Harris Design-2
All-Polyethylene
[89] Yes U ≤5% lost P ≥20 No
Harris-Galante II [45] Yes NC U U ≥20 No
Hofer-Imhof [90] Yes NC FC P ≥20 No
Hofer-Imhof [55] Yes U >5% lost P ≥20 No
JRI Threaded Cup [56] Yes C >5% lost P ≥20 Yes
Link [87] Yes NC ≤5% lost NP ≥20 No
Lord Threaded [77] Yes C U P ≥20 Yes
Mallory-Head
Cementless
[45] Yes NC U U ≥20 No
MOSC1: All Poly [49] Yes NC U U ≥20 No
MOSC1: Metal
Backed
[49] Yes NC U U ≥20 No
Morscher Press Fit [59] No NC FC P ≥20 No
Morscher Press Fit [60] Yes NC ≤5% lost P ≥20 No
Mueller [49] Yes NC U U ≥20 No
PCA Pegged [45] Yes NC U U ≥20 No
Romanus [45] Yes NC U U ≥20 No
Spectron [87] Yes NC ≤5% lost NP ≥20 No
T-28 [64] Yes NC ≤5% lost P ≥20 No
T-28 [49] Yes NC U U ≥20 No
Titan [87] Yes NC ≤5% lost NP ≥20 No
Trabecular Metal
Monoblock ACS2
[91] Yes NC FC NP ≥20 No
Universal [45] Yes NC U U ≥20 No
Universal [65] Yes NC ≤5% lost P ≥20 No
Weber Hemispheric [92] Yes U >5% lost U ≥20 Yes
ZA3 Screw Cup [93] Yes U ≤5% lost P ≥20 Yes
ZA3 Screw Cup [94] Yes NC U P ≥20 Yes
Table 2.7: Study Quality of all included Studies, describing the Survival
Probability of Acetabular Cups for Revision Aseptic Loosening. U: Unknown. C:
Consecutively; NC: Non-Consecutively. FC: Fully Completed. P: Predefined; NP: Non-
Predefined.
1: Miami Orthopaedic Surgical Clinic. 2: Acetabular Component System. 3: Zweymuller-
Alloclassic.
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ABG 1 [45] Yes NC U NP ≥20 No
ABG 1 [46] Yes U FC P <20 Yes
Anatomic Mesh [45] Yes NC U NP ≥20 No
Bimetric [69] Yes U ≤5% lost NP ≥20 No
Bimetric [45] Yes NC U NP ≥20 No
Bimetric [70] Yes U ≤5% lost P ≥20 Yes
Charnley [95] No U U NP ≥20 No
Charnley [87] Yes NC U P ≥20 No
Charnley [71] Yes C >5% lost NP ≥20 No
Charnley Elite-Plus [96] Yes NC U P ≥20 No
Charnley Elite-Plus [97] Yes NC U NP ≥20 No
Charnley Flat-back [97] Yes NC U NP ≥20 No
CLS Spotorno [45] Yes NC U NP ≥20 No
Corail [72] Yes U ≤5% lost NP ≥20 No
Exeter [87] Yes NC U P ≥20 No
Exeter Matt [97] Yes NC U NP ≥20 No
Exeter Universal [97] Yes NC U NP ≥20 No
Exeter Universal [73] Yes U ≤5% lost P ≥20 Yes
Exeter Universal [98] Yes U FC NP ≥20 No
Freeman Cemented [99] No U ≤5% lost P ≥20 No
Freeman Cemented [99] No U ≤5% lost P ≥20 No
Freeman Cemented [100] Yes U ≤5% lost NP <20 No
Freeman Cementless [101] Yes U ≤5% lost P ≥20 Yes
Freeman Cementless [74] Yes U >5% lost P ≥20 Yes
Furlong [56] Yes C ≤5% lost P ≥20 No
Harris Design 2 [89] Yes U ≤5% lost P ≥20 No
Harvard Femoral Stem [75] Yes U ≤5% lost NP ≥20 No
Interlok [97] Yes NC U NP ≥20 No
ITH [87] Yes NC U P ≥20 No
Lord Madreporique [45] Yes NC U NP ≥20 No
Lord Madreporique [77] Yes C ≤5% lost NP ≥20 No
Lubinus IP [97] Yes NC U NP ≥20 No
Lubinus SP II [97] Yes NC U NP ≥20 No
Mallory Head Cementless [80] Yes U >5% lost NP ≥20 No
Mallory Head Cementless [58] Yes NC ≤5% lost P ≥20 No
MS-30 [59] Yes U FC P ≥20 No
Muller Straight CNC1 [97] Yes NC U NP ≥20 No
Muller Straight CNC1 [102] Yes NC ≤5% lost NP ≥20 No
Muller Straight CNC1 [103] Yes U ≤5% lost P ≥20 No
Muller Straight Ti2 [104] Yes NC >5% lost NP ≥20 No
Muller Style Titanium [105] Yes NC ≤5% lost P ≥20 No
Omnifit Cemented [71] Yes C >5% lost NP ≥20 No
Osteonics Cemented [106] Yes C >5% lost NP ≥20 No
Osteonics Cementless [81] Yes U U NP ≥20 No
PCA [45] Yes NC U NP ≥20 No
Profile Porous [45] Yes NC U NP ≥20 No
R-B Interlok [71] Yes C >5% lost NP ≥20 No
SBG [82] Yes U >5% lost NP ≥20 No
Stanmore Custom Made [83] Yes NC FC P ≥20 No
Taperloc [65] Yes NC ≤5% lost P ≥20 No
Taperloc [84] Yes U ≤5% lost P ≥20 Yes
Titan [87] Yes NC U P ≥20 No
Zweymuller Alloclassic [94] Yes NC U P ≥20 Yes
Table 2.8: Study Quality of all included Studies, describing the Survival
Probability of Femoral Stems for Revision Aseptic Loosening. 1: Muller Straight
Protasul-10 Cobalt-Nickel-Chromium; 2: Muller Straight Protasul-100 Titanium. 29
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JRI Threaded Cup:   100% (95%−CI: 100−100)
Conserve Plus:   100% (95%−CI: 100−100)
Zweymuller−Alloclassic Screw Cup:   99% (95%−CI: 98−100)
Charnley Elite:   99% (95%−CI: 98−99)
Lubinus:   97% (95%−CI: 97−98)
Exeter Duration:   97% (95%−CI: 96−97)
Charnley:   96% (95%−CI: 96−97)
T−28:   96% (95%−CI: 95−96)
Morscher Press Fit:   98% (95%−CI: 92−100)
Exeter All−Polyethylene:   97% (95%−CI: 92−99)
CLS Spotorno:   96% (95%−CI: 95−98)
Novae:   96% (95%−CI: 90−99)
ATLAS III:   95% (95%−CI: 84−99)
Hofer−Imhof:   95% (95%−CI: 91−97)
Harris−Galante I:   95% (95%−CI: 84−98)
Trilogy HA:   94% (95%−CI: 93−96)
Harris Design−2:   92% (95%−CI: 87−96)
Miami Orthopaedic Surgical Clinic: All Polyethylene:   90% (95%−CI: 78−96)
Arthopor:   92% (95%−CI: 89−94)
RM:   91% (95%−CI: 85−95)
Plasmacup:   91% (95%−CI: 87−94)
ABG II HA:   91% (95%−CI: 86−94)
Lubinus Eccentric:   90% (95%−CI: 86−93)
Mallory−Head Cementless:   90% (95%−CI: 86−92)
ATLAS II:   88% (95%−CI: 81−93)
Harris−Galante II:   87% (95%−CI: 81−91)
ACS Triloc+:   84% (95%−CI: 79−88)
ABG I:   84% (95%−CI: 77−89)
Fitmore:   82% (95%−CI: 76−87)
Mueller:   81% (95%−CI: 72−87)
Universal:   79% (95%−CI: 79−80)
PCA Pegged:   75% (95%−CI: 68−80)
Romanus:   71% (95%−CI: 64−77)
Miami Orthopaedic Surgical Clinic: 
Metal Backed:   60% (95%−CI: 49−70)
0 10 20 30 40 50 60 70 80 90 100
Figure 2.2: Cumulative Survival and 95% Confidence Intervals of Acetabular
Cups at 10 years follow-up, using the endpoint Revision for Any reason. The
vertical line indicates the NICE benchmark; the color of the text indicates whether an
implant performs significantly better (green) or worse (red) than the NICE benchmark.
The size of the points indicates the sample size on which the estimates are based.
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Stanmore Custom Made:   100% (95%−CI: 100−100)
MS−30:   100% (95%−CI: 100−100)
Iowa Polished:   100% (95%−CI: 100−100)
R−B Interlok:   100% (95%−CI: 97−100)
Taperloc:   99% (95%−CI: 98−100)
Corail:   99% (95%−CI: 99−99)
Furlong:   99% (95%−CI: 99−99)
SBG:   99% (95%−CI: 95−100)
Zweymuller SL:   99% (95%−CI: 97−99)
CLS Spotorno:   99% (95%−CI: 98−99)
Mallory−Head Cementless:   99% (95%−CI: 98−99)
Osteonics Cementless:   98% (95%−CI: 95−99)
Lubinus SP II:   98% (95%−CI: 98−98)
ABG I:   98% (95%−CI: 97−98)
Exeter Polished:   97% (95%−CI: 97−98)
Exeter Universal:   97% (95%−CI: 94−99)
Freeman Cementless:   97% (95%−CI: 91−99)
Bicontact:   97% (95%−CI: 94−99)
Heritage:   97% (95%−CI: 92−99)
Lord Madreporique:   96% (95%−CI: 93−98)
Omnifit Cemented:   95% (95%−CI: 91−98)
Triumph:   94% (95%−CI: 90−97)
Lubinus SP:   94% (95%−CI: 90−97)
Profile Porous:   93% (95%−CI: 87−96)
PCA:   93% (95%−CI: 87−96)
Anatomic Mesh:   91% (95%−CI: 83−95)
Charnley:   94% (95%−CI: 94−95)
Bi−Metric:   94% (95%−CI: 94−94)
Conserve Plus:   88% (95%−CI: 80−93)
Lubinus IP:   88% (95%−CI: 85−91)
Mallory−Head Cemented:   84% (95%−CI: 56−95)
Harvard Femoral Stem:   74% (95%−CI: 69−79)
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Figure 2.3: Cumulative Survival and 95% Confidence Intervals of Femoral Stems
at 10 years follow-up, using the endpoint Revision for Any reason. The vertical
line indicates the NICE benchmark; the color of the text indicates whether an implant
performs significantly better (green) or worse (red) than the NICE benchmark. The size
of the points indicates the sample size on which the estimates are based.
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Weber Hemispheric:   100% (95%−CI: 100−100)
Trabecular Metal Monoblock Acetabular Component System:   100% (95%−CI: 100−100)
JRI Threaded Cup:   100% (95%−CI: 100−100)
Fitmore:   100% (95%−CI: 100−100)
Conserve Plus:   100% (95%−CI: 100−100)
Morscher Press Fit:   100% (95%−CI: 100−100)
Zweymuller−Alloclassic Screw Cup:   99% (95%−CI: 96−100)
Arthopor:   99% (95%−CI: 96−99)
ACS Triloc+:   99% (95%−CI: 96−100)
Charnley:   98% (95%−CI: 98−98)
Titan:   98% (95%−CI: 97−99)
Spectron:   98% (95%−CI: 97−99)
Charnley All−Polyethylene:   98% (95%−CI: 95−99)
Exeter:   98% (95%−CI: 97−98)
Link:   100% (95%−CI: 92−100)
T−28:   100% (95%−CI: 87−100)
Harris Design−2 All−Polyethylene:   99% (95%−CI: 82−100)
Hofer−Imhof:   98% (95%−CI: 94−100)
Lord Threaded:   98% (95%−CI: 93−99)
Elite Ogee:   97% (95%−CI: 83−100)
Exeter All−Polyethylene:   97% (95%−CI: 88−99)
Universal:   96% (95%−CI: 94−98)
ABG I:   95% (95%−CI: 91−97)
Harris−Galante II:   94% (95%−CI: 89−97)
Miami Orthopaedic Surgical Clinic: All Polyethylene:   90% (95%−CI: 81−95)
Romanus:   88% (95%−CI: 79−93)
Mallory−Head Cementless:   87% (95%−CI: 84−89)
Mueller:   81% (95%−CI: 73−87)
Brunswik:   80% (95%−CI: 72−86)
PCA Pegged:   76% (95%−CI: 66−84)
Miami Orthopaedic Surgical Clinic: 
Metal Backed: 60% (95%−CI: 2−94)
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Figure 2.4: Cumulative Survival and 95% Confidence Intervals of Acetabular
Cups at 10 years follow-up, using the endpoint Revision for Aseptic Loosening.
The vertical line indicates the NICE benchmark; the color of the text indicates whether
an implant performs significantly better (green) or worse (red) than the NICE benchmark.
The size of the points indicates the sample size on which the estimates are based.
32
CHAPTER 2: WHICH TOTAL HIP?
ABG I:   100% (95%−CI: 100−100)
Osteonics Cementless:   100% (95%−CI: 100−100)
R−B Interlok:   100% (95%−CI: 100−100)
Zweymuller Alloclassic:   100% (95%−CI: 100−100)
Freeman Cementless:   100% (95%−CI: 100−100)
Stanmore Custom Made:   100% (95%−CI: 100−100)
MS−30:   100% (95%−CI: 100−100)
Corail:   100% (95%−CI: 100−100)
Profile Porous:   100% (95%−CI: 100−100)
Bi−Metric:   99% (95%−CI: 98−100)
Mallory−Head Cementless:   99% (95%−CI: 99−99)
Taperloc:   99% (95%−CI: 98−100)
Omnifit Cemented:   99% (95%−CI: 97−100)
Furlong:   99% (95%−CI: 97−100)
CLS Spotorno:   99% (95%−CI: 97−100)
Harris Design−2:   99% (95%−CI: 97−100)
Exeter:   99% (95%−CI: 98−99)
Exeter Universal:   98% (95%−CI: 98−99)
Titan:   98% (95%−CI: 95−99)
Osteonics Cemented:   98% (95%−CI: 95−99)
Freeman Cemented:   97% (95%−CI: 95−98)
Charnley:   97% (95%−CI: 96−97)
Muller Straight Protasul−10 Cobalt−Nickle−Chromium:   96% (95%−CI: 95−97)
SBG:   98% (95%−CI: 95−100)
ITH:   98% (95%−CI: 94−99)
Muller Straight Protasul−100 Titanium:   96% (95%−CI: 92−98)
Lord Madreporique:   95% (95%−CI: 92−97)
Muller Style Titanium:   94% (95%−CI: 87−97)
PCA:   93% (95%−CI: 84−97)
Anatomic Mesh:   92% (95%−CI: 84−96)
Lubinus SP II:   94% (95%−CI: 93−95)
Interlok:   92% (95%−CI: 89−94)
Lubinus IP:   91% (95%−CI: 91−91)
Exeter Matt:   89% (95%−CI: 86−91)
Charnley Flat−back:   88% (95%−CI: 85−90)
Charnley Elite−Plus:   87% (95%−CI: 84−90)
Harvard Femoral Stem:   82% (95%−CI: 75−87)
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Figure 2.5: Cumulative Survival and 95% Confidence Intervals of Femoral Stems
at 10 years follow-up, using the endpoint Revision for Aseptic Loosening. The
vertical line indicates the NICE benchmark; the color of the text indicates whether an
implant performs significantly better (green) or worse (red) than the NICE benchmark.
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Abstract
Introduction Considerable evidence suggests that patients with more advantaged
Socio-Economic Positions undergo Total Hip and Knee Replacement (THR/TKR) more
often, despite having a lower need. We questioned whether more disadvantaged Socio-
Economic Position is associated with an lower improvement in Health-Related Quality
of Life (HRQoL) and a lower patient satisfaction after THR/TKR.
Methods Patients who underwent primary THR/TKR in one academic and three
community hospitals between 2005 and 2009, were eligible for inclusion. The highest
completed levels of schooling were aggregated to index social class. We compared the
improvement in HRQoL and postoperative satisfaction with surgery (measured using the
Short-Form 36 (SF36) and an 11-point numeric rating scale of satisfaction) between the
aggregated groups of highest completed levels of schooling, using linear mixed model
analysis, with center as a random effect and potential confounders (i.e. age, gender,
Body Mass Index and Charnley’s comorbidity classification) as fixed effects.
Results 586 THR patients and 400 TKR patients (40% of all eligible patients) agreed
to participate and completed all questionnaires sufficiently. We found no differences
in HRQoL improvement in any dimension of the SF36 in THR patients. Patients with
a higher completed level of schooling had a larger improvement in role-physical (9.38
points, 95%-CI:0.34–18.4), a larger improvement in general health (3.67 points, 95%-
CI:0.56–6.79) and a smaller improvement in mental health (3.60 points, 95%-CI:0.82–
6.38) after TKR. Postoperative patient satisfaction did not differ between different highest
completed level of schooling groups.
Discussion Completed level of schooling has no effect on the improvement in HRQoL
and patient satisfaction in a Dutch THR population and a small effect in a similar TKR
population. Undertreatment of patients with more disadvantaged Socio-Economic
Position cannot be justified, given the similar improvement in HRQoL and postoperative
level of satisfaction with surgery between the social groups examined.
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Introduction
Total Hip Replacement (THR) and Total Knee Replacement (TKR) are effective surgical
interventions, which alleviate pain and improve Health-Related Quality of Life (HRQoL)
in patients with hip or knee joint degeneration.[1] Although on average patients improve
markedly after THR or TKR, not all patients benefit from these surgeries. Persistent
pain is reported in 9% of THR patients and 20% of TKR patients at long term follow-
up.[11] Additionally, up to 30% of patients are dissatisfied after surgery, with higher
reported dissatisfaction rates for TKR patients.[12–18] Therapeutic options are limited
in patients with persistent pain or dissatisfaction after joint replacement: the outcome
of revision surgery performed without a specific mechanical or physiological indication
is highly unpredictable. Furthermore, revision THR or TKR surgery is associated with
a higher probability of orthopaedic and medical complications. Given the projected
increase of 137% and 601% in the annual number of THR and TKR performed in the
United States in 2030, the absolute number of patients with unfavorable outcomes after
joint replacement is expected to rise, potentially inducing large societal and medical
problems.[123]
Predicting which patient groups are at increased risk of an unfavourable outcome
after joint replacement may provide additional insights in the mechanisms involved and
offer the possibility of intervention in order to optimise the outcome. At the very least,
it allows patients to be well informed of their specific risks and expected gains before
surgery.
People attain unequal societal positions according to their occupation, educational
achievement, income level and status. The Socio-Economic Position (SEP)
encompasses both resource-based measures and prestige-based measures in
determining an individuals position in the socioeconomic hierarchy.[124] The patients
SEP might be a good predictor of a favorable outcome after joint replacement: a more
advantaged SEP is associated with better health,[125] which in turn is associated with
better outcomes after joint replacement surgery.[126, 127] As it does not require any
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invasive or expensive diagnostics, it would be easy to implement in clinical practice. We
therefore questioned whether SEP was associated with the improvement in HRQoL and
satisfaction after THR or TKR. We hypothesised that patients with more advantaged
SEP would have a larger improvement in HRQoL after THR and TKR and a higher
degree of satisfaction with their surgical results.
Methods
The presently reported study is an add-on to a multi-center follow-up study, conducted
at the departments of orthopaedic surgery of the Leiden University Medical Center, the
Slotervaart hospital in Amsterdam, the Albert Schweitzer hospital in Dordrecht and the
Groene Hart hospital in Gouda, the Netherlands, from August 2010 until August 2011
(see Study Time-line in figure 3.1 on the facing page). The study was approved by the
Medical Ethics Committee of the Leiden University Medical Center and the Medical
Ethical Committees of all other participating centers; all patients gave written informed
consent (CCMO-Nr: NL29018.058.09; MEC-Nr: P09.189). This study was registered
in the Netherlands Trial Register (NTR2190). It concerned the clinical follow-up of a
multi-center randomized controlled clinical trial, comparing different blood management
modalities in THR and TKR surgery (Netherlands Trial Register: NTR303). In this trial,
2442 primary and revision hip or knee replacements in 2257 patients were included
between 2004 and 2009 (see Study time line in figure 3.1 on the next page). All patients
who participated in the randomized controlled trial and completed preoperative HRQoL
questionnaires, who underwent primary THR of TKR and who were alive at the time of
inclusion for the present follow-up study were eligible for inclusion. In contrast to the
previous clinical trial, in which joint replacements were the subjects of interest, patients
are the subject of interest in the current study. Patients who participated more than
once in the previous trial, were only allowed to participate once in the current study; the
first joint replacement performed in the previous trial was chosen as the index surgery.
Records of the financial administration of all participating centers were checked in order
to ascertain that all eligible patients were still alive before being approached. All eligible
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Start of Patient Inclusion
in Previous Trial
Start of Patient Inclusion
in Current Study
End of Patient Inclusion
in Previous Trial
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Figure 3.1: Study time line.
patients were first sent an invitation letter signed by their treating orthopaedic surgeon,
an information brochure and a reply card. Patients who did not respond within 4 weeks
after the first invitation were sent another invitation letter. The remaining patients, who
did not respond to this second invitation, were contacted by telephone.
Outcome The improvement in different dimensions of HRQoL and satisfaction with the
surgical results were the outcome measures of interest. Important concepts in HRQoL
are elements of health status that people usually value (e.g. stair climbing) and peoples
rating of the value of their subjective experience of living.[128] In other words, both
objective functioning and subjective well-being should be considered when measuring
HRQoL.[129] We measured HRQoL preoperatively and in the present follow-up study
using the Short-Form 36 (SF36),[130] a health status instrument which includes several
sub-scales related to functioning as well as perceived well-being.[131, 132] The SF36 is
translated and validated in Dutch and allows studying small between-group differences
in HRQoL.[133, 134] The 36 items cover eight domains (physical function, role physical,
bodily pain, general health, vitality, social function, role emotional, and mental health),
for which a sub-scale score is calculated (100 indicating no symptoms and 0 indicating
extreme symptoms). Additionally, these scales are incorporated into two summary
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measures: a Physical Component Summary (PCS) and Mental Component Summary
(MCS). The HRQoL outcome measure was the mean improvement (i.e. the mean of
each patients postoperative sub-scale score minus their preoperative sub-scale score).
At follow-up one question was asked about satisfaction with the result in general,
namely: “How satisfied are you with your hip or knee replacement?”. Such as a single
item has been shown to provide additional insight into the impact of surgery, besides the
measurement of HRQoL.[135] Patient satisfaction with the surgical result was measured
using an 11-point Numeric Rating Scale of Satisfaction (NRSS; 0 indicating completely
dissatisfied, 10 indicating completely satisfied). The satisfaction outcome measure was
the mean NRSS score.
Exposure The follow-up questionnaire contained the following question: “What is
your highest completed level of schooling?”. We have aggregated these levels of
schooling into an approximation of the social classes, on the assumption that level of
schooling indexes the type of qualifications obtained, which in turn indicates the type
of occupations available to the subject and hence their own adult social class. Thus:
University, Higher vocational education and Preparatory higher vocational & scientific
education have been aggregated as indicating the professional and managerial social
classes; Middle vocational education and Preparatory middle vocational education have
been aggregated as indicating the skilled non-manual and manual social classes; and
Lower vocational education, Elementary schooling and No formal education have been
aggregated as indicating the semi- & unskilled manual social classes.
Potential confounders Socio-demographic characteristics collected at baseline in the
trial included: age at joint replacement and gender. Additionally, the following variables
were collected in the questionnaire of the follow-up study: length and weight, in order to
calculate the Body Mass Index (BMI) (<25, 25–30, 30–35, >35) and patient reported
Charnley classification of co-morbidity (Class A: patients in which the index operated hip
or knee are affected only; Class B: patients in which the other hip or knee is affected as
well; Class C: patients with a hip or knee replacement and other affected joints and/or a
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medical condition which affects the patients’ ability to ambulate).[136, 137]
Statistical analysis We performed descriptive analyses of patients baseline
characteristics. In order to investigate the possible extent of self-selection bias, we
compared the age at THR or TKR and gender of participants to non-participants.
Patients with missing preoperative SF36 questionnaires, missing SF36 questionnaires
at follow-up or missing highest level of schooling were excluded from analyses, as we
could not exclude a Missing Not At Random (MNAR) mechanism. Missing values of the
Charnley Co-morbidity Classification and BMI were deemed Missing At Random and
imputed using Multiple Imputations (MI), in order to improve efficiency of the regression
analyses and avert biased regression coefficients. We performed MI (m = 10) using
an Expectation-Maximization algorithm,[138] which is implemented in the Amelia 2
package for R.[139, 140]
We performed regression analyses in each imputed dataset in order to compare the
mean improvement in HRQoL and the mean NRSS between patients from different social
classes, whilst adjusting for confounders. As minimal clinically important differences
(MCIDs) in HRQoL differ between THR patients and TKR patients,[141] we performed
all analyses separately for THR and TKR. Possible confounders are age, gender, BMI
and poly-articular morbidity in both THR and TKR patients. We used the Charnley
classification as a proxy for poly-articular morbidity. As the length of follow-up varies
considerably, we first stratified our data in quartiles of follow-up length for each imputed
dataset. Within each stratum of follow-up length, we performed a multivariate mixed
effect linear regression analysis, with the mean improvement in HRQoL and the mean
NRSS as the dependent variable, the completed level of schooling and confounders as
independent variables and center as a random effect. Stratum-specific mean differences
in HRQoL between the KL grades were pooled using inverse variance weighting in order
to produce an overall estimate of the mean difference in HRQoL for each imputed data-
set. Finally, the m = 10 estimates of the mean differences in HRQoL were combined
into one estimate, according to Rubin.[142]
All analyses were performed using R, version 2.14.0.[43]
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U+HVE+PHVSE: MVE+PMVE: LVE+ES+NFE: All Patients:
n = 100 n = 150 n = 156 n = 406
Age: 62.5 (11.9) 63.8 (10.6) 66.3 (9.4) 64.4 (10.6)
Males: 51.0% 34.7% 35.9% 39.2%
Follow-up period: 3.13 (1.20) 3.19 (1.10) 3.17 (1.10) 3.16 (1.14)
Charnley Class A: 24.2% 20.0% 22.6% 22.0%
Charnley Class B: 12.6% 17.9% 11.6% 14.2%
Charnley Class C: 63.2% 62.1% 65.8% 63.7%
BMI <25: 50.0% 33.8% 27.0% 35.0%
BMI 25–30: 35.1% 41.2% 48.0% 42.4%
BMI 30–35: 12.8% 20.3% 19.1% 18.0%
BMI >35: 2.10% 4.70% 5.90% 4.60%
Table 3.1: Patient Characteristics of THR Patients. U+HVE+PHVSE: University,
Higher Vocational Education and Preparatory Higher Vocational & Scientific Education;
MVE+PMVE: Middle Vocational Education and Preparatory Middle Vocational Education;
LVE+ES+NFE: Lower Vocational Education, Elementary Schooling and No Formal
Education. Values are means (SD), unless stated otherwise.
Results
In the previous trial, 2579 THR and TKR were randomised in 2382 patients; 2442
joint replacements were evaluated. The first joint replacements of the 2382 patients
consisted of 2206 primary THR and TKR and 176 revision THR and TKR. Of these
2206 patients who underwent primary joint replacement, 285 patients did not complete
all preoperative questionnaires and 63 patients died, leaving 1858 patients with primary
joint replacement eligible. 986 patients agreed to participate, of which 668 patients
had returned all questionnaires sufficiently completed (response rate: 40%, figure 1.1
(p. 5)). Non-responding THR patients were on average 3.95 years older than participants
(95%CI: 2.6 – 5.3 years); Non-responding TKR patients were on average 3.31 years
older than participants (95%CI: 2.0 – 4.7 years). The proportion of males was similar in
participants and non-responders. An overview of the patient characteristics is provided
in table 3.1 and 3.2 on the facing page, an overview of preoperative HRQoL is presented
in table 3.3 on the next page for THR patients and 3.4 (p. 46) for TKR patients. Data
on age, gender, highest completed level of schooling, pre- and postoperative SF36,
satisfaction with surgery and length of follow-up was complete for all THR patients and
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U+HVE+PHVSE: MVE+PMVE: LVE+ES+NFE: All Patients:
n = 42 n = 98 n = 122 n = 262
Age: 63.7 (12.7) 67.6 (9.0) 69.2 (9.3) 67.7 (10.0)
Males: 40.5% 35.7% 29.5% 33.6%
Follow-up period: 3.25 (1.20) 3.02 (1.00) 3.28 (1.20) 3.18 (1.13)
Charnley Class A: 14,60% 14.0% 11.7% 13.0%
Charnley Class B: 14.6% 10.8% 10.0% 11.0%
Charnley Class C: 70.6% 75.3% 78.3% 76.0%
BMI <25: 23.7% 13.7% 15.5% 16.1%
BMI 25–30: 47.4% 56.8% 37.9% 46.6%
BMI 30–35: 23.7% 21.1% 26.7% 24.1%
BMI >35: 5.30% 8.40% 19.8% 13.3%
Table 3.2: Patient Characteristics of TKR patients. U+HVE+PHVSE: University,
Higher Vocational Education and Preparatory Higher Vocational & Scientific Education;
MVE+PMVE: Middle Vocational Education and Preparatory Middle Vocational Education;
LVE+ES+NFE: Lower Vocational Education, Elementary Schooling and No Formal
Education. Values are means (SD), unless stated otherwise.
U+HVE+PHVSE: MVE+PMVE: LVE+ES+NFE: All Patients:
n = 100 n = 150 n = 156 n = 406
Physical Functioning 43.0 (20.2) 39.1 (21.7) 39.8 (22.5) 40.3 (21.6)
Role-Physical 38.4 (40.7) 31.7 (39.6) 28.6 (38.1) 32.2 (39.4)
Bodily Pain 44.3 (19.3) 41.7 (20.6) 38.4 (20.7) 41.1 (20.4)
General Health 70.0 (19.9) 69.1 (19.4) 67.6 (19.3) 68.7 (19.5)
Vitality 67.2 (20.7) 59.6 (20.6) 59.5 (22.8) 61.4 (21.7)
Social Functioning 69.0 (22.8) 66.2 (26.6) 63.8 (30.6) 66.0 (27.4)
Role Emotional 79.7 (36.4) 71.1 (41.7) 67.1 (41.7) 71.7 (40.6)
Mental Health 78.9 (15.8) 74.0 (18.1) 73.4 (19.6) 75.0 (18.3)
PCS 38.0 (11.1) 38.5 (9.10) 38.8 (9.40) 38.5 (9.70)
MCS 54.8 (9.30) 51.7 (10.9) 50.9 (11.1) 52.2 (10.7)
Table 3.3: Quality of Life before Total Hip Replacement: A Comparison Between
Patients with different Completed Levels of Schooling. U+HVE+PHVSE: University,
Higher Vocational Education and Preparatory Higher Vocational & Scientific Education;
MVE+PMVE: Middle Vocational Education and Preparatory Middle Vocational Education;
LVE+ES+NFE: Lower Vocational Education, Elementary Schooling and No Formal
Education. Values are means (SD).
all TKR patients. In 20 THR patients and 8 TKR patients, the Charnley classification
was missing; in 12 THR patients and 13 TKR patients, the BMI was missing.
The mean improvement in HRQoL and mean NRSS per completed level of schooling
is shown in table 3.5 (p. 47) for THR patients and table 3.6 (p. 48) for TKR patients.
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U+HVE+PHVSE: MVE+PMVE: LVE+ES+NFE: All Patients:
n = 42 n = 98 n = 122 n = 262
Physical Functioning 40.4 (19.4) 41.3 (19.1) 38.4 (22.1) 39.8 (20.6)
Role-Physical 41.7 (41.9) 40.4 (42.3) 38.1 (42.9) 39.5 (42.4)
Bodily Pain 45.5 (19.4) 45.4 (19.7) 42.2 (21.6) 43.9 (20.6)
General Health 62.5 (19.0) 65.2 (18.7) 59.0 (21.1) 61.9 (20.0)
Vitality 63.2 (18.0) 63.1 (21.2) 57.7 (22.3) 60.6 (21.4)
Social Functioning 72.6 (22.1) 72.2 (23.0) 67.3 (26.3) 70.0 (24.5)
Role Emotional 82.5 (33.1) 74.5 (39.4) 62.0 (44.8) 70.0 (41.8)
Mental Health 79.6 (10.4) 76.4 (15.7) 68.1 (20.3) 73.1 (18.0)
PCS 36.8 (11.8) 40.2 (9.20) 40.8 (9.70) 39.9 (10.0)
MCS 55.5 (7.40) 53.0 (9.50) 48.8 (11.2) 51.5 (10.4)
Table 3.4: Quality of Life before Total Knee Replacement: A Comparison Between
Patients with different Completed Levels of Schooling. U+HVE+PHVSE: University,
Higher Vocational Education and Preparatory Higher Vocational & Scientific Education;
MVE+PMVE: Middle Vocational Education and Preparatory Middle Vocational Education;
LVE+ES+NFE: Lower Vocational Education, Elementary Schooling and No Formal
Education. Values are means (SD).
Adjusted differences in improvement in HRQoL and mean NRSS after joint replacement
per increasing category of completed level of schooling are shown in table 3.7 (p. 49)
for THR patients and table 3.8 (p. 50) for TKR patients. For each increasing completed
level of schooling, THR patients improved 0.88 points more in physical functioning, 3.09
points less in role-physical, 0.60 points less in bodily pain, 0.66 points less in general
health, 1.44 points less in vitality, 0.12 points more in social functioning, 0.34 points
less in role-emotional, 1.35 points less in mental health, 0.17 points less in the physical
component summary and 0.80 points less in the mental component summary; however,
none of these differences reached statistical significance (table 3.7 (p. 49)). For each
increasing completed level of schooling, TKR patients improved 3.64 points more in
physical functioning, 9.38 points more in role-physical, 3.68 points more in bodily pain,
3.67 points more in general health, 1.78 points less in vitality, 0.62 points more in social
functioning, 3.11 points less in role-emotional, 3.60 points less in mental health, 2.74
points more in the physical component summary and 2.08 points less in the mental
component summary; however, only role-physical, general health, mental health, the
physical component summary and the mental component summary reached statistical
significance (table 3.8 (p. 50)). For each increasing completed level of schooling, the
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U+HVE+PHVSE: MVE+PMVE: LVE+ES+NFE:
n = 100 n = 150 n = 156
Physical Functioning 27.8 (23.3 – 32.3) 26.6 (22.4 – 30.7) 24.9 (20.5 – 29.2)
Role-Physical 35.7 (26.6 – 44.7) 40.7 (32.9 – 48.6) 42.3 (35.0 – 49.5)
Bodily Pain 38.0 (33.1 – 42.9) 33.4 (29.3 – 37.6) 38.9 (34.9 – 42.9)
General Health -1.20 (-4.80 – 2.50) -0.70 (-3.70 – 2.30) -0.20 (-3.50 – 3.10)
Vitality 3.40 (0.20 – 6.60) 8.50 (5.80 – 11.3) 6.70 (3.10 – 10.2)
Social Functioning 16.0 (11.3 – 20.7) 18.1 (13.5 – 22.7) 20.0 (15.4 – 24.5)
Role Emotional 5.70 (-2.60 – 13.9) 16.0 (8.80 – 23.2) 11.9 (4.70 – 19.0)
Mental Health 2.10 (-0.60 – 4.80) 6.40 (3.90 – 9.00) 5.90 (3.30 – 8.50)
PCS 12.8 (11.1 – 14.6) 10.8 (9.20 – 12.3) 11.4 (9.80 – 13.0)
MCS -1.60 (-3.40 – 0.30) 1.50 (-0.10 – 3.00) 0.60 (-1.00 – 2.20)
NRS Satisfaction 8.9 (8.6 – 9.3) 8.7 (8.4 – 9.0) 8.6 (8.3 – 8.9)
Table 3.5: Improvement in Health-Related Quality of Life and Satisfaction after
Hip Replacement: A Comparison Between Patients with different Completed
Levels of Schooling. U+HVE+PHVSE: University, Higher Vocational Education
and Preparatory Higher Vocational & Scientific Education; MVE+PMVE: Middle
Vocational Education and Preparatory Middle Vocational Education; LVE+ES+NFE:
Lower Vocational Education, Elementary Schooling and No Formal Education. Values
are means (95%-Confidence Intervals).
NRSS increased 0.1 points for THR patients and 0.0 points for TKR patients. None
of these differences reached statistical significance (table 3.7 (p. 49) and 3.8 (p. 50)).
Adjusted differences in improvement in HRQoL and mean NRSS after joint replacement
between each completed level of schooling category are shown in table 3.9 (p. 51) for
THR patients and table 3.10 (p. 52) for TKR patients. The larger improvement in role-
physical functioning in patients with a higher level of completed schooling is mainly due
to the large difference between patients with Middle Vocational Education or Preparatory
Middle Vocational Education and patients with Lower Vocational Education, Elementary
Schooling or No Formal Education. The larger improvement in general health is constant
across all groups of level of completed schooling. The larger improvement in the Physical
Component Summary Scale in patients with a higher level of completed schooling is
mainly due to the large difference between patients with Middle Vocational Education or
Preparatory Middle Vocational Education and patients with Lower Vocational Education,
Elementary Schooling or No Formal Education. The smaller improvement in mental
health in patients with a higher level of completed schooling is mainly due to the
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U+HVE+PHVSE: MVE+PMVE: LVE+ES+NFE:
n = 42 n = 98 n = 122
Physical Functioning 20.4 (12.4–28.5) 14.0 (8.70–19.3) 10.3 (6.40–14.2)
Role-Physical 31.5 (15.6–47.5) 25.2 (14.4–35.9) 15.6 (7.40–23.7)
Bodily Pain 24.9 (17.6–32.2) 25.5 (19.7–31.2) 21.0 (16.5–25.5)
General Health 4.00 (-0.60–8.60) -1.60 (-5.20–2.10) -3.60 (-6.90—0.30)
Vitality 1.30 (-3.60–6.30) -1.00 (-4.70–2.80) 2.60 (-0.90–6.10)
Social Functioning 11.6 (2.80–20.4) 7.80 (1.80–13.8) 8.80 (4.40–13.2)
Role Emotional 9.50 (-1.50–20.5) 3.40 (-6.30–13.1) 10.9 (2.60–19.2)
Mental Health 3.30 (0.20–6.40) 1.30 (-2.30–4.90) 6.20 (3.40–9.10)
PCS 7.70 (4.20–11.3) 7.00 (4.90–9.00) 4.20 (2.70–5.70)
MCS -0.40 (-3.00–2.20) -1.70 (-3.7–0.30) 1.70 (0.00–3.40)
NRS Satisfaction 8.3 (7.6–9.1) 8.1 (7.6–8.6) 7.9 (7.4–8.4)
Table 3.6: Improvement in Health-Related Quality of Life and Satisfaction after
Knee Replacement: A Comparison Between Patients with different Completed
Levels of Schooling. U+HVE+PHVSE: University, Higher Vocational Education
and Preparatory Higher Vocational & Scientific Education; MVE+PMVE: Middle
Vocational Education and Preparatory Middle Vocational Education; LVE+ES+NFE:
Lower Vocational Education, Elementary Schooling and No Formal Education. Values
are means (95%-Confidence Intervals).
large difference between patients with Middle Vocational Education or Preparatory
Middle Vocational Education and patients with Lower Vocational Education, Elementary
Schooling or No Formal Education. Finally, the smaller improvement in the Mental
Component Summary Scale in patients with a higher level of completed schooling is
mainly due to the large difference between patients with Middle Vocational Education or
Preparatory Middle Vocational Education and patients with Lower Vocational Education,
Elementary Schooling or No Formal Education.
Discussion
Regardless of their completed level of schooling, patients improve in HRQoL and have
a high satisfaction after THR. After TKR, we found that patients with higher completed
levels of schooling had a larger improvement in role-physical functioning, general health
and the Physical Component Summary scale and a smaller improvement in mental
health and the Mental Component Summary scale, although the found differences in
the SF36 subscales were smaller than recently published within-group MCIDs at two-
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Adjusted difference per increasing
Completed Levels of Schooling (95% CI) p-value
Physical Functioning -0.88 (-4.14–2.38) 0.59
Role-Physical 3.09 (-2.89–9.07) 0.31
Bodily Pain 0.60 (-2.70–3.89) 0.72
General Health 0.66 (-1.81–3.13) 0.60
Vitality 1.44 (-1.04–3.92) 0.25
Social Functioning -0.12 (-3.59–3.36) 0.94
Role Emotional 0.34 (-5.31–6.00) 0.90
Mental Health 1.35 (-0.61–3.30) 0.18
Physical Component Summary Scale 0.17 (-1.04–1.38) 0.79
Mental Component Summary Scale 0.80 (-0.42–2.03) 0.20
Numeric Rating Scale of Satisfaction -0.1 (-0.4–0.1) 0.29
Table 3.7: Adjusted Difference in Improvement in Health-Related Quality of Life
and Satisfaction after Hip Replacement: A Comparison Between Patients with
different Completed Levels of Schooling. Negative values indicate a higher mean
improvement in HRQoL after THR in patients with increasing Completed Levels of
Schooling. The mean differences between education level are adjusted for age, sex,
Body Mass Index and Charnley Classification of Comorbidity and stratified for quartiles
of follow-up.
years follow-up.[141] All other dimensions of HRQoL and patient satisfaction showed
no differences between the completed levels of schooling, thereby failing to refute our
hypothesis.
Strengths of our study include the rigorous efforts to minimise confounding and the
generalisability of our study population, due to the multi-center setting and the similarity
of the demographics of our study population to those of large-scaled national joint
registries.[143]
Weaknesses of the study include the low participation rate and the variation in follow-
up period after joint replacement. Although participation rates of 100% are feasible in
small-scaled studies with hard endpoints,[34, 116] participation rates in epidemiological
studies have been steadily declining in the last 30 years.[144] Even sharper declines
have been reported in the past few years.[145] Unfortunately, the participation rate of this
study follows this general trend, and therefore we cannot exclude the presence of self-
selection bias. In order to limit the extent of this bias, we have sent multiple reminders
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Adjusted difference per increasing
Completed Levels of Schooling (95% CI) p-value
Physical Functioning -3.64 (-8.03–0.74) 0.10
Role-Physical -9.38 (-18.4—0.34) 0.04
Bodily Pain -3.68 (-8.39–1.03) 0.13
General Health -3.67 (-6.79—0.56) 0.02
Vitality 1.78 (-1.51–5.08) 0.29
Social Functioning -0.62 (-5.37–4.14) 0.80
Role Emotional 3.11 (-5.07–11.3) 0.46
Mental Health 3.60 (0.82–6.38) 0.01
Physical Component Summary Scale -2.74 (-4.41—1.07) 0.001
Mental Component Summary Scale 2.08 (0.37–3.79) 0.02
Numeric Rating Scale of Satisfaction 0.0 (-0.5–0.4) 0.83
Table 3.8: Adjusted Difference in Improvement in Health-Related Quality of Life
and Satisfaction after Knee Replacement: A Comparison Between Patients with
different Completed Levels of Schooling. Negative values indicate a higher mean
improvement in HRQoL after TKR in patients with increasing Completed Levels of
Schooling. The mean differences between education level are adjusted for age, sex,
Body Mass Index and Charnley Classification of Comorbidity and stratified for quartiles
of follow-up.
and have called all patients who did not answer our reminders and who did not return
the questionnaire. As incentives, we have included an appealing information brochure
in which the primary goals of the follow-up study were explained and a study pen as
a small gift. Additionally, patients were urged to participate by their treating physician.
However, the participation rate alone does not determine the extent of bias present in
any particular study.[145] The difference between participants and nonparticipants is far
more important.[146] As the found differences in demographics were small, it is unlikely
that the study results will be severely biased.
The follow-up period after joint replacement varies between 1.5 and 6 years in this
study (figure 3.1 (p. 41)). Theoretically, this broad range could influence our findings.
In order to exclude this variable, all patients should have been followed for the exact
same amount of time. In our data, we found no clear evidence of a relationship between
the improvement in HRQoL after joint replacement and the follow-up period (See
Appendix S1 and S2 for scatter plots of the improvement in HRQoL as a function of
the follow-up period length, stratified per completed levels of schooling and Appendix
50
CHAPTER 3: SOCIO-ECONOMIC POSITION







Physical Functioning -1.96 (-8.56–4.64) 0.91 (-5.16–6.97) -1.94 (-8.53–4.66)
Role-Physical 6.21 (-5.85–18.3) 2.66 (-8.04–13.4) 6.21 (-5.91–18.3)
Bodily Pain -6.27 (-12.9–0.33) 7.28 (1.69–12.7) -0.33 (-6.94–6.29)
General Health -0.70 (-5.72–4.31) 1.57 (-2.95–6.08) 1.16 (-3.85–6.17)
Vitality 5.11 (0.09–10.1) -1.08 (-5.76–3.61) 3.18 (-1.83–8.19)
Social Functioning -0.50 (-7.57–6.57) 0.85 (-5.72–7.42) -0.34 (-7.37–6.70)
Role Emotional 5.63 (-5.81–17.1) -2.95 (-13.3–7.42) 1.89 (-9.59–13.4)
Mental Health 3.43 (-0.59–7.44) -0.19 (-3.86–3.48) 2.98 (-0.99–6.95)
PCS -1.64 (-4.07–0.79) 1.85 (-0.29–3.99) -0.05 (-2.49–2.38)
MCS 2.69 (0.20–5.19) -0.70 (-2.95–1.55) 1.93 (-0.55–4.41)
NRS Satisfaction -0.3 (-0.8–0.2) 0.1 (-0.3–0.6) -0.3 (-0.9–0.2)
Table 3.9: Adjusted Difference in Improvement in Health-Related Quality of Life
and Satisfaction after Hip Replacement: A Comparison Between Patients with
different Completed Levels of Schooling. U+HVE+PHVSE: University, Higher
Vocational Education and Preparatory Higher Vocational & Scientific Education;
MVE+PMVE: Middle Vocational Education and Preparatory Middle Vocational Education;
LVE+ES+NFE: Lower Vocational Education, Elementary Schooling and No Formal
Education.
* Negative values indicate a higher mean improvement in HRQoL after THR in
U+HVE+PHVSE patients, compared to MVE+PMVE patients. ** Negative values
indicate a higher mean improvement in HRQoL after THR in MVE+PMVE patients,
compared to LVE+ES+NFE patients. *** Negative values indicate a higher mean
improvement in HRQoL after THR in U+HVE+PHVSE patients, compared to
LVE+ES+NFE patients.
The mean differences between education level are adjusted for age, sex, Body Mass
Index and Charnley Classification of Comorbidity and stratified for quartiles of follow-up.
S3 and S4 for scatter plots of the NRSS after surgery as a function of the follow-up
period length, stratified per completed levels of schooling. All appendices are freely
available at: http://dx.plos.org/10.1371/journal.pone.0056785). In order to account for
this range, we stratified our analysis per quartile of follow-up period. Stratifying for an
additional variable inevitably leads to a loss of power, thereby increasing the probability
of a type 2-error. In our analysis, this loss of power was negligible, as unstratified
analyses showed similar results, supporting our conclusions (data not shown). Although
a residual effect of follow-up length within each stratum cannot be excluded, we do not
think this is very plausible, as recent evidence suggests that the improvement in HRQoL
after completion of the initial rehabilitation-period is sustained up to 7 years after joint
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Physical Functioning -5.80 (-15.1–3.53) -2.24 (-9.14–4.65) -7.99 (-17.2–1.26)
Role-Physical -3.37 (-22.5–15.7) -12.2 (-26.5–2.18) -16.5 (-35.4–2.53)
Bodily Pain 1.00 (-9.02–11.0) -6.46 (-14.1–1.20) -6.13 (-16.1–3.81)
General Health -4.84 (-11.4–1.72) -2.84 (-7.88–2.21) -7.64 (-14.2—1.10)
Vitality -0.60 (-7.57–6.36) 3.57 (-1.70–8.83) 2.98 (-3.93–9.89)
Social Functioning -3.22 (-13.4–6.94) 0.87 (-6.47–8.21) -2.09 (-12.2–7.94)
Role Emotional -1.26 (-18.8–16.2) 5.73 (-7.79–19.3) 4.49 (-12.8–21.8)
Mental Health -0.80 (-6.69–5.08) 5.84 (1.11–10.6) 6.32 (0.53–12.1)
PCS -1.36 (-4.90–2.18) -3.42 (-6.04—0.80) -5.04 (-8.56—1.52)
MCS 0.03 (-3.63–3.70) 3.04 (0.19–5.88) 3.58 (-0.03–7.19)
NRS Satisfaction 0.2 (-0.8–1.1) -0.1 (-0.8–0.6) -0.1 (-1.0–0.8)
Table 3.10: Adjusted Difference in Improvement in Health-Related Quality of
Life and Satisfaction after Knee Replacement: A Comparison Between Patients
with different Completed Levels of Schooling. U+HVE+PHVSE: University, Higher
Vocational Education and Preparatory Higher Vocational & Scientific Education;
MVE+PMVE: Middle Vocational Education and Preparatory Middle Vocational Education;
LVE+ES+NFE: Lower Vocational Education, Elementary Schooling and No Formal
Education. PCS: Physical Component Summary Scale; MCS: Mental Component
Summary Scale; NRS: Numeric Rating Scale.
* Negative values indicate a higher mean improvement in HRQoL after TKR in
U+HVE+PHVSE patients, compared to MVE+PMVE patients. ** Negative values
indicate a higher mean improvement in HRQoL after TKR in MVE+PMVE patients,
compared to LVE+ES+NFE patients. *** Negative values indicate a higher mean
improvement in HRQoL after TKR in U+HVE+PHVSE patients, compared to
LVE+ES+NFE patients.
The mean differences between education level are adjusted for age, sex, Body Mass
Index and Charnley Classification of Comorbidity and stratified for quartiles of follow-up.
replacement surgery.[147, 148] The minimum follow-up period is well beyond the length
of the expected rehabilitation-period, suggested by a recently published systematic
review.[149]
Two other studies have investigated the relation between SEP and patient-reported
outcomes after THR or TKR.[150, 151] Allen Butler et. al. have studied this relation in a
randomised controlled trial, which compared two THR designs.[150] In this study, the
effect of SEP was studied on a multitude of outcome measures, including the WOMAC,
Short Form-12 (SF12) and degree of patient satisfaction. An association was found
between lower levels of education and a degree of satisfaction which was “less than
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very satisfied”. Unfortunately, the authors have only reported their significant findings;
differences in WOMAC or SF12 between social classes are not reported. A dditionally,
only p-values are reported instead of mean differences or relative risks, precluding
any judgment on the clinical relevance of their findings. Finally, it is unclear for which
factors any associations were adjusted, as the authors applied forward stepwise logistic
regression modeling, without mentioning which variables were included in the final
model. Davis et. al. have measured WOMAC scores before surgery and at 3, 12
and 24 months after TKR.[151] Whilst comparing WOMAC scores at each time point
between patients of different income categories, patients with more disadvantaged SEP
had worse preoperative WOMAC scores and similar postoperative WOMAC scores as
patients with less disadvantaged SEP. These findings imply a larger improvement in
disease-specific quality of life in patients with more disadvantaged SEP than in patients
with less disadvantaged SEP. However, not all patients were measured at each time
point. A cross-sectional comparison at each time point precludes judgment on the actual
within-patient improvement in disease-specific quality of life.
Due to methodological shortcomings of both other studies which investigated the relation
between SEP and patient-reported outcomes after joint replacement, no meaningful
comparison of results can be made.
Our findings have large implications for policymakers, as a more advantaged SEP
is associated with greater use of health services in general.[125] A recent systematic
review and numerous studies indicate that this also holds for THR[152–161] and
TKR[152, 156–158, 160–162] in post-industrialised countries. Additionally, the need
for joint replacement appears to be higher in patients with more disadvantaged
SEP,[158, 161, 162] thereby increasing the inequity in access to joint replacement.
Undertreatment of patients with more disadvantaged SEP cannot be justified, given
the similar improvement in HRQoL and postoperative level of satisfaction with surgery
between the examined groups of completed level of schooling.
53
PART II: PATIENT AND SURGEON FACTORS
A number of factors might explain the found differences in improvement in HRQoL after
between THR and TKR patients per completed level of schooling groups. Biomechanical
factors might play a role. The hip joint is a relatively simple ball and socket joint, which is
adequately mimicked by a THR. The adequate mimicry of the biomechanics is reflected
in a highly consistent improvement in HRQoL, regardless of completed level of schooling.
The biomechanical aspects of the knee joint are more difficult to imitate, as the knee is
a pivotal hinge joint with 6 degrees of freedom. These degrees of freedom are generally
not restored after TKR, which is substantiated in kinematic and kinetic studies.[163]
However, more complex biomechanics might explain a less consistent improvement in
HRQoL in TKR patients, but does not explain differences between patient groups with
different completed levels of schooling.
Differences between THR and TKR patients might be part of the explanation.
Better general health, physical, emotional and social function, motivation and self-
efficacy and lower levels of pain before surgery and during the rehabilitation period
are associated with improved short- and medium-term outcomes.[11] In our study
population, differences in the preoperative health status between completed level of
schooling groups are more pronounced in TKR patients than in THR patients (table 3.3
(p. 45) and 3.4 (p. 46)). Finally, differences in rehabilitational options could play an
important role. TKR patients require more rehabilitation than THR patients in order to
achieve optimal results.[164] TKR patients with higher completed Level of Schooling
might have better access to physical therapy or other rehabilitational facilities, and
therefore gain more in role-physical functioning and general health than less advantaged
patients. This effect might be exacerbated by the higher prevalence of obesity and
co-morbidity in TKR patients compared to THR patients. Unfortunately, we do not have
any information on the rehabilitational regime of our THR and TKR patients, leaving this
hypothesis to be addressed in future research.
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Abstract
Introduction Although Total Hip and Knee Replacements (THR/TKR) improve Health-
Related Quality of Life (HRQoL) at the group level, up to 30% of patients are dissatisfied
after surgery due to unfulfilled expectations. We aimed to assess whether the pre-
operative radiographic severity of osteoarthritis (OA) is related to the improvement in
HRQoL after THR or TKR, both at the population and individual level.
Methods In this multi-center observational cohort study, HRQoL of OA patients requiring
THR or TKR was measured 2 weeks before surgery and at 2–5 years follow-up, using
the Short-Form 36 (SF36). Additionally, we measured patient satisfaction on a 11-point
Numeric Rating Scale (NRSS). The radiographic severity of OA was classified according
to Kellgren and Lawrence (KL) by an independent experienced musculoskeletal
radiologist, blinded for the outcome. We compared the mean improvement and
probability of a relevant improvement (defined as a patients change score ≥ Minimal
Clinically Important Difference) between patients with mild OA (KL Grade 0–2) and
severe OA (KL Grade 3+4), whilst adjusting for confounders.
Results Severe OA patients improved more and had a higher probability of a relevant
improvement in physical functioning after both THR and TKR. For TKR patients with
severe OA, larger improvements were found in General Health, Vitality and the Physical
Component Summary Scale. The mean NRSS was also higher in severe OA TKR
patients.
Discussion Patients with severe OA have a better prognosis after THR and TKR than
patients with mild OA. These findings might help to prevent dissatisfaction after THR
and TKR by means of patient selection or expectation management.
Introduction
Total Hip Replacement (THR) and Total Knee Replacement (TKR) are effective surgical
interventions, which alleviate pain and improve Health-Related Quality of Life (HRQoL)
in patients with hip or knee joint degeneration at the population level.[1] Although on
average patients improve markedly after THR or TKR, not all patients benefit from
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these surgeries. Persistent pain is reported in 9% of THR patients and 20% of TKR
patients at long term follow-up.[11] Additionally, up to 30% of patients are dissatisfied
after surgery, with higher reported dissatisfaction rates for TKR patients.[12–18] The
relatively high dissatisfaction rate is especially worrying, as the therapeutic options are
limited in dissatisfied patients after joint replacement. Moreover, given the projected
increase in the annual number of THR and TKR performed in the United States, the
absolute number of dissatisfied patients is expected to rise.[165]
Unattained expectations of surgery are thought to play an important role in
dissatisfaction after joint replacement.[12, 13, 15, 166] In order to successfully manage
patient expectations, accurate prediction of the probability of a meaningful improvement
for each individual patient is of paramount importance. This probability can be assessed
at the individual level using the Minimal Clinically Important Difference (MCID), which is
defined as the minimal difference in scores of an outcome measure that is perceived
by patients as beneficial or harmful.[167, 168] MCIDs in HRQoL, measured using the
Short-Form 36, have been established for THR and TKR.[141, 169, 170]
Reports of the effect of the preoperative radiographic severity of osteoarthritis (OA)
on the outcome of THR are conflicting: at the population level, Nilsdotter et al showed
no effect at one year follow-up, while Meding et al found less postoperative pain at one
year follow-up in patients with more preoperative joint space narrowing.[171, 172] At
the individual level, patients with severe preoperative radiographic OA were more likely
to improve in physical functioning.[173] We found no studies addressing the effect of
the preoperative radiographic severity of osteoarthritis (OA) on the outcome of TKR.
From a clinical perspective, the preoperative radiographic severity of OA would be
a helpful predictor of improvement in HRQoL, as it is both inexpensive and performed
routinely for templating purposes. Moreover, the assessment of the severity of
preoperative OA could be standardised, whereas this would be more difficult with
subjective symptoms such as pain.
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We questioned whether the radiographic severity of OA affects the improvement in
HRQoL after THR and TKR, both at the population and individual level. Additionally,
we questioned whether patient satisfaction with the surgical results differed between
patients with mild or severe preoperative radiographical OA.
Methods
We conducted a multi-center follow-up study at the departments of orthopaedic surgery
of the Leiden University Medical Center, the Slotervaart hospital in Amsterdam, the
Albert Schweitzer hospital in Dordrecht and the Groene Hart hospital in Gouda, the
Netherlands, from August 2010 until August 2011.[21] The study was approved by the
Medical Ethics Committee of the Leiden University Medical Center and the Medical
Ethical Committees of all other participating centers; all patients gave written informed
consent (CCMO-Nr: NL29018.058.09; MEC-Nr: P09.189). This study was registered
in the Netherlands Trial Register (NTR2190). It concerned the clinical follow-up of a
multi-center randomized controlled clinical trial, comparing different blood management
modalities in THR and TKR surgery (Netherlands Trial Register: NTR303). In this trial,
2442 primary and revision hip or knee replacements in 2257 patients were included
between 2004 and 2009.
All patients who participated in the randomized controlled trial and completed
preoperative HRQoL questionnaires, who underwent primary THR of TKR for primary
OA and who were alive at the time of inclusion for the present follow-up study were
eligible for inclusion. In this study, patients are the subject of interest. Patients who
participated more than once in the previous trial, were only allowed to participate once in
the current study; the first joint replacement performed in the previous trial was chosen
as the index surgery.
Records of the financial administration of all participating centers were checked in order
to ascertain that all eligible patients were still alive before being approached. All eligible
patients were first sent an invitation letter signed by their treating orthopaedic surgeon,
an information brochure and a reply card. Patients who did not respond within 4 weeks
58
CHAPTER 4: RADIOGRAPHIC OSTEOARTHRITIS
after the first invitation were sent another invitation letter. The remaining patients, who
did not respond to this second invitation, were contacted by telephone.
Assessments The assessments of the follow-up study consisted of patient-reported
questionnaires, examination of patient records and preoperative radiographs.
Outcomes: HRQoL was measured preoperatively and in the present follow-up study
using the SF36, which is translated and validated in the Dutch language.[130, 133]
The 36 items cover eight domains (physical function, role physical, bodily pain, general
health, vitality, social function, role emotional, and mental health), for which a sub-scale
score is calculated (100 indicating no symptoms and 0 indicating extreme symptoms).
Additionally, these scales are incorporated into two summary measures: a Physical
Component Summary (PCS) and Mental Component Summary (MCS).
At the population level, the HRQoL outcome measure was the mean change score, i.e.
the mean of each patients postoperative sub-scale score minus their pre-operative sub-
scale score). At the individual level, the change scores were used to categorise patients
in responders and non-responders, using previously published MCIDs.[141, 169, 170]
Patients with a change score equal to or larger than the MCID of that particular sub-scale
were categorised as a responder; patients whose change score was less than the CID
of that particular sub-scale were categorised as non-responders.
Patient satisfaction with the surgical result was measured using an 11-point Numeric
Rating Scale of Satisfaction (NRSS; 0 indicating completely dissatisfied, 10 indicating
completely satisfied). At the population level, the satisfaction outcome measure was the
mean NRSS score. The proportion of patients who achieved a satisfactory outcome
(defined as a NRSS > 8, according to Brokelman et al[14]) was the satisfaction outcome
measure at the individual level.
Exposure: Pre-operative radiographs of the hips (anterior–posterior) and knees
(posterior–anterior) were collected from the participating patients’ medical records
and radiology department. These radiographs were routinely made in each participating
center for pre-operative templating purposes. All radiographs were assessed by
an experienced musculoskeletal radiologist (HMK), who was blinded for patient
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characteristics and HRQoL assessments. The method of scoring OA followed that
described by Kellgren and Lawrence (KL) (0 indicating no OA, 1 doubtful OA, 2 minimal
OA, 3 moderate OA and 4 indicating severe OA).[174] All radiographs were scored twice:
both readings were used to establish intra-reader reliability (Intra-Class Correlation hip
radiographs: 0.85 (95%CI: 0.82 – 0.88); Intra-Class Correlation knee radiographs: 0.87
(95%CI: 0.83 – 0.89)). The second reading was used for further statistical analyses.
As KL grade 0 to 2 and grade 3 and 4 are deemed similar from a clinical perspective,
we grouped the severity of pre-operative OA in 2 categories: mild radiographic OA (KL
grade 0, 1 or 2) and severe radiographic OA (KL grade 3 or 4).
Potential confounders: Socio-demographic characteristics collected at baseline in
the trial included: age at joint replacement and gender. Additionally, the following
socio-demographic variables were collected in the questionnaire of the follow-up study:
length and weight, in order to calculate the Body Mass Index (BMI) (<25, 25–30, 30–35,
>35) and patient reported Charnley classification of co-morbidity (Class A: patients in
which the index operated hip or knee are affected only; Class B: patients in which the
other hip or knee is affected as well; Class C: patients with a hip or knee replacement
and other affected joints and/or a medical condition which affects the patients’ ability to
ambulate).[136, 137]
Statistical Analysis We performed descriptive analyses of patients baseline
characteristics. In order to investigate the possible extent of self-selection bias, we
compared the age at THR or TKR and gender of participants to non-participants.
Patients with missing pre-operative SF36 questionnaires, missing SF36 questionnaires
at follow-up or missing pre-operative radiographs were excluded from analyses, as we
could not exclude a Missing Not At Random (MNAR) mechanism. Missing values of the
Charnley Co-morbidity Classification and BMI were deemed Missing At Random and
imputed using Multiple Imputations (MI), in order to improve efficiency of the regression
analyses and avert biased regression coefficients. We performed MI (m = 10) using
an Expectation-Maximization algorithm,[138] which is implemented in the Amelia 2
package for R.[139, 140]
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We performed regression analyses in each imputed dataset in order to compare the
mean improvement in HRQoL and the probability of achieving a MCID in HRQoL after
THR and TKR, between patients with KL grade 0, 1 or 2 and grade 3 or 4. As MCIDs
in HRQoL differ between THR patients and TKR patients, we performed all analyses
separately for THR and TKR. Possible confounders are age, gender, BMI and poly-
articular OA in both THR and TKR patients. We used the Charnley classification as
a proxy for poly-articular OA. As the length of follow-up varied considerably, we first
stratified our data in quartiles of follow-up length for each imputed dataset. Within each
stratum of follow-up length, we performed a multivariate mixed effect linear regression
analysis, with the mean improvement in HRQoL and the mean NRSS as the dependent
variable, the KL grade and confounders as independent variables and center as a
random effect. Stratum-specific mean differences in HRQoL between the KL grades
were pooled using inverse variance weighting in order to produce an overall estimate of
the mean difference in HRQoL for each imputed data-set. Finally, the m = 10 estimates
of the mean differences in HRQoL were combined into one estimate, according to
Rubin.[142]
Within each stratum of follow-up length, we also performed a multivariate mixed effect
logistic regression analysis, with the probability of attaining a MCID in HRQoL and
a satisfactory NRSS as the dependent variable, the KL grade and confounders as
independent variables and center as a random effect. Stratum-specific odds ratios of
attaining a MCID in HRQoL between the KL grades were pooled using inverse variance
weighting in order to produce an overall estimate of the odds ratio of attaining a MCID in
HRQoL for each imputed data-set. Finally, the m = 10 estimates of the mean differences
in HRQoL were combined into one estimate, according to Rubin.[142]
All analyses were performed using R, version 2.14.0.[43]
Results
At 2 to 5 years after joint replacement, 723 patients agreed to participate and returned
the questionnaires sufficiently completed (participation rate: 46%, figure 4.1 and 1.1
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Figure 4.1: Study time line.
Kellgren Grade 0–2 Kellgren Grade 3+4 All Patients
Age at Joint Replacement 65.1 (7.8) 67.4 (8.7) 66.6 (8.5)
Males 23.90% 44.30% 37.50%
Follow-up years (SD) 2.83 (1.0) 2.79 (0.9) 2.8 (0.93)
Charnley Class A: 25.8% 24.0% 24.6%
Charnley Class B: 14.6% 13.7% 14.0%
Charnley Class C: 59.6% 62.3% 61.4%
BMI <25: 29.2% 34.1% 32.5%
BMI 25–30: 41.6% 46.4% 44.8%
BMI 30–35: 23.6% 16.2% 18.7%
BMI >35: 5.60% 3.40% 4.10%
Table 4.1: Patient Characteristics of THR Patients.
(p. 5)). Non-participating THR patients were on average 4.32 years older than
participants (95%CI: 2.93 – 5.70 years); Non-participating TKR patients were on
average 2.68 years older than participants (95%CI: 1.28 – 4.09 years). The proportion
of males was similar in participants and non-responders. An overview of the patient
characteristics is provided in table 4.1 and table 4.2 on the facing page. In 13 THR
patients and 7 TKR patients, the Charnley classification was missing; in 9 THR patients
and 11 TKR patients, the BMI was missing. These missing values were imputed using
multiple imputation.
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Kellgren Grade 0–2 Kellgren Grade 3+4 All Patients
Age at Joint Replacement 65.1 (10.3) 69.5 (8.6) 69.1 (8.9)
Males 31.80% 30.90% 31.00%
Follow-up years (SD) 3.1 (1.1) 2.79 (0.9) 2.82 (0.93)
Charnley Class A: 4.50% 19.0% 17.5%
Charnley Class B: 4.50% 11.4% 10.7%
Charnley Class C: 90.9% 69.6% 71.8%
BMI <25: 33.3% 14.7% 16.3%
BMI 25–30: 27.8% 46.7% 45.0%
BMI 30–35: 33.3% 21.2% 22.3%
BMI >35: 5.60% 17.4% 16.3%
Table 4.2: Patient Characteristics of TKR Patients.
The mean improvement in HRQoL and mean NRSS per KL grade is shown in table 4.3
on the next page for THR patients and table 4.4 (p. 65) for TKR patients. In THR, patients
with severe radiographic OA had a larger improvement in Physical Functioning than
patients with mild radiographic OA. The improvement in other domains of HRQoL
and the mean NRSS was similar for THR patients of all severities of radiographic OA.
In TKR, patients with severe radiographic OA had a larger improvement in Physical
functioning than patients with mild radiographic OA. Additionally, patients with severe
radiographic OA had a larger improvement in General Health, a larger improvement in
the Physical Component Summary Scale and a higher NRSS than patients with mild
radiographic OA. The crude probabilities of achieving a MCID in each dimension of
HRQoL are presented in table 4.5 (p. 66) for THR patients and table 4.6 (p. 67) for
TKR patients. In THR, the probability of achieving a relevant improvement in Physical
Functioning was higher in patients with severe radiographic OA than in patients with
mild radiographic OA. The probability of achieving a satisfactory outcome was also
higher in patients with severe radiographic OA than in patients with mild radiographic
OA. The probability of achieving a relevant improvement in other domains of HRQoL
was similar for THR patients of all severities of radiographic OA. In TKR, the probability
of achieving a relevant improvement in Physical Functioning was higher in patients with
severe radiographic OA than in patients with mild radiographic OA. Additionally, the
probability of achieving a relevant improvement in General Health and the probability of
63
PART II: PATIENT AND SURGEON FACTORS








Physical Functioning 19.2 (14.2 – 24.1) 26.2 (22.4 – 30.0) 8.93 (2.14 – 15.7) 0.01
Role-Physical 36.3 (26.7 – 45.9) 42.2 (35.4 – 48.9) 6.39 (-5.89 – 18.7) 0.31
Bodily Pain 35.9 (30.4 – 41.3) 36.5 (32.8 – 40.2) 0.88 (-6.08 – 7.84) 0.80
General Health 0.60 (-3.50 – 4.60) -1.50 (-4.50 – 1.50) -0.66 (-5.66 – 4.34) 0.79
Vitality 9.30 (5.00 – 13.5) 3.70 (0.80 – 6.70) -3.53 (-9.03 – 1.97) 0.21
Social Functioning 19.4 (13.6 – 25.2) 14.6 (10.7 – 18.4) -4.11 (-11.2 – 2.97) 0.25
Role Emotional 6.90 (-1.10 – 14.9) 11.3 (4.70 – 17.8) 3.11 (-8.22 – 14.4) 0.59
Mental Health 7.20 (4.00 – 10.5) 4.60 (2.10 – 7.10) -1.80 (-6.13 – 2.50) 0.41
PCS 10.7 (8.70 – 12.6) 11.2 (9.90 – 12.6) 1.94 (-0.57 – 4.44) 0.13
MCS 1.50 (-0.40 – 3.40) -0.50 (-1.80 – 0.90) -2.03 (-4.46 – 0.39) 0.10
NRS Satisfaction 8.5 (8.0 – 8.9) 8.9 (8.6 – 9.2) 0.3 (-0.2 – 0.9) 0.19
Table 4.3: Improvement in Health-Related Quality of Life and Satisfaction after
Hip Replacement: A Comparison Between Patients with Mild to Moderate and
Severe Radiographical Pre-Operative Osteoarthritis. Positive values indicate a
higher mean improvement in HRQoL after THR in patients with Kellgren Grade 3+4,
compared to Grade 0–2. The mean differences between radiographic severity are
adjusted for age, sex, Charnley Comorbidity Classification and BMI and stratified for
quartiles of follow-up.
achieving a satisfactory outcome was also higher in patients with severe radiographic
OA than in patients with mild radiographic OA.
Discussion
At the population level, patients with severe radiographic OA improve more in Physical
Functioning than patients with mild radiographic OA, both for THR and TKR. At the
individual level, THR and TKR patients with severe radiographic OA have a larger
probability of a relevant improvement in Physical Functioning than patients with mild
radiographic OA. The effects of the preoperative severity of radiographic OA on Physical
Functioning are more pronounced in TKR patients than in THR patients. Other
domains of HRQoL do not appear to be influenced by the preoperative severity of
OA, except General Health and the Physical Component Summary Scale in TKR
patients. Additionally, patient satisfaction appears to be better in patients with more
severe preoperative radiographic OA.
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Physical Functioning -2.10 (-10.5 – 6.30) 15.1 (11.7 – 18.5) 19.1 (8.48 – 29.7) <0.001
Role-Physical 9.10 (-11.9 – 30.1) 20.6 (-13.5 – 27.7) 17.4 (-6.32 – 41.1) 0.15
Bodily Pain 14.5 (3.50 – 25.5) 25.2 (21.5 – 29.0) 9.02 (-3.43 – 21.5) 0.15
General Health -9.10 (-16.9 – -1.30) -1.50 (-3.80 – 0.80) 9.23 (1.31 – 17.2) 0.02
Vitality -5.40 (-13.0 – 2.30) 1.20 (-1.40 – 3.80) 8.44 (-0.28 – 17.2) 0.06
Social Functioning 2.80 (-8.00 – 13.6) 8.90 (5.40 – 12.4) 7.44 (-4.18 – 19.1) 0.21
Role Emotional 4.50 (-17.5 – 26.6) 5.80 (-0.60 – 12.1) 8.87 (-11.8 – 29.6) 0.40
Mental Health 3.40 (-4.00 – 10.8) 3.00 (0.80 – 5.10) 0.29 (-6.93 – 7.50) 0.94
PCS 1.50 (-2.90 – 6.00) 6.40 (5.10 – 7.70) 5.64 (1.26 – 10.0) 0.01
MCS 0.10 (-4.30 – 4.40) -0.30 (-1.60 – 1.00) -0.18 (-4.45 – 4.10) 0.94
NRS Satisfaction 7.4 (6.1 – 8.6) 8.2 (7.9 – 8.6) 1.2 (0.1 – 2.4) 0.04
Table 4.4: Improvement in Health-Related Quality of Life and Satisfaction after
Knee Replacement: A Comparison Between Patients with Mild to Moderate and
Severe Radiographical Pre-Operative Osteoarthritis. Positive values indicate a
higher mean improvement in HRQoL after TKR in patients with Kellgren Grade 3+4,
compared to Grade 0–2. The mean differences between radiographic severity are
adjusted for age, sex, Charnley Comorbidity Classification and BMI and stratified for
quartiles of follow-up.
Limitations of the study include the participation rate and range of follow-up period
after joint replacement. Although participation rates of 100% are feasible in small-scaled
studies with hard endpoints,[34, 116] participation rates in epidemiological studies have
been steadily declining in the last 30 years.[144] Even sharper declines have been
reported in the past few years.[145] Unfortunately, the participation rate of this study
follows this general trend, resulting in a participation rate of 46%. Therefore, we cannot
exclude the presence of self-selection bias. In order to limit the extent of this bias,
we have sent multiple reminders and have called all patients who did not answer our
reminders and who did not return the questionnaire. As incentives, we have included
an appealing information brochure in which the primary goals of the follow-up study
were explained and a study pen as a small gift. Additionally, patients were urged to
participate by their treating physician. However, the participation rate alone does not
determine the extent of bias present in any particular study.[145] The difference between
participants and non-participants is far more important.[146] As the found differences in
demographics were of little clinical relevance, it is unlikely that the study results will be
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Physical Functioning 64 / 92: 69.6% 146 / 185: 78.9% 1.87 (0.97 – 3.60) 0.06
Role-Physical 55 / 92: 59.8% 124 / 185: 67.0% 1.50 (0.82 – 2.72) 0.19
Bodily Pain 71 / 92: 77.2% 141 / 185: 76.2% 1.03 (0.52 – 2.05) 0.93
General Health 62 / 92: 67.4% 117 / 185: 63.2% 0.91 (0.47 – 1.77) 0.78
Vitality 34 / 92: 37.0% 54 / 185: 29.2% 0.84 (0.46 – 1.55) 0.58
Social Functioning 42 / 92: 45.7% 80 / 185: 43.2% 0.87 (0.49 – 1.55) 0.64
Role Emotional 21 / 92: 22.8% 51 / 185: 27.6% 1.01 (0.51 – 2.01) 0.98
Mental Health 17 / 92: 18.5% 40 / 185: 21.6% 1.26 (0.62 – 2.58) 0.53
NRS Satisfaction > 8 53 / 92: 57.6% 136 / 185: 73.5% 1.95 (1.06 – 3.59) 0.03
Table 4.5: Improvement in Health-Related Quality of Life and Satisfaction after
Hip Replacement: A Comparison Between Patients with Mild to Moderate and
Severe Radiographical Pre-Operative Osteoarthritis. Odds Ratios > 1 indicate a
higher probability of achieving a Minimal Clinically Important Difference in HRQoL after
THR in patients with Kellgren Grade 3+4, compared to Grade 0–2. The odds ratios are
adjusted for age, sex, Charnley Comorbidity Classification and BMI and stratified for
quartiles of follow-up.
severely biased. Finally, the patient demographics of our study population were similar
to those of large-scaled national joint registry studies, regarding age, gender, Charnley
classification and BMI.[143, 175]
The follow-up period after joint replacement varies between 2 and 5 years. Although
a residual effect of follow-up length cannot be excluded, we do not think this is very
plausible, as recent evidence suggests that the improvement in HRQoL is sustained up
to 5 years after joint replacement surgery.[147, 148]
Although joint replacements are highly effective in improving HRQoL at the group
level,[1] this is not the case for each individual patient, judging from the relatively high
dissatisfaction rates.[19, 20] Studying HRQoL at the individual level, using the probability
of achieving a clinically important difference as an outcome measure, enables a better
prediction of a successful outcome. Moreover, it could provide a helpful way to fine-tune
the indication for joint replacement, for which there are no clear cut-off points currently
available.[176]
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Physical Functioning 5 / 22: 22.7% 105 / 191: 55.0% 5.44 (1.45 – 20.3) 0.01
Role-Physical 9 / 22: 40.9% 88 / 191: 46.1% 1.46 (0.49 – 4.32) 0.50
Bodily Pain 15 / 22: 68.2% 136 / 191: 71.2% 1.15 (0.32 – 4.16) 0.83
General Health 9 / 22: 40.9% 122 / 191: 63.9% 3.56 (1.23 – 10.4) 0.02
Vitality 8 / 22: 36.4% 86 / 191: 45.0% 1.09 (0.35 – 3.44) 0.88
Social Functioning 7 / 22: 31.8% 98 / 191: 51.3% 2.84 (0.87 – 9.32) 0.08
Role Emotional 6 / 22: 27.3% 41 / 191: 21.5% 0.85 (0.26 – 3.02) 0.85
Mental Health 8 / 22: 36.4% 79 / 191: 41.4% 2.79 (0.70 – 11.2) 0.15
NRS Satisfaction > 8 9 / 22: 40.9% 116 / 191: 60.7% 2.25 (0.78 – 6.52) 0.14
Table 4.6: Improvement in Health-Related Quality of Life and Satisfaction after
Knee Replacement: A Comparison Between Patients with Mild to Moderate and
Severe Radiographical Pre-Operative Osteoarthritis. Odds Ratios > 1 indicate a
higher probability of achieving a Minimal Clinically Important Difference in HRQoL after
TKR in patients with Kellgren Grade 3+4, compared to Grade 0–2. The odds ratios are
adjusted for age, sex, Charnley Comorbidity Classification and BMI and stratified for
quartiles of follow-up.
Regardless of age, gender, co-morbidity and BMI, we have shown that joint
replacement patients with severe preoperative OA have a better prognosis in
improvement in Physical Functioning and patient satisfaction with the surgical results.
These effects are more pronounced in TKR patients than in THR patients, which might
be explained in part by biomechanical factors. The hip joint is a relatively simple ball and
socket joint, which is adequately mimicked by a THR. The biomechanical aspects of the
knee joint are more difficult to imitate, as the knee is a pivotal hinge joint with 6 degrees
of freedom. These degrees of freedom are generally not restored after TKR, which
is substantiated in kinematic and kinetic studies.[163] This additional disadvantage of
TKR patients who underwent joint replacement for mild radiographic OA is reflected
in a smaller increase in Physical Functioning than THR patients who underwent joint
replacement for mild radiographic OA. Additionally, the odds of achieving a MCID in
Physical Functioning is smaller and the difference in satisfaction is larger.
Clinically, these are promising findings, as dissatisfaction rates are higher in TKR
patients than in THR patients.[13, 15] Patient satisfaction is thought to be closely related
to unfulfilled expectations. Although patient expectations of THR and TKR are similar,
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recent evidence suggests that THR meets important patient expectations better than
TKR.[15, 166, 177] Our findings could lead to a more fitting expectation management
regarding the expected improvement in Physical Functioning, using a single predictor.
This improvement in expectation management might lead to higher satisfaction rates.
Plain radiographs have a number of appealing aspects. In the first place, they are
inexpensive and easily available, as they are currently a part of the clinical work-up to
joint replacement. Secondly, due to the non-invasive character of the test, radiographs
are a patient-friendly modality. Finally, they offer a more objective approach to joint
complaints. These aspects would make it easy to implement the KL grade in clinical
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Abstract
Introduction The Kaplan-Meier estimation is widely used in orthopedics to calculate the
probability of revision surgery. Using data from a long-term follow-up study, we aimed to
assess the amount of bias introduced by the Kaplan-Meier estimator in a competing risk
setting.
Methods We describe both the Kaplan-Meier estimator and the competing risk model,
and explain why the competing risk model is a more appropriate approach to estimate
the probability of revision surgery when patients die in a hip revision surgery cohort. In
our study, a total of 62 acetabular revisions were performed. After a mean of 25 years,
no patients were lost to follow-up, 13 patients had undergone revision surgery and 33
patients died of causes unrelated to their hip.
Results The Kaplan-Meier estimator overestimates the probability of revision surgery
in our example by 3%, 11%, 28%, 32% and 60% at five, ten, 15, 20 and 25 years,
respectively. As the cumulative incidence of the competing event increases over time,
as does the amount of bias.
Discussion Ignoring competing risks leads to biased estimations of the probability of
revision surgery. In order to guide choosing the appropriate statistical analysis in future
clinical studies, we propose a flowchart.
Introduction
One of the most important outcome measures in orthopaedic surgery is the time to a
certain event. In joint replacement surgery, for instance, the time to revision surgery
is seen as the most important determinant of the clinical success of any prosthesis.
Techniques from the field of survival analysis, such as the Kaplan-Meier estimator,[22]
have been used to estimate time to revision surgery since the 1980s.[178, 179] The time
from implantation of a prosthesis until a specified event of interest is used in survival
analyses. An important advantage of survival analyses is that these techniques allow
analyses with “censored data”, i.e. data concerning patients for which revision surgery
has not yet taken place within the study period.[22] If the endpoint of interest has not
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yet occurred at the end of the observation window, the event time is censored. The
probability of revision surgery can be estimated with the Kaplan-Meier estimator at any
specific point in time.
At first glance, the Kaplan-Meier estimator seems ideal for orthopaedics since
analyses can be performed before revision surgery has occurred in all patients. However,
this method makes a number of assumptions.[115, 180] The Kaplan-Meier estimator
is specifically developed for studies with a single time to a certain event, which in turn
is able to be censored. The assumption of independence of the time to event and the
censoring distributions is of critical importance. The probability of the event of interest is
estimated by assuming that patients whose time is censored have the same probability
of revision at any later time. When estimating the time to revision surgery, often more
types of events play a role, which may prevent the event of interest from occurring. For
instance, revision of an implant may be unobservable because the patient dies. In this
particular case, death is a competing event, which poses a competing risk — a risk that
may be high, especially in studies with long-term follow-up.
The Kaplan-Meier method of censoring patients who experience a competing
event is not ideal when the estimation of the probability of the event of interest
is the goal, since this implicitly assumes that the event of interest still could
occur after the time point at which censoring occurred.[181–183] If a patient does
experience a competing event, the event of interest can no longer occur: therefore
the potential contribution to the estimate from this patient should become zero. The
probability of the event of interest must be estimated by taking into account the
probability of the competing events; ignoring the competing risks leads to a biased
estimation of the probability of the event of interest (see Appendix 1, available at
http://www.bjr.boneandjoint.org.uk/content/1/10/258/suppl/DC1).[180, 184–186]
In this study we compare the Kaplan-Meier estimator with the cumulative incidence
estimator in a competing risk setting and show how the level of bias introduced by
violating critical assumptions of the Kaplan-Meier estimator. We propose a simple
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algorithm to help select the appropriate data analysis technique to estimate the
probability of revision surgery in future studies. In order to illustrate these statistical
methods, developed by Kaplan and Meier[22] and Bernoulli,[185, 186] we used data
from a previous cohort of acetabular revision patients.[34]
Methods
In our published cohort study, 62 acetabular revisions were performed in 58 patients
between January 1979 and March 1986, at the Radboud University Medical Center in
Nijmegen, The Netherlands.[34] There were 13 men and 45 women with a mean age
at revision of 59.2 years (range: 23 – 82). Revision was undertaken using impacted
morsellised bone grafts and a cemented acetabular component in all cases. All patients
were followed prospectively with yearly clinical and radiological assessments.
Competing risks versus Kaplan-Meier Competing risks are applied to situations
where more than one competing endpoints are possible. Their competing in that one
event will preclude the other occurring. In our situation there are two different endpoints:
revision surgery and death. The occurrence of death prevents the occurrence of
the event of interest, namely revision surgery. The competing risks model can be
represented as an initial state (alive after initial revision surgery) and two different
competing endpoints: revision surgery and death. We are interested in the probability
of revision surgery (event of interest) in the presence of the competing event of death —
which clearly prevents the occurrence of revision.
The Kaplan-Meier estimator is often used to estimate this probability. However, in this
model the competing cause endpoints (i.e., death) are treated as censored observations.
If a patient has experienced death, he or she has zero probability of experiencing the
event of interest, and this must be considered in the model.
The cumulative incidence estimator is used to estimate the probability of each competing
event. The cumulative incidence function of cause k is defined as the probability of
failing from cause k before time t. Here we are interested in the cumulative incidence
function of revision surgery in the presence of death.
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Statistical analysis All analyses concerning competing risks models have been
performed using the mstate library[187, 188] in R.[43] For technical details concerning
the software, see de Wreede et al.[187, 188]
Results
At a mean of 23 years (20 to 25) after surgery, no patients were lost to follow-up. A total
of 13 hips in 12 patients had undergone revision surgery, and 30 patients (33 hips) had
died of causes unrelated to their hip surgery (table 5.1).
The estimated survival rates with revision surgery as the endpoint obtained by applying
the Kaplan-Meier method at five, ten, 15, 20 and 25 years were, respectively, 98% (95%
confidence interval (CI): 95 – 100), 93% (95% CI: 86 – 99), 81% (95% CI: 67 – 95), 75%
(95% CI: 57 – 93) and 66% (95% CI: 49 – 83).
The estimated risk of revision surgery (1 - estimated survival of the implant) obtained
with the Kaplan-Meier estimator, is shown in figure 5.1 on the following page. These
estimated risks of revision surgery were therefore 2%, 7%, 19%, 25% and 34% at
five, ten, 15, 20 and 25 years, respectively. The cumulative incidence estimators for
both competing events, i.e. revision surgery and death, are shown in figure 5.2 (p. 77).
The cumulative incidence estimator of revision surgery by the competing risks method
at five, ten, 15, 20 and 25 years is 2%, 6%, 15%, 18% and 21%, respectively. The
cumulative incidence of death represents the probability of dying before revision surgery.
If death occurs first, the observation will not be considered censored in the competing
Acetabular revisions Patients
Total 62 58
Lost to follow-up 0 0




Mismatch during femoral revision 1
Wear 2
Table 5.1: Details of the 62 consecutive acetabular revisions.
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Figure 5.1: Kaplan-Meier curve showing the cumulative incidence of revision
surgery. The risk of revision surgery in the Kaplan-Meier approach can be represented
as: risk at time t = 1 - survival at time t.
risk approach (in contrast to the Kaplan-Meier approach), but it will contribute to the
competing event of death. In the dataset described above, the Kaplan-Meier model can
be seen to overestimate the probability of revision surgery by 3%, 11%, 28%, 32% and
60% at five, ten, 15, 20 and 25 years, respectively (fig. 5.3 (p. 78)).
Discussion
In the current orthopaedic literature, the Kaplan-Meier estimator is an accepted standard
in estimating the probability of revision surgery in cohort studies of any type of joint
replacement. In the absence of competing risks, this method is valid. However, in the
presence of competing risks, the Kaplan-Meier estimator overestimates the probability
of revision surgery. In our example, the probability of revision surgery is overestimated
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Figure 5.2: Kaplan-Meier curve showing the cumulative incidence of revision
surgery. The risk of revision surgery in the Kaplan-Meier approach can be represented
as: risk at time t = 1 - survival at time t.
by 60% at a follow-up of 25 years. In the Kaplan-Meier approach failures from the
competing causes are treated as censored observations. Individuals who will never be
revised because they have died, are censored and thus treated as if they still could
be revised. In other words, the Kaplan-Meier estimator allows patients to be revised
after they have died. Clearly, this results in an incorrect or biased estimate of the actual
probability of revision surgery at that specific time point.
When competing risks are absent (i.e., the competing event death has not occurred),
the Kaplan-Meier estimator gives a valid estimation of the probability of revision surgery.
However, in our example involving a long follow-up, competing events such as death
do occur frequently. Also, it can be seen from our dataset that the first patient died
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Kaplan Meier Estimator
Competing Risk Analysis













N Dead 0 6 15 24 33 35
N Revised 0 1 4 9 11 13






























0% 3% 11% 28% 32% 60%
Overestimation:
Figure 5.3: Comparison of cumulative incidence of revision surgery estimated
with the Kaplan-Meier estimator and the competing risks method. The discrepancy
between the lines represents the bias, which is introduced by erroneous usage of the
Kaplan-Meier estimator.
as early as one year after surgery (fig. 5.2 on the previous page). By five years after
the initial surgery, a total of six patients had died, compared with only one patient who
had undergone revision surgery, resulting in a 3% overestimation of the probability
of revision surgery (fig. 5.3). In other words, the hazard of the competing events is
considerable, leading to an overestimation of the revision surgery probability, even at
mid-term follow-up.
In this paper a competing risks model has been applied to a cohort where only two
competing events are present. However, in other clinical situations, more competing
events can occur. Consider estimating the probability of revision surgery due to a specific
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event, for instance the probability of revision surgery due to recurrent dislocations. In this
situation, there are three competing events: revision surgery for recurrent dislocations,
revision surgery for any other reason and death of a patient. The competing risk model
can easily be extended to deal with another competing event.
From a statistical point of view, competing risk analysis should be used whenever
competing risks are present. In order to aid in deciding which analysis should be used to
estimate the probability of revision surgery in future clinical studies, we propose a simple
algorithm (fig. 5.4 on the next page). Every clinical study that investigates the probability
of revision surgery should address the occurrence of competing events. When no
competing events have occurred, the Kaplan-Meier estimator of revision surgery will be
valid. However, whenever any competing event occurs, the Kaplan-Meier estimator will
introduce bias. The resulting bias is greater when the “competition” is heavier, i.e. when
the hazard of the competing events is larger. See Appendix 2 of the Supplementary
Material for a concise summary of necessary variables to perform a competing risk
analysis (available at http://www.bjr.boneandjoint.org.uk/content/1/10/258/suppl/DC1).
Recently, minimal clinically important differences (MCIDs) have gained attention in
the literature.[141, 169, 170] Using MCIDs, patients can be classified as responders or
non-responders to a particular therapy. Theoretically, one could investigate the time to
a MCID after joint replacement, using MCIDs in health-related quality of life (HRQoL).
However, contrary to the occurrence of revision surgery or the first occurrence of a
complication,[189] which can be assessed over a time period, whether or not a patient
has attained a MCID in HRQoL is typically measured using a questionnaire at a specific
point in time. Neither the Kaplan-Meier estimator nor a competing risk model is an
appropriate approach, unless the assessment of the occurrence of an MCID is repeated
at small time intervals.
The competing risk analysis can be performed using the mstate library[187, 188] in
R.[43] R and the mstate package are both freely available at The R Project for Statistical
Computing and The Comprehensive R Archive Network.
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Figure 5.4: Algorithm detailing the appropriate data analysis technique to
estimate the probability of revision surgery. The possibility and actual occurrence
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Abstract
Objectives We aimed first to summarise minimal clinically important differences
(MCIDs) after total hip (THR) or knee replacement (TKR) in health-related quality
of life (HRQoL), measured using the Short-Form 36 (SF-36). Secondly, we aimed to
improve the precision of MCID estimates by means of meta-analysis.
Methods We conducted a systematic review of English and non-English articles using
MEDLINE, the Cochrane Controlled Trials Register (1960 – 2011), EMBASE (1991 –
2011), Web of Science, Academic Search Premier and Science Direct. Bibliographies
of included studies were searched in order to find additional studies. Search terms
included MCID or minimal clinically important change, THR or TKR and Short-Form 36.
We included longitudinal studies that estimated MCID of SF-36 after THR or TKR.
Results Three studies met our inclusion criteria, describing a distinct study population:
primary THR, primary TKR and revision THR. No synthesis of study results can be
given.
Conclusions Although we found MCIDs in HRQoL after THR or TKR have limited
precision and are not validated using external criteria, these are still the best known
estimates of MCIDs in HRQoL after THR and TKR to date. We therefore advise these
MCIDs to be used as absolute thresholds, but with caution.
Introduction
Total hip (THR) and knee replacement (TKR) are effective surgical interventions,
which alleviate pain and improve function and health-related quality of life (HRQoL) in
patients with end-stage degeneration of the hip or knee joint, respectively.[190] Typically,
studies report the mean improvement in HRQoL at the population level, which provides
information for the average patient in a population. However, this information may not be
meaningful for individual patients encountered in clinical practice, who will be concerned
with the likelihood that they will experience a meaningful improvement in return for the
risk undertaken when undergoing an intervention.[191] More relevant for the individual
patient therefore is the minimal clinically important difference (MCID), defined as the
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minimal difference in scores of an outcome measure that is perceived by patients as
beneficial or harmful.[167, 168] The MCID enables patients to be classified as either a
responder or a non-responder to a particular therapy, based on their own assessment
of their pre- and post-operative HRQoL. Additionally, the MCID allows an estimation of
the probability of a relevant improvement in HRQoL of a particular therapy.
Expected benefits of treatment must be weighed against its adverse effects,
inconvenience and costs.[192] Therefore, there is not necessarily a single MCID value
for any one outcome measure of HRQoL, which can be used for all applications and
patient samples.[193] For instance, the benefits of treatment in patients suffering from
end-stage osteoarthritis are considerably larger for THR and TKR compared with
rehabilitational interventions. On the other hand, the risk of adverse effects is also
considerably higher. These differences complicate the direct use of MCIDs in HRQoL
as established for rehabilitational interventions,[194] in THR or TKR patients. The use
of specific MCIDs in HRQoL after THR or TKR should be encouraged.
MCIDs can be established using two different methods. Anchor-based approaches
use an external indicator to assign patients into several groups reflecting different
amounts of change in health status.[193] The within-person global change rating is
often used as an anchor, which is measured using Likert scales, ranging from five to 15
options.[193] Positive MCIDs are usually estimated by the mean difference between pre-
and post-operative scores of patients, who indicate that their condition is “somewhat
better”; negative MCIDs are usually estimated by the mean difference between pre-
and post-operative scores of patients who indicate that their condition is “somewhat
worse”.[192, 195] Distribution-based methods offer another approach in the estimation
of MCIDs, which interpret results in terms of the relation between the magnitude of
effect and some measure of variability in results.[192] Individual effect size standards
are often used to estimate the MCID, which is defined as the difference between a
patient’s pre- and post-operative HRQoL scores, normed to the standard deviation of
the pre-operative scores.[195] Generally accepted individual effect size standards are
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equal to the group effect size standards, as defined by Cohen.[196] Therefore, the MCID
is calculated by multiplying the standard deviation of patients at baseline by 0.5.
Recently Quintana et al[169] and Escobar et al[170] have estimated MCIDs for the
SF-36 after THR and TKR. However, these authors have advised against using the
found estimates of MCIDs as absolute thresholds, due to the imprecision of these
estimates caused by small sample sizes. The precision of an estimate can be enhanced
by pooling results of multiple studies in a meta-analysis. Therefore, the purpose of our
study was to enhance the precision of the MCIDs after THR and TKR, by means of a
systematic review and meta-analysis.
Methods
This systematic review was performed in November 2011, using the PRISMA-Statement
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) as a guideline
in the development of the study protocol and the report of the current study.[36] The
inclusion criteria and methods of analysis were specified in advance and documented
in a protocol.
Information sources and search strategy Longitudinal studies that estimate the
MCID in HRQol, measured using the Short-Form 36 (SF-36), after primary or revision
THR or TKR, were eligible for inclusion. No language, publication date, or publication
status restrictions were imposed. Studies were identified by searching electronic
databases. No limits were applied for language and foreign papers were translated.
This search strategy was applied to PubMed, MEDLINE, Embase, Web of Science,
COCHRANE, ScienceDirect and Academic Search Premier. The search was run on 8
November 2011. The following search terms were used in PubMed, and were adapted
for the other databases:
(Mcid[tw] OR cid[tw] OR “Minimal clinically important differences” OR “Minimal clinically
important difference” OR “clinically important differences” OR “clinically important
difference” OR MCIC[tw] OR “Minimal clinically important changes” OR “Minimal
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clinically important change” OR “clinically important changes” OR “clinically important
change” OR “Minimal clinical important differences” OR “Minimal clinical important
difference” OR “clinical important differences” OR “clinical important difference” OR
“clinical important changes” OR “minimal detectable change” OR “minimal detectable
changes” OR “minimally detectable change” OR “meaningful changes” OR “meaningful
change”) AND (tka[tw] OR “knee replacement arthroplasty” OR “knee arthroplasty” OR
“knee replacement” OR “knee prosthesis” OR tha[tw] OR “hip replacement arthroplasty”
OR “hip arthroplasty” OR “hip replacement” OR “hip prosthesis” OR “knee” OR “knees”
OR “hip” OR “hips”) AND (“SF36” OR “SF-36” OR “short form 36” OR “shortform 36”)
Study selection Two authors (JCK and FRvT) independently screened titles and
abstracts of the papers resulting from the database search using predefined eligibility
criteria. Papers were considered eligible for inclusion if they met two criteria; they
were to concern primary or revision THR or TKR and should include an estimate of a
MCID. The full text of all included papers, based on titles and abstracts, were screened
using the same inclusion criteria. Disagreements between reviewers were resolved by
consensus.
HRQoL measured using SF-36 The SF-36 consists of 36 items, covering eight
domains (physical function, role physical, bodily pain, general health, vitality, social
function, role emotional, and mental health), for which a transformed score is calculated
(100 indicating no symptoms and 0 indicating extreme symptoms).[197]
Data collection process and data items Both authors extracted the data
independently, using a predefined data extraction form. Areas of disagreement or
uncertainty were resolved by consensus. Estimates of MCIDs were extracted from
included studies. For anchor-based estimates of MCIDs, we extracted the number of
patients, on which the estimate was based, and the standard deviation. For distribution-
based estimates, we extracted the number of patient on which the estimate was based.
Additionally, study characteristics, concerning follow-up period, sample size, proportion
of patients who underwent joint replacement for osteoarthritis, proportion of males,
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mean patient age and proportion lost to follow-up, were collected.
Risk of bias in individual studies We assessed the risk of bias in the included
studies through a modified Newcastle-Ottawa Quality Assessment Scale,[198] which
included the following questions: “which approach was used to estimate the MCID?”
(anchor-based versus distribution-based); “was any form of additional validation
performed?” (yes / no); “was the study population representative of THR or TKR
in general?” (truly representative / somewhat representative / selected population /
not enough information given); “was the follow-up adequate?” (no loss to follow-up / <
5% lost to follow-up (unlikely to bias results) / > 5% lost to follow-up (results possibly
biased)). We chose the cut-off point of 5% lost to follow-up according to Pijls et al,[37]
who established this threshold for observational studies in orthopaedic literature, using
a Delphi approach to form consensus between a group of experts in the fields of THR,
TKR or evidence-based medicine.
Summary measures and planned methods of analysis The primary outcome
measure was the MCID in HRQoL, measured using SF-36, for primary THR, primary
TKR, revision THR and revision TKR. Whenever possible, estimates of MCIDs were
pooled using inverse variance weighting. 95% confidence intervals (CI) were calculated
for all MCID estimates.
Results
Study selection The search strategy revealed a total of 126 results (fig. 6.1 on the
facing page). After removal of duplicate entries, 114 unique papers remained. Screening
of titles and abstracts revealed 29 papers eligible for inclusion. Further assessment
of eligibility, based on full-text papers, led to the exclusion of 26 papers: two did not
address THR or TKR and 24 presented no estimation of an MCID. This left three papers,
describing three studies, for further analysis.[169, 170, 199]
Study characteristics An overview of the study characteristics of all included studies
is presented in table 6.1 (p. 88). Quintana et al[169] describe the MCID in SF-36 after
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-no THR / TKR: 2
-no MCID estimated: 24
Included:
3 Full-text papers
Figure 6.1: Flow-chart of study inclusion. THR, total hip replacement; TKR, total
knee replacement; MCID, minimal clinically important difference.
primary THR at follow-up periods of six months and two years; Escobar et al[170]
describe the MCID in SF-36 after primary TKR at follow-up periods of six months
and two years; and Shi et al[199] describe the MCID in SF-36 after revision THR
at a follow-up period of six months (table 6.1 on the following page). All included
studies were multi-center studies. All studies estimated positive MCIDs (i.e. the minimal
difference in scores of the SF-36 that is perceived by patients as beneficial); no study
estimated negative MCIDs (the minimal difference in scores of an outcome measure
that is perceived by patients as harmful). The sample for the estimation of the MCIDs
was 43 patients after six months and 33 after two years for Quintana et al[169]; 76 after
six months and 65 after two years for Escobar et al[170]; and 67 after six months for
Shi et al[199] (table 6.1 on the next page). The indication for joint replacement was
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[169] Primary THR 6 months Multi-centre + 485 43 100 49,3 69,4 21,86
Primary THR 2 years Multi-centre + 310 33 100 49,3 69,4 36,08
[170] Primary TKR 6 months Multi-centre + 423 76 100 25 71,6 22,39
Primary TKR 2 years Multi-centre + 364 65 100 25 71,6 33,21
[199] Revision THR 6 months Multi-centre + 67 67 n/a 56,7 70,2 16,25
Table 6.1: Study characteristics of the three included studies. 1: Positive or











Quintana[169] 6 months Anchor-based No Truly representative >5% lost
2 years Anchor-based No Truly representative >5% lost
Escobar[170] 6 months Anchor-based No Truly representative >5% lost
2 years Anchor-based No Truly representative >5% lost
Shi[199] 6 months Distribution-
based
No Description of cohort
incomplete
>5% lost
Table 6.2: Risk of bias within the three included studies.
osteoarthritis in all patients of Quintana et al[169] and Escobar et al,[170] while Shi et
al[199] offered no statement of the indication for joint replacement (table 6.1). In all
studies, some patients were lost to follow-up.
Risk of bias within studies An overview of the risk of bias within studies is
presented in table 6.2. Two studies used anchor-based approaches to estimate the
MCID,[169, 170] while the other used a distribution-based approach.[199] No study
performed any form of additional validation. The study populations of Quintana et al[169]
and Escobar et al[170] are truly representative of THR and TKR patients in general,
while Shi et al[199] did not provide enough information to assess the representativeness
by leaving out the indication of joint replacement. All studies lost >5% of patients to
follow-up, rendering a possibility of biased results.
Synthesis of results All studies have described a distinct study population, precluding
any meaningful synthesis of study results. An overview of the results of all individual
studies is presented in table 6.3 and figure 6.2 and figure 6.3. The MCIDs are
presented with 95% confidence intervals for each of the SF-36 domains in primary
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MCID (95% confidence interval)
SF-36 domain At six months At two years
Primary THR[169] Physical functioning 20.40 (14.4 – 26.4) 8.29 (-1.8 – 18.4)
Role physical 10.78 (1.5 – 20.0) 11.00 (-1.3 – 23.3)
Bodily pain 14.67 (6.8 – 22.6) 18.34 (9.1 – 27.6)
General health 0.40 (-5.2 – 6.0) -6.37 (-10.9 – -1.9)
Vitality 10.14 (3.1 – 17.2) 14.51 (6.4 – 22.6)
Social functioning 8.63 (0.9 – 16.4) 17.97 (7.8 – 28.1)
Role emotional -6.45 (-24.5 – 11.6) 20.83 (-0.6 – 42.3)
Mental health 8.99 (2.3 – 15.7) 16.15 (9.0 – 23.3)
Primary TKR[170] Physical functioning 11.57 (6.5 – 16.7) 11.07 (5.8 – 16.3)
Role physical 11.69 (3.8 – 19.6) 13.16 (3.5 – 22.8)
Bodily pain 16.86 (9.7 – 24.0) 6.69 (-0.4 – 13.8)
General health 0.85 (-3.2 – 4.9) -7.30 (-11.3 – -3.3)
Vitality 3.86 (-1.7 – 9.4) 3.44 (-2.2 – 9.1)
Social functioning 11.66 (3.7 – 19.6) 6.15 (-1.7 – 14.0)
Role emotional 7.65 (-4.5 – 19.8) 2.42 (-9.2 – 14.1)
Mental health -0.32 (-5.5 – 4.9) 4.02 (-1.7 – 9.7)
Revision THR[199] Physical functioning 3.25 (2.8 – 3.9) -
Role physical 4.78 (4.1 – 5.8) -
Bodily pain 14.91 (12.7 – 18.0) -
General health 14.12 (12.1 – 17.0) -
Vitality 22.81 (19.5 – 27.5) -
Social functioning 15.83 (13.5 – 19.1) -
Role emotional 19.98 (17.1 – 24.1) -
Mental health 12.37 (10.6 – 14.9) -
Table 6.3: Minimal clinically important differences (MCIDs) in Short-Form 36 (SF-
36) domains after primary and revision total hip replacement (THR) and primary
total knee replacement (TKR).
TKR and primary and revision THR at six months (fig. 6.2 on the following page,
table 6.3)[169, 170, 199] and for primary TKR and THR at two years post-operatively
(fig. 6.3 (p. 91), table 6.3).[169, 170]
Discussion
We have found one study describing MCIDs in SF-36 after primary THR,[169] one
after primary TKR[170] and one after revision THR[199]; we did not find any studies
describing MCIDs after revision TKR. As all studies have described a distinct study
population, no synthesis of study results can be given. Therefore, we were unable to
improve the precision of each MCID estimate.
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Figure 6.2: Graph showing the minimal clinically important differences (MCIDs)
in the domains of the Short-Form 36 (SF-36) at six months after primary total hip
(THR)[169] and total knee replacement (TKR)[170] and revision THR.[199] The
size of the coloured circles represents the sample sizes used to estimate the MCID, and
the error bars denote the 95% confidence intervals. PF, physical functioning; RP, role
physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role
emotional; MH, mental health.
However, in order to visualise the precision of all MCID estimates, we calculated 95%
confidence intervals of all MCID estimates, which were not presented in the original
studies. These confidence intervals are presented in figure 6.2 and figure 6.3 on the
next page.
The findings of this systematic review underline the need to identify MCIDs for each
specific population. As can be seen from figure 6.2 and figure 6.3 on the next page,
MCIDs differ both between SF-36 subscales and patient populations. The use of a
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Figure 6.3: Graph showing the minimal clinically important differences (MCIDs)
in the domains of the Short-Form 36 (SF-36) at two years after primary total hip
(THR)[169] and total knee replacement (TKR).[170] The size of the coloured circles
represents the sample sizes used to estimate the MCID, and the error bars denote the
95% confidence intervals. PF, physical functioning; RP, role physical; BP, bodily pain;
GH, general health; VT, vitality; SF, social functioning; RE, role emotional; MH, mental
health.
“one-size-fits-all” MCID does not appear justified, as patients suffering from osteoarthritis
of the hip and knee, which are regarded as similar disease entities, have different MCIDs
in HRQoL.[200–202] In order to study patient-relevant improvements in HRQoL at the
individual level in revision TKR patients, MCIDs need to be established in this particular
population as well.
Limitations of the included studies include imprecision as a result of small sample
sizes, the lack of validation of the MCID estimates and the rates of loss to follow-up.
Anchor-based approaches in particular suffer from imprecision due to small sample
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sizes, as this approach uses only a part of all data to estimate the MCID. A precise
estimation of the MCID is further hampered by the clinical success of joint replacement:
typically, one expects a large effect of THR or TKR.[203] The group sizes of patients who
indicate that their condition has “somewhat improved” are therefore expected to be small,
which contributes to an imprecise estimation of MCIDs. Unfortunately, there are only two
ways to improve the precision of anchor-based MCID estimates: one can either perform
larger studies, or pool study results in a meta-analysis. To date, the only studies that
have established anchor-based MCIDs in HRQoL after primary THR or TKR were those
of Quintana et al[169] and Escobar et al.[170] More research is required to improve
the precision of MCIDs in HRQoL. Estimates with higher precision are generated by
distribution-based approaches, which use data from the entire population to estimate
the MCID. However, these approaches are criticised for the arbitrariness of the individual
effect size standards.[192]
A strongly recommended method of determining MCIDs is by triangulation of multiple
approaches.[193] None of the included studies has applied any form of additional
validation, such as secondary anchor questions; all used a single approach. Besides
a limited precision, caused by small group sizes, the accuracy of the MCID estimates
might be limited as well due to this lack of additional validation.[204] Therefore, further
research is needed to provide external validation of the established MCIDs in HRQoL.
However, until further research is performed, the MCID estimates of these three
studies[169, 170, 199] are the best available estimates. Cautious use of these estimates
should be encouraged in order to study improvement in HRQoL at the individual level, the
most relevant outcome measure for individual patients encountered in clinical practice.
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Abstract
Objective To determine Clinically Important Differences (CIDs) in Health-Related
Quality of Life (HRQoL) after Total Hip (THR) or Total Knee Replacement (TKR), using
the Short-Form 36 (SF36).
Methods SF36 scores were collected 2 weeks before and at 2-6 years after joint
replacement in 586 THR and 400 TKR patients in a multi-center cohort study. We
calculated distribution based CIDs (0.8 standard deviations of the preoperative score)
for each SF36 sub-scale. Responders (patients with an improvement in HRQoL ≥ CID
of a particular sub-scale) were compared to non-responders using an external validation
question: willingness to undergo surgery again.
Results CIDs for THR/TKR were: Physical Functioning (PF): 17.9/16.7; Role-Physical
(RP): 31.1/33.4; Bodily Pain (BP): 16.8/16.2; General Health (GH): 15.5/15.7; Vitality
(VT): 17.3/16.7; Social Functioning (SF): 22.0/19.9; Role-Emotional (RE): 33.7/33.6;
Mental Health (MH): 14.8/14.1. CIDs of PF, RP, BP and SF were validated by the
validation question.
Conclusions Valid and precise CIDs are estimated of PF, RP, BP and SF, which are
relevant HRQoL subscales for THR and TKR patients. CIDs of all other subscales
should be used cautiously.
Introduction
Total Hip (THR) and Knee Replacement (TKR) alleviate pain and improve Health-
Related Quality of Life (HRQoL) at the population level.[1] This information may not be
meaningful for individual patients in clinical practice, who are interested in the likelihood
of experiencing a meaningful improvement for the risk they take with an intervention.[191]
Clinically Important Differences (CIDs), defined as a difference in scores of an outcome
measure that is perceived by patients as beneficial or harmful,[167, 168] can be used to
estimate the probability of achieving a meaningful improvement. Patients experience a
meaningful improvement if their improvement ≥ the CID threshold; patients who improve
less or deteriorate are considered non-responders.
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As risks, costs and expected benefits vary widely between different interventions,[192]
CIDs for a generic HRQoL instrument (e.g. the Short-Form 36;SF36) may vary across
applications.[193] Minimal CIDs (MCIDs) after THR and TKR for the SF36 were recently
summarized in a systematic review.[141, 169, 170] However, these estimates were
not validated using external criteria.[141] Additionally, the relevance of a minimal
improvement after THR or TKR is debatable, as one would generally expect a larger
improvement after joint replacement.[203] Finally, the recommended anchor-based
approach yielded imprecise CID estimates, which are not suitable for clinical practice.
As large improvements in HRQoL are expected from joint replacement, the number of
patients who rated their improvement after joint replacement as “somewhat better” was
small, rendering imprecise CID estimates.
In order to overcome this limitation of anchor-based CID estimates in treatments with
a large effect-sizes, such as joint replacements, we propose a new approach, combining
efficient distribution-based CID estimation with anchor-based external validation. We
used this approach to estimate CIDs in HRQoL after THR and TKR.
Methods
The current study is part of a multi-center follow-up study of HRQoL after THR or TKR
(NTR2190). IRB approval was obtained from all participating centers, all patients gave
written informed consent (CCMO-Nr:NL29018.058.09;MEC-Nr:P09.189). The data used
in this report constitute a subset of patients, who underwent primary THR or TKR and
have completed pre-operative and post-operative HRQoL questionnaires.
Assessments HRQoL was measured 2 weeks before TKR / THR and 1.5-6 years after
surgery, using the Dutch SF36.[130, 133] The 36 items cover eight domains (physical
function (PF), role physical (RP), bodily pain (BP), general health (GH), vitality VT),
social function (SF), role emotional (RE), and mental health (MH)), for which a sub-scale
score is calculated (100 indicating no symptoms and 0 indicating extreme symptoms).
Missing items were imputed according to Ware whenever possible.[197]
95
PART III: RESEARCH METHODOLOGY
A validation question (VQ) was included in the questionnaire: “knowing what your hip or
knee replacement surgery did for you, would you still have undergone this surgery (yes
/ no)?”. This validation question was previously used in a similar study, which validated
WOMAC CIDs after THR and TKR.[203]
Outcome measures CIDs can be established using anchor-based or distribution-
based methods.[192, 193, 195] In an achor-based approach, the target instrument is
related to an independent measure (an anchor).[192] Typically, within-patient global
change ratings (measured using a Likert-scale) are used as anchors; the CID is
estimated by the mean improvement of patients who report that their condition is
at least “somewhat better”.[195] In a distribution-based approach, the magnitude of the
effect is related to a measure of variability of results.[192] Typically, Cohen’s effect-size
benchmarks[196] are adapted for individual effect sizes, giving 0.3 or 0.5 times the
standard deviation of the baseline score for a minimal CID and 0.8 times the standard
deviation of the baseline score for a CID.[195]
In order to estimate CIDs, we chose the following, two-phased approach. In the first
phase, we estimated the CID using a distribution-based approach. This approach
generates a more precise estimate of the CID, because information from the entire
cohort is used, instead of only a part of the population as is the case in anchor-based
methods. In the second phase, the distribution-based CIDs were validated by the
validation question VQ.
Statistical analyses Baseline characteristics were compared using descriptive
statistics. Distribution-based CIDs in HRQoL of THR and TKR patients were calculated
by multiplying the standard deviation of the untransformed sub-scale scores at baseline
by 0.8, which indicates a large group change.[195] We validated the CIDs using the VQ.
Each individual patients’ improvement (ie the postoperative score minus the preoperative
score) was computed and compared to the CID. A 2 by 2 contingency table was
constructed for each subscale of the VQ to display the numbers of individuals who had
an improvement equal to or larger than the CID and gave positive or negative answers
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to the VQ or had an improvement smaller than that of the CID and gave positive or
negative answers to the VQ. For each contingency table, an odds ratio was calculated,
which can be interpreted as the ratio of the odds of having experienced a CID when
patients have expressed willingness to undergo surgery again, relative to the odds of
not having experienced a CID when patients have expressed willingness to undergo
surgery again. An odds ratio larger than 1 indicates that that particular CID is able to
discriminate patients who answered the VQ positively from patients who answered the
VQ negatively.
Sensitivity analyses: in order to check whether the odds ratios of the validation procedure
were robust across different arbitrary CID threshold, we repeated all analyses using the
following CID thresholds: 0.3 * SD and 0.5 * SD.
In order to verify whether the estimated CIDs are consistent across different
subpopulations, we calculated the CIDs separately for different subgroups and compared
these to the overall CID estimates. Subgroup CID estimates were calculated for strata
of the following variables: sex, age (<65 vs ≥65 years old) and Charnley classification
(Class A: patients in which the index operated hip or knee are affected only; Class B:
patients in which the other hip or knee is affected as well; Class C: patients with a hip or
knee replacement and other affected joints and/or a medical condition which affects the
patients’ ability to ambulate).[136, 137]
Results
Population Patient characteristics are presented in table 7.1 on the following page.
586 patients underwent THR and 400 underwent TKR. The average follow-up period
was similar for THR and TKR patients (3.2 years (SD 1.1), both for THR and TKR).
THR patients were slightly younger at joint replacement surgery (mean age at joint
replacement (SD): THR 66 (10.6); TKR 69.1 (9.6)). The proportion of males was similar
(THR 34.1%, TKR 33.3%). TKR patients had a higher mean BMI and were more often
obese or morbidly obese. The majority underwent joint replacement for primary OA.
2206 patients underwent primary joint replacement and were eligible for inclusion in this
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Primary THR: Primary TKR:
n = 586 n = 400
Mean Follow-up Years (SD);
Median (IQR)
3.2 (1.1);
3.0 (2.3 – 4)
3.2 (1.1);




67 (60.4 – 73.6)
69.1 (9.6);
70.4 (63.1 – 76.5)
≤ 50 Years (%) 46 (7.8) 9 (2.3)
51 - 60 Years (%) 95 (16.2) 65 (16.5)
61 - 70 Years (%) 221 (37.7) 118 (30.0)
71 - 80 Years (%) 187 (31.9) 156 (39.7)
> 80 Years (%) 37 (6.3) 45 (11.5)




26.6 (24.2 – 29.4)
29.2 (4.9);
28.5 (25.8 – 32)
<25 (%) 191 (34.3) 68 (18.0)
25-30 (%) 243 (43.6) 168 (44.4)
30-35 (%) 98 (17.6) 97 (25.7)
>35 (%) 25 (4.5) 45 (11.9)
Indication for Joint Replacement:
Osteoarthritis (%) 501 (86.2) 354 (89.4)
Rheumatoid arthritis (%) 13 (2.2) 26 (6.6)
Other (%) 68 (11.7) 16 (4.0)
Table 7.1: Patient Characteristics. *Measured at follow-up.
follow-up study. 285 patients did not complete all pre-operative questionnaires and 63
patients died, leaving 1858 patients with primary joint replacement eligible. 986 patients
agreed to participate and returned the questionnaires sufficiently completed (response
rate: 53%). Non-responding THR patients were on average 3.95 years older than
participants (95%CI: 2.6-5.3 years); Non-responding TKR patients were on average
3.31 years older than participants (95%CI: 2.0-4.7 years). The proportion of males was
similar in participants and non-responders.
Phase 1: CID Estimation The mean preoperative scores of the SF36 subscales
are presented in table 7.2 on the next page and 7.3 on the facing page. For THR
patients, the following improvement in HRQoL scores after joint replacement constitutes
a CID: physical functioning: 17.9; role-physical 31.1; bodily pain: 16.8; general health:
15.5; vitality: 17.3; social functioning: 22.0; role-emotional: 33.7; mental health: 14.8.
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SF36 Subscale Mean Pre-Operative Score (SD) Clinically Important Difference (95%CI)
Physical Functioning 40.1 (22.3) 17.9 (16.9–19.0)
Role-Physical 30.9 (38.9) 31.1 (29.4–33.1)
Bodily Pain 40.3 (20.9) 16.8 (15.8–17.8)
General Health 67.8 (19.3) 15.5 (14.6–16.4)
Vitality 61.0 (21.6) 17.3 (16.3–18.4)
Social Functioning 65.6 (27.5) 22.0 (20.8–23.4)
Role-Emotional 68.9 (42.2) 33.7 (31.8–35.9)
Mental Health 74.3 (18.5) 14.8 (14.0–15.7)
Table 7.2: Pre-operative HRQoL and CIDs in HRQoL of Primary THR.
SF36 Subscale Mean Pre-Operative Score (SD) Clinically Important Difference (95%CI)
Physical Functioning 40.3 (20.8) 16.7 (15.5–18.0)
Role-Physical 38.8 (41.8) 33.4 (31.2–36.0)
Bodily Pain 44.9 (20.3) 16.2 (15.1–17.5)
General Health 62.8 (19.7) 15.7 (14.7–16.9)
Vitality 60.9 (20.9) 16.7 (15.6–18.0)
Social Functioning 70.5 (24.9) 19.9 (18.6–21.5)
Role-Emotional 68.8 (42.0) 33.6 (31.3–36.2)
Mental Health 73.5 (17.7) 14.1 (13.2–15.2)
Table 7.3: Pre-operative HRQoL and CIDs in HRQoL of Primary TKR.
For TKR patients, the following improvement in HRQoL scores after joint replacement
constitutes a CID: physical functioning: 16.7; role-physical 33.4; bodily pain: 16.2;
general health: 15.7; vitality: 16.7; social functioning: 19.9; role-emotional: 33.6; mental
health: 14.1.
Phase 2: Validation Box plots of the improvement in eight dimensions of HRQoL after
joint replacement in relation to the CID threshold for each dimension, stratified by the
response to the validation question, are shown in figure 7.1 on the next page for THR
patients and in figure 7.2 (p. 101) for TKR patients. THR patients who reported having
a larger improvement in physical functioning, role-physical, bodily pain, general heath,
social functioning and role-emotional than the CIDs, had also expressed willingness to
undergo surgery again more often. These findings are also reflected in the odds ratios,
which are larger than 1 (table 7.4 (p. 102)). TKR patients who reported having a larger
improvement in physical functioning, role-physical, bodily pain and social functioning
than the CIDs, had also expressed willingness to undergo surgery again more often.
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Physical Functioning Role−Physical
Bodily Pain General Health
Vitality Social Functioning





























Figure 7.1: Improvement in HRQoL after THR per Validation Question. The vertical
blue lines indicate the CID of each sub-scale with its confidence interval shown in
purple; the boxplots indicate the median, IQR and range of patients, who answered the
Validation Question positively and negatively.
These findings are also reflected in the odds ratios, which are larger than 1 (table 7.4
(p. 102)). All contingency tables from which these odds ratios were calculated, can be
found online at http://www.ncbi.nlm.nih.gov/pubmed/23850406.
Sensitivity analyses showed similar odds ratios for different CID thresholds, indicating
a robustness of the association between achieving a CID and expressing willingness
to undergo surgery again, for different thresholds (contingency tables can be found
online at http://www.ncbi.nlm.nih.gov/pubmed/23850406). CIDs were similar for men
and women, for patients younger and older than 65 years and for different Charnley
classes (data not shown).
Discussion
We have established CIDs in HRQoL after THR and TKR and have validated these
estimates using a relevant validation question. The CID estimates of physical functioning,
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Physical Functioning Role−Physical
Bodily Pain General Health
Vitality Social Functioning





























Figure 7.2: Improvement in HRQoL after TKR per Validation Question. The vertical
blue lines indicate the CID of each sub-scale with its confidence interval shown in
purple; the boxplots indicate the median, IQR and range of patients, who answered the
Validation Question positively and negatively.
role-physical, bodily pain and social functioning are both precise (judged by the narrow
confidence intervals)[204] and accurate (due to the validation procedure), enabling
further research in HRQoL gains after THR or TKR at the individual level. CIDs of all
other SF36 subscales should be used cautiously.
A limitation of our study is the variable length of follow-up, which ranges from 1.5
to 6 years after surgery. CIDs might be different for patients with different lengths of
follow-up. However, recent evidence suggests that gains in HRQoL are sustained up to
7 years after joint replacement.[147, 148]
In establishing a CID for a specific outcome measure, it is recommended to use
multiple approaches and triangulation of methods.[193] Anchor-based approaches are
preferred, as these are explicitly attached to observed mean changes. Distribution-
based approaches have been criticized for being non-intuitive and arbitrary in the choice
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Odds Ratio (95%-Confidence Interval)
SF36 Subscale THR TKR
Physical Functioning 5.86 (3.13–11.7) 1.80 (0.78–4.52)
Role Physical 2.08 (1.13–3.95) 2.98 (1.19–9.20)
Bodily Pain 3.30 (1.81–5.98) 4.72 (2.07–11.8)
General Health 4.92 (1.76–21.2) 1.26 (0.46–4.51)
Vitality 1.11 (0.59–2.22) 0.78 (0.32–2.20)
Social Functioning 1.89 (1.02–3.62) 3.35 (1.25–11.9)
Role Emotional 2.84 (1.11–9.83) 0.68 (0.29–1.81)
Mental Health 1.06 (0.55–2.18) 0.95 (0.39–2.70)
Table 7.4: Odds ratios of attaining a CID and being willing to undergo surgery
again for primary THR and TKR. An odds ratio >1 indicates that that particular CID
is able to discriminate patients who answered the VQ positively from patients who
answered the VQ negatively.
of the individual effect size standards.[192, 195] However, anchor-based methods might
not be feasible in THR or TKR. Quintana and Escobar advise against using their MCIDs
due to the imprecision of these estimates.[169, 170] To augment the precision of these
estimates, one would need very large cohorts. For instance, Quintana started with 586
eligible THR patients and ended with 33 patients at two years follow-up, who described
their status as “somewhat better”. In order to end up with 100 patients and achieve a
more precise CID, approximately 1750 eligible patients would be necessary. Additionally,
arbitrary thresholds also play a role in anchor-based approaches. Chesworth et al
have defined the CID as the mean improvement in the WOMAC score of patients who
indicated +5 on a 15-point general transition Likert scale.[203] Similar to the arbitrary
effect sizes of Cohen, +5 might be reasonable, but remains an arbitrary choice.
Our new approach overcomes these limitations in treatments with large effect-sizes.
In order to ensure precise estimates, we estimated CIDs using the distribution-based
approach. This approach uses data of the entire cohort, enhancing the precision of the
estimate as compared to anchor-based approaches. To overcome the non-intuitivity of
the distribution-based approach, we have validated the CID estimates using a patient
relevant external criterion. Clinical meaningfulness is regained by means of the odds
ratios.
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Why are CIDs useful in treatments with large effect-sizes? Although on average
patients improve markedly after THR or TKR, not all patients benefit from these
surgeries. Persistent pain is reported in 9% of THR patients and 20% of TKR patients
at long term follow-up.[11] Additionally, up to 30% of patients are dissatisfied with the
surgical results.[12–15] Therapeutic options are limited in patients with persistent pain or
dissatisfaction after joint replacement: the outcome of revision surgery performed without
a specific mechanical or physiological indication is highly unpredictable. Furthermore,
revision surgery is associated with a higher probability of orthopaedic and medical
complications. Unfulfilled patient expectations are thought to play a crucial role in
unfavourable outcomes after joint replacement.[166] CIDs might bridge the gap between
patient expectation and satisfaction. Using CID thresholds, it will be possible to predict
the probability of a relevant improvement in various relevant areas of HRQoL, using
clinical prediction models. These predictions for individual patients could be made before
surgery has taken place, and could form a solid base for expectation management.
Such a tailored approach could lower the probability of unfavourable outcomes after
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Abstract
Objectives To define Patient Acceptable Symptom State (PASS) thresholds for the
Oxford Hip Score (OHS) and Oxford Knee Score (OKS) at mid-term follow-up.
Methods In a prospective multicenter cohort study, OHS and OKS were collected at
an average of 3 years follow-up, combined with a Numeric Rating Scale of Satisfaction
(NRSS) and an external validation question (VQ): willingness to undergo surgery again.
Results 550 patients underwent THR and 367 underwent TKR. Receiver operating
characteristic (ROC) curves identified a PASS threshold of 42 for the OHS after THR
and 37 for the OKS after TKR. THR patients with an OHS≥42 and TKR patients with an
OKS≥37 had a higher Numeric Rating Scale of Satisfaction and a larger odds of being
willing to undergo surgery again.
Conclusions PASS thresholds appear larger at mid-term follow-up than at 6 months
after surgery. Without external validation, we would advise against using these PASS
thresholds as absolute thresholds in defining whether or not a patients has attained an
acceptable symptom state after THR/TKR.
Introduction
Several distinct types of outcome measures are of interest in orthopaedic surgery. The
time to a certain event, such as revision surgery, has historically been the principal
outcome of interest in joint replacement patients.[116] In recent years, patient-reported
outcome measures (PROMs) have become popular, allowing the assessment of the
clinical outcome of joint replacement from the patient’s perspective.[205] PROMs can
be summarised in numerous ways. In the orthopaedic literature, mean scores of the
study population are frequently presented. The mean pre-operative score provides
information on the “average” patient before surgery. Similarly, the mean post-operative
score provides information on the “average” patient after surgery, and the mean change
in these scores provides information on the improvement (or deterioration) experienced
by the “average” patient, who does improve substantially after joint replacement.[1]
However, a large proportion of joint replacement patients suffer from persisting pain,
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or are dissatisfied with the surgical results.[11, 15, 166] Data regarding the mean
improvement after joint replacement mainly report the improvement of many patients
with successful outcomes, but can neglect patients with suboptimal outcomes, making it
of limited use for individual patients encountered in clinical practice.
Patient Acceptable Symptom States (PASS) and Minimal Clinically Important
Differences (MCIDs) are two complementary constructs, which allow a more
individualised approach to the analysis of PROMs.[193, 206, 207] PASS is defined
as an outcome score threshold of the post-operative score, above which a patient is
defined as experiencing a satisfactory outcome, and below which an unsatisfactory
outcome is experienced. MCID is defined as the minimum amount of improvement
between pre- and post-operative scores that a patient should experience after a specific
intervention in order to have achieved a minimally important difference. PASSs and
MCIDs allow estimation of the probability of a satisfactory outcome or a relevant
improvement. These probabilities are relevant for individual patients, encountered
in clinical practice, who either do or do not achieve an acceptable state or experience a
relevant improvement.[191] Recently, PASSs have been estimated for the Oxford Hip
Score (OHS)[208] and Oxford Knee Score (OKS)[209] at short-term follow-up.[210]
An important issue is whether the chosen follow-up period of six months after joint
replacement is adequate. A recent systematic review has suggested that patients may
not have fully recovered at six months after THR.[149] Thresholds that define whether
or not patients have achieved an acceptable symptom state, such as the PASS, may
therefore differ between patients who are still recovering from their surgery and patients
who have recovered fully. Therefore, we questioned whether PASS thresholds are
different at mid-term compared with short-term follow-up. We questioned whether the
OHS and OKS are correlated to patient satisfaction at mid-term follow-up. Additionally,
we questioned whether responders (i.e., patients who have an acceptable symptom
state according to the PASS) are more satisfied than non-responders. Finally, we
questioned whether responders were more likely to be willing to undergo surgery again,
compared with non-responders.
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Materials and Methods
The current study is part of a multicentre cohort study of health-related quality of
life (HRQoL) after THR/TKR (NTR2190), performed from August 2010 to August
2011.[21, 27, 28] Institutional Review Board approval was obtained from all participating
centres and all patients gave written informed consent (CCMO-Nr: NL29018.058.09;
MEC-Nr: P09.189). It concerned the clinical follow-up of a multi-centre randomised
controlled clinical trial, comparing the use of the drug erythropoietin and two re-infusion
techniques of autologous blood in order to decrease allogenic blood transfusions
(Netherlands Trial Register: NTR303). In this trial, 2442 primary and revision hip
or knee replacements in 2257 patients were included between 2004 and 2009. All
patients who participated in the randomised controlled trial completed pre-operative
HRQoL questionnaires, underwent primary THR or TKR and who were alive at the
time of inclusion for the present follow-up study, were eligible for inclusion. The first
joint replacement was selected for inclusion in the follow-up study for patients who
participated more than once in the previous study. Records of the financial administration
of all participating centres were checked in order to ascertain that all eligible patients
were alive before being approached by the first author (JCK). For the present follow-up
study, all eligible patients were first sent an invitation letter signed by their treating
orthopaedic surgeon, an information brochure and a reply card. Patients who indicated
that they were willing to participate were sent a questionnaire. Patients who did not
respond to the first invitation within four weeks were sent another invitation letter. Those
who did not respond to this second invitation were contacted by telephone by the first
author. Patients who did not return their questionnaire within four weeks were also
contacted by telephone by the first author. The data used in this report constitute a
subset of patients who completed post-operative questionnaires.
Outcome measures: We measured the overall satisfaction with the outcome of
surgery on a numeric rating scale (NRS), which ranged from 0 (extremely dissatisfied)
to 10 (extremely satisfied). We added a validation question to the questionnaire, which
took the following form: “Knowing what your hip or knee replacement surgery did for
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you, would you still have undergone this surgery?”, with dichotomous answers of ‘yes’
vs ‘no’. This validation question was previously used in a similar validation study of
clinically important differences after THR and TKR.[203]
Joint-specific PROMs were measured using the OHS for THR patients and the
OKS for patients undergoing TKR, both of which were translated and validated in
Dutch.[211, 212] Each questionnaire comprises 12 questions regarding pain and
functioning of the hip or knee during the previous four weeks. Each question is answered
on a five-point Likert scale, and an overall score is calculated by summarising the
responses to each of the 12 questions. This sum score ranges from 0 to 48, where 0
indicates the most severe symptoms and 48 the least severe symptoms.
Potential confounders included age at joint replacement, gender, body mass index
(BMI), indication for joint replacement (osteoarthritis (OA) vs other), patient-reported
Charnley classification of comorbidity (A, patients in which the index operated hip or
knee are affected only; B, patients in which the other hip or knee is affected as well;
C, patients with a hip or knee replacement and other affected joints and/or a medical
condition which affects the patients’ ability to ambulate)[136, 137] and pre-operative
HRQoL. HRQoL was measured pre-operatively using the Short-Form (SF-)36,[197]
which is translated and validated in the Dutch language.[133] The 36 items cover eight
domains (physical function, role physical, bodily pain, general health, vitality, social
function, role emotional, and mental health), for which a sub-scale score is calculated
(100 indicating no symptoms and 0 indicating extreme symptoms). These sub-scales
can be summarised in a physical component summary (PCS) and a mental component
summary (MCS).
Statistical Analysis: We performed descriptive analyses of the patients’ baseline
characteristics. All analyses were performed separately for THR and TKR, as MCIDs
have been shown to differ considerably between these surgical interventions.[141]
The correlation between OHS or OKS and NRS for satisfaction was calculated using
Pearson’s correlation coefficient. Receiver operating characteristic (ROC) curves were
used to identify thresholds for OHS/OKS scores at mid-term follow-up, which are
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associated with an acceptable level of patient satisfaction with joint replacement. An
acceptable level of patient satisfaction was defined as a NRS for satisfaction ≥ 5, which
is the equivalent of a visual analogue scale satisfaction score ≥ 50.[18, 205] This
particular threshold has been used previously to compare satisfied and dissatisfied
patients after joint replacement.[210] The chosen PASS thresholds were equivalent to
the point at which sensitivity and specificity were closest.[213] The 95% confidence
intervals (CI) around the thresholds were estimated using percentile bootstrap methods,
based on 1000 random samples with replacement from the original data. In order to
explore whether the found thresholds are consistent across subgroups, we identified
separate thresholds for subgroups based on the following variables: length of follow-up
(< 3 years vs ≥ 3 years), gender, age (< 70 years vs ≥ 70 years), BMI (< 30 kg/m2 vs ≥
30 kg/m2), Charnley classification (A/B vs C), SF-36 PCS (< 50 vs ≥ 50) and SF-36
MCS (< 50 vs ≥ 50).
Based on the overall PASS thresholds, we divided patients into responders (those
with an OHS or OKS ≥ the PASS threshold) and non-responders (OHS/OKS < PASS
threshold). We compared the mean NRS for satisfaction between responders and
non-responders separately for THR and TKR patients, using three different models.
In the first model, we calculated the mean NRS for satisfaction of all responders and
the mean NRS of all non-responders, stratified by centre. In the second model, we
performed linear mixed model regression analyses, with age and gender as fixed effects
and the centre as a random effect, while stratifying for quartile of follow-up length. The
final model consisted of linear mixed model regression analyses, with age, gender, BMI,
Charnley classification, indication (OA vs other), and pre-operative SF-36 PCS and
MCS as fixed effects and the centre as a random effect, while stratifying for quartile of
follow-up length.
Finally, we compared the odds of responding the validation question positively between
responders and non-responders, using three different models. In the first model, we
calculated crude odds ratios. In the second model, we performed logistic mixed model
regression analyses, with age and gender as fixed effects and the centre as a random
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effect, while stratifying for quartile of follow-up length. In the final model, we performed
logistic mixed model regression analyses, with age, gender, BMI, Charnley classification,
indication (OA vs other), and pre-operative SF-36 PCS and MCS as fixed effects and
the centre as a random effect, while stratifying for quartile of follow-up length.
All analyses were performed using R v2.14.1.[43]
Results
A total of 550 patients underwent THR and 367 underwent TKR (see study flowchart
in figure 1.1 (p. 5)). Patient characteristics are described in Table 8.1 on the following
page. The mean follow-up was similar for THR and TKR patients, at 3.2 years (1.5 to
6.0) and 3.2 years (1.3 to 6.0), respectively. THR patients were slightly younger at joint
replacement surgery than TKR patients. The proportion of males was similar. TKR were
more often obese or morbidly obese. The majority of THR and TKR patients underwent
joint replacement for primary OA.
The mean and median OHS scores at mid-term follow-up were 41.5 (sd 7.93) and 44
(interquartile range (IQR) 39 to 47), respectively. The mean NRS for satisfaction was
8.55 (sd 2.19) and 94.7% (521 of 550) of all THR patients were satisfied (defined as
NRS ≥5). The mean and median OKS scores at mid-term follow-up were 39.1 (sd 9.04)
and 42 (IQR 35 to 46), respectively. The mean NRS for satisfaction was 8.07 (sd 2.61)
and 90.7% (333 of 367) of all TKR patients were satisfied.
The NRS correlated with both the OHS (Pearson correlation coefficient 0.52 (95% CI
0.46 to 0.58)) and the OKS (Pearson correlation coefficient 0.64 (95% CI 0.57 to 0.69)),
indicating a strong correlation.
ROC curves of OHS thresholds and OKS thresholds are shown in Figures 8.1 (p. 113)
and 8.2 (p. 114). The OHS ROC curve revealed a PASS threshold of 42, with a sensitivity
of 67.0% and a specificity of 65.5%. The area under the ROC curve (AUC) was 0.72
(95% CI 0.60 to 0.84). The OKS ROC curve revealed a PASS threshold of 37, with
a sensitivity of 76.3% and a specificity of 76.5%. The AUC was 0.83 (95% CI 0.74 to
0.93). ROC curves of subgroups showed variation in the thresholds found (Tables II and
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Primary THR: Primary TKR:
n = 550 n = 367
Mean Follow-up Years (SD); Range 3.2 (1.1); 1.5 – 6.0 3.2 (1.1); 1.3 – 6.0
Mean Age at Joint Replacement (SD) 65.9 (10.5) 68.7 (9.64)
% Men: 34,2 33,3
BMI*
% <25: 34,3 17,9
% 25-30: 42,6 44,5
% 30-35: 17,7 23,4
% >35: 5,82 14,2
Indication for Joint Replacement
% Osteoarthritis: 86,3 89
Patient-reported Charnley Classification*
% A: 23,1 13,9
% B: 14,3 10,2
% C: 62,6 75,9
Median Preoperative SF36 Summary Scores (IQR)
Physical Component Summary 39.8 (34.1 – 45.3) 41.3 (35.0 – 47.3)
Mental Component Summary 54.8 (45.6 – 60.0) 54.1 (45.4 – 59.1)
Table 8.1: Patient Characteristics. *Measured at follow-up.
III). The variation appears larger in OHS thresholds than in OKS thresholds.
The mean NRS for satisfaction was significantly higher in responders than in non-
responders, both for THR and TKR (Table 8.4 (p. 116)). Both models showed a mean
difference between responders and non-responders of approximately two points for
THR patients and three points for TKR patients. Responders were more likely to be
willing to undergo surgery again (Table 8.5 (p. 117)). All models showed odds ratios of
approximately 7, indicating a seven-times higher odds of willingness to undergo surgery
again in responders versus non-responders, while controlling for confounding (Table 8.5
(p. 117)).
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Figure 8.1: Receiver Operating Characteristic (ROC) curves to identify
thresholds for the mid-term follow-up Oxford Hip Score (OHS) associated with
mid-term satisfaction with surgery. Area under ROC curve (AUC): 0.72 (95%-CI:
0.60–0.84). Sensitivity: 67.0%, Specificity: 65.5%.
Discussion
PASS thresholds for the OHS and OKS are considerably higher at mid-term follow-
up than those at six months post-operatively. The multiple approaches in validating
the PASS thresholds and the rigorous efforts to minimise confounding are the main
strengths of this study. All approaches show that the thresholds of 42 points for the OHS
and 37 points for the OKS can discriminate between successful and less successful
patient outcomes after THR or TKR in this study population, according to the overall
satisfaction assessment and the willingness to undergo surgery again.
A limitation of our study is that we did not measure the OHS or OKS pre-operatively.
Consequently, we could not investigate whether the PASS thresholds are valid across
strata of baseline OHS or OKS scores. As a surrogate measurement of pre-operative
joint functioning, we investigated differences in PASS thresholds in strata of the pre-
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Figure 8.2: Receiver Operating Characteristic (ROC) curves to identify
thresholds for the mid-term follow-up Oxford Knee Score (OKS) associated with
mid-term satisfaction with surgery. Area under ROC curve (AUC): 0.83 (95%-CI:
0.74–0.93). Sensitivity: 76.3%, Specificity: 76.5%.
operative physical and mental component summaries of the SF-36, which only had a
small effect. Furthermore, other evidence from the same research group suggests that
baseline OHS or OKS values are poor predictors of overall patient satisfaction with the
outcome of the joint replacement.[210, 214]
Another limitation of our study is the broad range in follow-up length. In order to account
for this range, we stratified our analysis per quartile of follow-up period. Although a
residual effect of follow-up length cannot be excluded, we do not think this is very
plausible, as recent evidence suggests that after full recovery has taken place, the
improvement in joint function is sustained throughout mid-term follow-up.[148]
Demographically, our study population is similar to that of Judge et al.[210] Cultural
differences cannot be excluded from explaining the differences found in PASS thresholds,
although this is unlikely, given the resemblance of English and Dutch urban joint
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Thresholds (95% CI) Satisfactory Symptom State: n (%)
Entire Population 42 (38.5 – 44.2) 359 (65.3)
Follow-up < 3 yrs 45 (39.6 – 46.5) 134 (47.2)
Follow-up ≥ 3 yrs 39 (30.5 – 42.5) 184 (69.2)
Males 47 (44.2 – 47.5) 85 (45.2)
Females 38 (30.5 – 41.2) 258 (71.3)
Age < 70 yrs 44 (39.1 – 45.5) 204 (60.0)
Age ≥ 70 yrs 40 (30.5 – 42.5) 127 (60.5)
BMI < 30 43 (39.6 – 45.5) 280 (68.6)
BMI ≥ 30 36 (25.5 – 43.5) 55 (45.1)
Charnley Class A / B 45 (26.0 – 47.5) 150 (77.7)
Charnley Class C 41 (37.0 – 43.5) 177 (54.8)
PCS < 50 43 (37.5 – 44.7) 287 (64.8)
PCS ≥ 50 47 (34.0 – 48.0) 94 (90.0)
MCS < 50 38 (28.7 – 41.5) 94 (54.0)
MCS ≥ 50 45 (40.7 – 46.5) 156 (48.3)
Table 8.2: Patient acceptable symptom state (PASS) score thresholds (95%
Confidence Intervals) for Mid-term follow-up Oxford Hip Score and percentage
of patients classified as reaching a satisfactory symptom state, per relevant
subgroups.
replacement patients. A more plausible explanation could be the difference in physical
recovery. Patients who are fully recovered at mid-term follow-up could be less prone to
be satisfied with lower OHS or OKS scores, as the probability of further improvement
in physical functioning is small. Six months after joint replacement, patients might be
more readily satisfied with suboptimal OHS or OKS scores, as the speed of recovery is
quite high.
Conceptually, MCIDs and PASSs are complementary. Both approach an individual
patient’s health state, but from a slightly different angle. In MCIDs, the emphasis is on
whether or not an individual has improved after a certain therapy.[215] In PASSs, the
emphasis is on whether or not the achieved outcome is acceptable from the patients
perspective.[215] Both MCIDs and PASS have gained in interest recently.[141, 216–218]
PASS might be more important than the MCID, as Dougados[219] phrased eloquently:
“It’s good to feel better but it’s better to feel good.” Similar methodological difficulties
are encountered both in MCIDs and PASSs: both approaches lead to a loss of power
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Thresholds (95% CI) Satisfactory Symptom State: n (%)
Entire Population 37 (31.8 – 38.5) 271 (73.8)
Follow-up < 3 yrs 34 (29.7 – 37.5) 144 (78.7)
Follow-up ≥ 3 yrs 38 (32.5 – 41.5) 131 (74.0)
Males 39 (33.5 – 44.4) 89 (73.6)
Females 33 (30.5 – 37.5) 171 (70.7)
Age < 70 yrs 34 (29.7 – 38.1) 139 (77.7)
Age ≥ 70 yrs 38 (31.3 – 41.7) 140 (77.3)
BMI < 30 38 (32.0 – 39.5) 170 (78.7)
BMI ≥ 30 35 (29.7 – 40.5) 84 (64.6)
Charnley Class A / B 39 (30.8 – 45.5) 53 (62.4)
Charnley Class C 36 (30.5 – 38.5) 180 (67.4)
PCS < 50 35 (31.3 – 38.5) 172 (63.2)
PCS ≥ 50 39 (25.0 – 47.0) 23 (39.0)
MCS < 50 33 (21.5 – 38.5) 108 (86.4)
MCS ≥ 50 38 (33.5 – 42.3) 147 (71.4)
Table 8.3: Patient acceptable symptom state (PASS) score thresholds (95%
Confidence Intervals) for Mid-term follow-up Oxford Knee Score and percentage
of patients classified as reaching a satisfactory symptom state, per relevant
subgroups.
Responders: Non-responders: Mean Difference
Adjusted for Age and
Sex*
Mean Difference
Adjusted for All Potential
Confounders**
THR 9.28 (9.26 – 9.29) 7.26 (7.22 – 7.31) 1.89 (1.53 – 2.25) 1.87 (1.47 – 2.26)
TKR 9.04 (9.01 – 9.06) 6.78 (6.71 – 6.84) 2.89 (2.40 – 3.38) 2.96 (2.44 – 3.48)
Table 8.4: Comparison of Mean Numerical Rating Scale of Satisfaction between
responders and non-responders according to the Patient acceptable symptom
state (PASS) score thresholds for THR and TKR. * Stratified by quartiles of follow-up
length. ** Adjusted for Age, Sex, BMI, Charnley Classification, OA vs other indications for
joint replacement, preoperative Physical Component Summary Scale and preoperative
Mental Component Summary Scale and stratified by quartiles of follow-up length.
compared with the population-level mean difference, both approaches depend on
population and contextual characteristics and there is no clear consensus on the optimal
statistical approach.[167, 193, 206] Despite these difficulties, MCIDs and PASSs are
the best tools available to analyse PROM data at the individual level.
In this study, we estimated PASS in OHS/OKS at mid-term follow-up in a Dutch
population. We found evidence suggesting that PASSs are time-dependent. Besides
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Crude Odds Ratio Odds Ratio Adjusted for Age
and Sex*
Odds Ratio Adjusted for All
Potential Confounders**
THR 7.64 (4.09 – 15.3) 6.97 (3.51 – 13.8) 8.53 (3.80 – 19.1)
TKR 7.28 (3.85 – 14.3) 7.92 (3.79 – 16.6) 7.73 (2.84 – 21.0)
Table 8.5: Comparison of Willingness to Undergo Surgery Again between
responders and non-responders according to the Patient acceptable symptom
state (PASS) score thresholds for THR and TKR. An Odds Ratio >1 indicates a
larger odds of Willingness to Undergo Surgery Again in Responders than in Non-
responders. * Stratified by quartiles of follow-up length. ** Adjusted for Age, Sex, BMI,
Charnley Classification, OA vs other indications for joint replacement, preoperative
Physical Component Summary Scale and preoperative Mental Component Summary
Scale and stratified by quartiles of follow-up length.
being time-dependent, PASS might also be population-dependent, as different sub-
groups had different PASS thresholds. Without any form of external validation at a similar
follow-up period, we would advise against using these PASS thresholds as absolute
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Abstract
Introduction Electronic forms of data collection have gained interest in recent
years. In orthopaedics, little is known about patient preference regarding pen-
and-paper or electronic questionnaires. We aimed to determine whether patients
undergoing total hip (THR) or total knee replacement (TKR) prefer pen-and-paper or
electronic questionnaires and to identify variables that predict preference for electronic
questionnaires.
Methods We asked patients who participated in a multi-centre cohort study investigating
improvement in health-related quality of life (HRQoL) after THR and TKR using pen-and-
paper questionnaires, which mode of questionnaire they preferred. Patient age, gender,
highest completed level of schooling, body mass index (BMI), comorbidities, indication
for joint replacement and pre-operative HRQoL were compared between the groups
preferring different modes of questionnaire. We then performed logistic regression
analyses to investigate which variables independently predicted preference of electronic
questionnaires.
Results A total of 565 THR patients and 387 TKR patients completed the preference
question. Of the THR patients, 81.8% (95% confidence interval (CI) 78.4 to 84.7)
preferred pen-and-paper questionnaires to electronic questionnaires, as did 86.8%
(95% CI 83.1 to 89.8) of TKR patients. Younger age, male gender, higher completed
level of schooling and higher BMI independently predicted preference of electronic
questionnaires in THR patients. Younger age and higher completed level of schooling
independently predicted preference of electronic questionnaires in TKR patients.
Discussion The majority of THR and TKR patients prefer pen-and-paper questionnaires.
Patients preferring electronic questionnaires differed from patients who preferred pen-
and-paper questionnaires. Restricting the mode of patient-reported outcome measures
to electronic questionnaires might introduce selection bias.
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Introduction
Traditionally, the assessment of outcome in orthopaedics has focussed on technical
aspects. In total hip (THR) or knee replacement (TKR), the cumulative incidence of
revision surgery is often used to compare the outcome of different implants or surgical
techniques.[116] The underlying assumption of the traditional orthopaedic approach
is that the technical aspects are the most important determinants of clinical success.
However, a technically well-performed joint replacement does not guarantee clinical
success, as no information is provided on functional status and pain. Additionally, the
indication for revision surgery varies widely between orthopaedic surgeons.[115] Patient-
reported outcome measures (PROMs), defined as questionnaires that are completed by
patients, provide complementary information as they give an impression of a patient’s
experience of the surgical procedure and their concerns with regard to health status,
health-related quality of life (HRQoL) and the results of the treatment received.[220]
PROMs can be measured using traditional pen-and-paper questionnaires or various
electronic counterparts, including touch screens,[221] personal digital assistants,[24,
222] tablets or mobile phones.[223] Expected advantages of electronic questionnaires
include more complete data capturing, immediate availability of results and lower costs
of administrating and entering data.[23, 24]
On the other hand, electronic questionnaires may induce selection bias. A meta-
analysis performed in 2008 showed that mail surveys had higher response rates than
those based online.[224] A recent randomised controlled trial, in which 2400 patients
were randomised to receive either a pen-and-paper questionnaire or an internet-based
questionnaire at four years after THR, revealed an enormous difference in response
rate: 92% for the pen-and-paper group versus 49% for the internet-based group.[225]
Selection bias can occur if the association between exposure and outcome differs
between participants and all eligible patients.[23]
To our knowledge, no study has investigated patient preference for electronic
questionnaires after THR and TKR. The majority of members of a senior citizens
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club prefers electronic to pen-and-paper questionnaires.[226] Given the similar age of
THR/TKR patients, we would expect a preference for electronic questionnaires. We
aimed to estimate the proportion of patients who prefer pen-and-paper questionnaires
to electronic questionnaires and to estimate predictors of electronic questionnaire
preference.
Materials and Methods
The current study is part of a multi-centre cohort study of HRQoL after THR/TKR
(NTR2190), performed from August 2010 to August 2011.[21, 27, 28, 227] Institutional
review board approval was obtained from all participating centers, all patients gave
written informed consent (CCMO-Nr:NL29018.058.09;MEC-Nr:P09.189). The data used
in this report constitutes a subset of patients who underwent primary THR or TKR and
who completed pre-operative HRQoL questionnaires and a question regarding their
preference for a mode of questionnaire at a mean of three years (1.5 to 6) after surgery.
We performed this study in order to investigate the preference for a mode of
questionnaire for future studies in HRQoL after THR or TKR in a Dutch population.
A prerequisite for such future studies is that patients can participate without outpatient
department visits, thereby facilitating participation and forestalling the occurrence of
selection bias. We selected a web-based questionnaire as the most feasible electronic
option. At follow-up, we asked all THR and TKR patients which mode of questionnaire
they preferred: pen-and-paper questionnaires or web-based electronic questionnaires,
each completed at home.
In order to judge whether patients who preferred pen-and-paper questionnaires dif-
fered from patients who preferred electronic questionnaires, we compared age, gender,
highest completed level of schooling, body mass index (BMI) categories (< 25 kg/m2, 25
to 30 kg/m2, 30 to 35 kg/m2, > 35 kg/m2), comorbidity, indication for joint replacement
(osteoarthritis vs other indications) and pre-operative HRQoL between both groups.
We have aggregated the levels of schooling into an approximation of the social classes,
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on the assumption that level of schooling indexes the type of qualifications obtained,
which in turn indicates the type of occupations available to the subject and hence
their own adult social class.[21] Thus: University, Higher vocational education and
Preparatory higher vocational and scientific education have been aggregated as indicat-
ing the professional and managerial social classes; Middle vocational education and
Preparatory middle vocational education have been aggregated as indicating the skilled
non-manual and manual social classes; and Lower vocational education, Elementary
schooling and No formal education have been aggregated as indicating the semi- and
unskilled manual social classes.
Comorbidity was measured using a patient-reported Charnley classification (A, patients
in which the index operated hip or knee are affected only; B, patients in which the other
hip or knee is affected as well; and C, patients with a hip or knee replacement and
other affected joints and/or a medical condition which affects the patients’ ability to
ambulate).[136, 137]
HRQoL was measured two weeks before TKR/THR, using the Dutch version of the
Short-Form 36 (SF-36).[133, 197] This questionnaire comprises 36 items covering eight
domains (physical function, role physical, bodily pain, general health, vitality, social func-
tion, role emotional and mental health), for each of which a subscale score is calculated
(100 indicating no symptoms and 0 indicating extreme symptoms). Additionally, these
scales are incorporated into two summary measures: a physical component summary
(PCS) and mental component summary (MCS). Missing items were imputed whenever
possible according to Ware.[197] We compared pre-operative PCS and MCS between
both preference groups.
Statistical analyses: We performed all analyses separately for THR and TKR patients,
as clinically important differences differ considerably between these patient groups. [141]
We performed descriptive analyses of baseline patient characteristics. In order to predict
which factors increased the probability of preference for electronic questionnaires, we
performed multivariate mixed model logistic regression analyses. We considered the
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following potential predictors: age, gender, highest completed level of schooling category,
BMI category, Charnley classification of comorbidity, indication for joint replacement
and pre- operative PCS and MCS scores. In the mixed model regression analyses,
patient preference was the dependent variable, all potential predictors were included as
fixed effects and center was included as a random effect. The explained variation was
estimated using Nagelkerke’s generalised r2 and the discriminative ability was estimated
using the area under the receiver operating characteristic (ROC) curve (AUC).[228]
The extent of optimism in the r2 and AUC estimates was estimated using bootstrap
resampling (n = 1000 bootstrap samples). [229–231]
All analyses were performed using R, version 2.15.2.[43]
Results
Patient characteristics are shown in table 9.1 on the facing page. A total of 565 THR
patients and 387 TKR patients completed the preference question. Pen-and-paper
questionnaires were preferred by 462 THR patients (81.8% (95% confidence interval
(CI) 78.4 to 84.7) and by 336 TKR patients (86.8% (95% CI 83.1 to 89.8)) (table 9.2 on
the next page).
Patient characteristics per preference group are show in table 9.3 (p. 126) for THR
patients and table 9.4 (p. 127) for TKR patients, respectively. THR patients preferring
electronic questionnaires tended to be younger, more often male, more often obese,
less comorbid, more often highly educated and had worse pre-operative physical health.
Age, gender and highest completed level of education remained associated with mode
of questionnaire preference while adjusting for age and gender (table 9.3 (p. 126)). TKR
patients who preferred electronic questionnaires were younger, more often male, less
often morbidly obese, less often Charnley class B and more often Charnley class C,
more often highly educated and had worse pre-operative physical health. Age and
highest completed level of education remained associated with mode of questionnaire
preference while adjusting for age and gender (table 9.4 (p. 127)).
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Primary THR: Primary TKR:
n = 565 n = 387
Mean Follow-up Years (SD); Range 3.20 (1.13); 1.5 – 6.0 3.14 (1.12); 1.3 – 6.0
Mean Age at Joint Replacement (SD) 65.9 (10.6) 68.9 (9.66)
% Men: 35.0 32.6
BMI*
% <25: 34.3 17.8
% 25-30: 42.9 44.1
% 30-35: 17.1 23.8
% >35: 5.71 14.2
Indication for Joint Replacement
% Osteoarthritis: 86.1 89.3
Patient-reported Charnley Classification*
% A: 23.3 14.6
% B: 14.2 10.5
% C: 62.6 74.9
Highest Completed Level of Schooling:
% University, Higher Vocational Education
and Preparatory Higher Vocational & Scientific
Education:
22.6 15.4
% Middle Vocational Education and Preparatory
Middle Vocational Education:
36.6 35.5
% Lower Vocational Education, Elementary
Schooling and No Formal Education:
40.7 49.1
Mean Preoperative SF36 Summary Scores (SD)
Physical Component Summary 38.9 (9.61) 40.6 (9.53)
Mental Component Summary 51.8 (10.8) 51.5 (10.2)
Table 9.1: Patient Characteristics. *Measured at follow-up.
Joint Replacement: Proportion (%, 95% CI):
Total Hip Replacement 462 / 565 (81.8%; 78.4 – 84.7)
Total Knee Replacement 336 / 387 (86.8%; 83.1 – 89.8)
Table 9.2: Proportion Of Patients Who Prefer Pen And Paper Questionnaires To
Electronic Questionnaires, Per Joint Replacement.
Multivariate prediction of electronic questionnaire preference showed that lower
age, male gender, higher completed level of schooling and higher BMI independently
predicted preference of electronic questionnaires in THR patients (table 9.5 (p. 128)). In
TKR patients, multivariate prediction of electronic questionnaire preference showed that
lower age and higher completed level of schooling independently predicted preference
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Pen and Paper Electronic Age and Gender-
adjusted Odds Ratio
Mean Follow-up Years (SD) 3.17 (1.13) 3.31 (1.11) -
Mean Age at Joint Replacement (SD) 67.5 (9.45) 58.5 (12.2) 0.93 (0.91 – 0.95)
% Men: 30,3 56,3 0.35 (0.22 – 0.56)
BMI
% <25: 35,4 29,3 ref.
% 25-30: 42,1 46,5 1.32 (0.75 – 2.32)
% 30-35: 17,6 15,2 0.88 (0.42 – 1.83)
% >35: 4,95 9,09 2.18 (0.84 – 5.69)
Indication for Joint Replacement
% Osteoarthritis: 88,5 75,5 0.75 (0.40 – 1.43)
Patient-reported Charnley Classification
% A: 23,2 23,5 ref.
% B: 13,2 18,4 1.28 (0.59 – 2.79)
% C: 63,6 58,2 1.10 (0.61 – 1.98)
Highest Completed Level of Schooling
% University, Higher Vocational Education
and Preparatory Higher Vocational &
Scientific Education:
19,1 37 ref.
% Middle Vocational Education and
Preparatory Middle Vocational Education:
34,3 46 0.82 (0.47 – 1.45)
% Lower Vocational Education, Elemen-
tary Schooling and No Formal Education:
46,6 17 0.24 (0.12 – 0.47)
Mean Preoperative SF36 Summary
Scores (SD)
Physical Component Summary 39.5 (8.87) 35.8 (11.9) 1.00 (0.97 – 1.03)
Mental Component Summary 51.2 (10.6) 54.8 (10.9) 1.01 (0.99 – 1.04)
Table 9.3: Comparison of Patients Who Prefer Pen And Paper Questionnaires
With Patients Who Prefer Electronic Questionnaires: Total Hip Replacement.
of electronic questionnaires (table 9.6 (p. 129)). The prediction model of Electronic
questionnaire preference in THR patients had an r2 of 0.31 with an optimism estimate
of 0.04, yielding an optimism-corrected r2 estimate of 0.27. The Area under the ROC
curve was 0.81, with an optimism estimate of -0.02, indicating absence of optimism.
The prediction model of Electronic questionnaire preference in TKR patients had an r2
of 0.41 with an optimism estimate of -0.24, indicating absence of optimism. The Area
under the ROC curve was 0.88, with an optimism estimate of -0.004, indicating absence
of optimism.
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Pen and Paper Electronic Age and Gender-
adjusted Odds Ratio
Mean Follow-up Years (SD) 3.10 (1.09) 3.44 (1.32) -
Mean Age at Joint Replacement (SD) 70.3 (8.91) 59.9 (9.72) 0.90 (0.86 – 0.93)
% Men: 30,7 45,1 0.61 (0.31 – 1.18)
BMI
% <25: 17,5 19,6 ref.
% 25-30: 43,3 49 0.86 (0.34 – 2.20)
% 30-35: 23,9 23,5 0.65 (0.23 – 1.83)
% >35: 15,3 7,84 0.41 (0.11 – 1.57)
Indication for Joint Replacement
% Osteoarthritis: 90,4 81,6 1.29 (0.48 – 3.45)
Patient-reported Charnley Classification
% A: 14,9 12,2 ref.
% B: 11,2 6,12 0.83 (0.18 – 3.83)
% C: 73,9 81,6 1.35 (0.52 – 3.52)
Highest Completed Level of Schooling
% University, Higher Vocational Education
and Preparatory Higher Vocational &
Scientific Education:
11,7 37,5 ref.
% Middle Vocational Education and
Preparatory Middle Vocational Education:
33,1 50 0.55 (0.24 – 1.26)
% Lower Vocational Education, Elemen-
tary Schooling and No Formal Education:
55,2 12,5 0.08 (0.03 – 0.25)
Mean Preoperative SF36 Summary
Scores (SD)
Physical Component Summary 41.1 (8.81) 36.7 (12.9) 1.02 (0.98 – 1.06)
Mental Component Summary 51.2 (10.4) 53.5 (8.87) 1.02 (0.99 – 1.06)
Table 9.4: Comparison of Patients Who Prefer Pen And Paper Questionnaires
With Patients Who Prefer Electronic Questionnaires: Total Knee Replacement.
Discussion
The vast majority of THR and TKR patients prefer pen-and-paper questionnaires. THR
patients who prefer electronic questionnaires are younger, more often male, have
completed higher levels of schooling and are more often obese. TKR patients who
prefer electronic questionnaires are younger and have completed higher levels of
schooling.
A limitation of our study is the mode of questionnaire used to capture the data.
In this study, we invited patients to participate by conventional mail. Additionally, all
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Odds Ratio (95%CI) p-value
Age at Joint Replacement (Years) 0.93 (0.90 – 0.96) < 0.001
Male vs Female Gender 0.31 (0.17 – 0.56) < 0.001
BMI: 25-30 vs <25 2.06 (1.03 – 4.11) 0.04
BMI: 30-35 vs <25 1.17 (0.48 – 2.81) 0.73
BMI: >35 vs <25 5.49 (1.74 – 17.3) 0.004
Other Indications vs Osteo-Arthritis 0.59 (0.28 – 1.26) 0.17
Charnley Classification: A vs B 0.99 (0.40 – 2.42) 0.98
Charnley Classification: A vs C 0.87 (0.43 – 1.78) 0.70
Schooling: U+HVE+PHVSE vs MVE+PMVE 0.89 (0.45 – 1.77) 0.74
Schooling: U+HVE+PHVSE vs LVE+ES+NFE 0.27 (0.12 – 0.59) < 0.001
Physical Component Summary 1.00 (0.97 – 1.03) 0.80
Mental Component Summary 1.00 (0.98 – 1.03) 0.87
Table 9.5: Multivariate Prediction of Electronic Questionnaires Preference: Total
Hip Replacement. Odds ratios > 1 indicate a higher odds of preferring an Electronic
Questionnaire, per increasing predictor unit. r2 = 0.31; AUC = 0.81.
U+HVE+PHVSE: University, Higher Vocational Education and Preparatory Higher
Vocational & Scientific Education. MVE+PMVE: Middle Vocational Education and
Preparatory Middle Vocational Education. LVE+ES+NFE: Lower Vocational Education,
Elementary Schooling and No Formal Education.
questionnaires consisted of pen-and-paper questionnaires. Patients willing to participate
in this study might be more inclined to prefer pen-and-paper questionnaires than THR
and TKR patients in general, thus leading to an overestimation of the proportion of
patients preferring pen-and-paper questionnaires. However, we consider it unlikely that
the entire preference for pen-and-paper questionnaires is based on such selection bias.
Additionally, the identified predictors for electronic questionnaire preference, such as
age and completed level of schooling, are plausible, thereby indirectly validating our
results.
Strengths of our study include the large sample size, allowing precise estimation and
multivariate prediction of patient preference. Although the low r2 values indicate that
not all variance is explained by the predictors, the high AUC values indicate that the
prediction models have a high discriminatory ability. The limited extent of optimism in
r2 and AUC estimates indicate that overfitting did not play a role in our study.[231] In
other words, it is unlikely that the prediction models in this study have captured the
peculiarities in this data set; conversely, it is likely that predictions, based on this data,
will be generalisable to other, similar populations.
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Odds Ratio (95%CI) p-value
Age at Joint Replacement (Years) 0.89 (0.84 – 0.94) < 0.001
Male Gender 0.53 (0.21 – 1.34) 0.18
BMI: 25-30 vs <25 1.05 (0.26 – 4.28) 0.94
BMI: 30-35 vs <25 1.27 (0.30 – 5.38) 0.75
BMI: >35 vs <25 1.59 (0.28 – 8.91) 0.60
Other Indications vs Osteo-Arthritis 2.05 (0.53 – 7.89) 0.30
Charnley Classification: A vs B 1.40 (0.23 – 8.58) 0.72
Charnley Classification: A vs C 2.07 (0.58 – 7.31) 0.26
Schooling: U+HVE+PHVSE vs MVE+PMVE 0.33 (0.13 – 0.85) 0.02
Schooling: U+HVE+PHVSE vs LVE+ES+NFE 0.04 (0.01 – 0.15) < 0.001
Physical Component Summary 1.01 (0.96 – 1.06) 0.63
Mental Component Summary 0.99 (0.95 – 1.04) 0.75
Table 9.6: Multivariate Prediction of Electronic Questionnaires Preference: Total
Knee Replacement. Odds ratios > 1 indicate a higher odds of preferring an Electronic
Questionnaire, per increasing predictor unit. r2 = 0.41; AUC = 0.88.
U+HVE+PHVSE: University, Higher Vocational Education and Preparatory Higher
Vocational & Scientific Education. MVE+PMVE: Middle Vocational Education and
Preparatory Middle Vocational Education. LVE+ES+NFE: Lower Vocational Education,
Elementary Schooling and No Formal Education.
Unfortunately, we do not have any information on the availability of Internet access
of our patients. Although The Netherlands is rated as one of the most mature
internet markets,[232] recent evidence suggests that non-users of the internet are
more likely to be elderly,[233] which could explain pen-and-paper questionnaire
preference. Practical advantages of electronic questionnaires are stressed in the
current orthopaedic literature.[24, 234] Patients are sometimes considered to prefer
electronic questionnaires, without any evidence supporting this claim.[234] Although
electronic questionnaires certainly appear more efficient, our results reveal limitations in
line with the findings of Rolfson et al.[225] Future studies, which only measure PROMs
using electronic questionnaires, might suffer from limited generalizability, as elderly and
lowly educated patients are less likely to participate. Moreover, selection bias might
occur if the association of interest is related to age or social class.
When planning a study in which PROMs will be completed by THR and TKR
patients at home, we recommend using pen-and-paper questionnaires, despite their
logistic limitations. Such studies should at least provide the option of pen-and-paper






Implants In chapter 2 (p. 9), we systematically searched and appraised the current
literature, regarding the probability of revision surgery at ten years for each individual
Total Hip Implant. We compared the study results to the NICE benchmark,[35] and
found that 8 out of 34 acetabular cups and 15 out of 32 femoral stems outperform the
benchmarks. 16 out of 34 acetabular cups and 6 out of 32 femoral stems performed
significantly worse than the NICE benchmark. Most studies were of low methodological
quality, the risk of bias is therefore high.
Patient and Surgeon Factors In this thesis, we investigated whether two patient
characteristics, namely the patients Socio-Economic Position and the preoperative
radiographic severity were predictors of improvement in HRQoL and patient satisfaction
after THR/TKR.
In chapter 3 (p. 37), we questioned whether more disadvantaged Socio-Economic Posi-
tion is associated with an lower improvement in Health-Related Quality of Life (HRQoL)
and a lower patient satisfaction after THR/TKR in a multi-center cohort study. We found
no differences in HRQoL improvement in THR patients and small, clinically irrelevant
differences in HRQoL improvement in some subscales for TKR patients. Additionally,
we found no differences in patient satisfaction, both for THR patients and TKR patients.
131
In conclusion, Socio-Economic Position is no useful patient characteristic to predict
HRQoL improvement and patient satisfaction in the Netherlands.
In chapter 4 (p. 55), we assessed whether the pre-operative radiographic OA severity is
related to the improvement in HRQoL after THR or TKR, both at the population and indi-
vidual level. Severe OA patients improved more and had a higher probability of a relevant
improvement in physical functioning after both THR and TKR. Patient satisfaction was
also higher in severe OA TKR patients. In conclusion, the radiographic OA severity could
be a useful patient characteristic to predict HRQoL improvement and patient satisfaction.
Research Methodology
Competing Risks: In chapter 5 (p. 71), we assessed how much bias is introduced
in the estimation of the probability of revision surgery, when a crucial assumption of
the Kaplan-Meier estimator is violated. Independence of the time to event and the
censoring distribution is assumed in the Kaplan-Meier estimator. In the presence of
competing events, this assumption does not hold. Using the Kaplan-Meier estimator
when competing risks are present, will always lead to an overestimation of the cumulative
probability in question.
Clinimetrics: In chapter 6 (p. 81), we aimed to summarise minimal clinically important
differences (MCIDs) after total hip (THR) or knee replacement (TKR) in health-related
quality of life (HRQoL), measured using the Short-Form 36 (SF-36). We also aimed to
improve the precision of MCID estimates by means of meta-analysis. Our systematic
review of the literature yielded three studies, each describing a distinct study population:
primary THR, primary TKR and revision THR. No synthesis of study results can be
given. The MCID estimates which we have found were not validated using external
criteria and had limited precision. Nonetheless, these are the best known estimates
of MCIDs in HRQoL after THR and TKR to date. We therefore advise cautious use of
these MCIDs as absolute thresholds.
In chapter 7 (p. 93), we aimed to determine Clinically Important Differences (CIDs) in
Health-Related Quality of Life (HRQoL) after Total Hip (THR) or Total Knee Replacement
132
CHAPTER 10: DISCUSSION
(TKR), using the Short-Form 36 (SF36). CIDs are more relevant than MCIDs in THR and
TKR, as one would expect a substantial improvement in HRQoL after joint replacement,
instead of just a minimal improvement. CIDs of Physical Functioning, Role Physical,
Bodily Pain and Social Functioning were validated by the validation question “knowing
what your hip or knee replacement surgery did for you, would you still have undergone
this surgery (yes / no)?”. CIDs of all other subscales should be used cautiously, as
these were not validated using external criteria.
In chapter 8 (p. 105), we aimed to define Patient Acceptable Symptom State (PASS)
thresholds for the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) at mid-term
follow-up. Receiver operating characteristic (ROC) curves identified a PASS threshold of
42 points for the OHS after THR and 37 points for the OKS after TKR. THR patients with
an OHS ≥ 42 points and TKR patients with an OKS ≥ 37 points had a higher Numeric
Rating Scale of Satisfaction and a larger odds of being willing to undergo surgery again.
However, PASS thresholds differed considerably between relevant subgroups. PASS
thresholds appear larger at mid-term follow-up than at 6 months after surgery. Without
external validation, we would advise against using these PASS thresholds as absolute
thresholds in defining whether or not a patients has attained an acceptable symptom
state after THR/TKR.
Questionnaire Mode Preference: In chapter 9 (p. 119), we assessed patient
preference for the questionnaire mode in a multi-center cohort study. The
majority of THR and TKR patients prefer pen-and-paper questionnaires. Patients
preferring electronic questionnaires differed from patients who preferred pen-and-paper
questionnaires. Restricting the mode of PROMs to electronic questionnaires might
introduce selection bias.
Recommendations for Future Research
Implants The ideal THI has a low probability of revision surgery and has little systemic
adverse effects. In chapter 2 (p. 9), we systematically searched and appraised the
literature, regarding the probability of revision surgery of THI at ten years follow-up. A
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number of THI outperform current benchmarks. However, the majority of found survival
estimates were based on a single study, performed in a single center. The results of this
study should not be viewed as conclusive evidence, but as the best available evidence
at this point in time.
Post-market surveillance studies, which are summarised in our systematic review
(chapter 2 (p. 9)), remain of vital importance to detect implants with a high probability
of revision surgery. A major drawback of such studies is that, if published at all, their
results are available many years after an implant has been introduced in clinical practice.
National joint registries, given an annual update, solve the first problem, but not the
second. Solely relying on post-market surveillance and national joint registry studies
to detect poor implants will therefore expose many patients to unproven designs and
facilitates large-scale implant recalls, as we have seen in the ASR case.[111]
Imaging techniques, such as 3D Röntgen Stereophotogrammetry Analysis (RSA), could
play a crucial role in preventing future implant disasters. The probability of revision
surgery can be predicted using RSA.[42, 114, 235] A recent study shows that implants,
which have published RSA studies at two years follow-up, have 22–35% less revisions
up to 5 years after surgery.[119] Phased introduction of new implants using RSA could
therefore lead to better patient care and could substantially reduce health-care costs
associated with revision surgery.
Patient and Surgeon Factors We have assessed the role of the patients Socio-
Economic Position and the severity of preoperative radiographic OA in predicting the
Patient-Reported Outcome after THR and TKR. The number of potential predictors of
the improvement in clinical outcome is endless.
One potential predictor, which is often stressed in the literature, is the preoperative
patient expectation of the outcome after joint replacement.[166] These expectations
can be modified by preoperative educational classes, which opens up possibilities
for preoperative optimalisation.[236] In future cohort studies, the role of pre-operative
expectations on the probability of a relevant improvement in HRQoL should be studied,
in order to investigate whether or not expectation management can lower the relatively
134
CHAPTER 10: DISCUSSION
high rate of dissatisfaction after joint replacement.
Research Methodology
Competing Risks: In chapter 5 (p. 71), we have shown that the Kaplan-Meier (KM)
estimator introduces bias in the presence of competing events. When estimating the cu-
mulative probability of revision surgery, competing events are likely to occur in the case
of THR or TKR. A recently developed guideline for the statistical analysis of arthroplasty
data acknowledges that the KM estimator yields biased results.[237] Unfortunately, the
authors of this guideline miss the point in interpreting the consequences of this bias.
Two poor arguments in favour of the KM estimator are proposed. In the first place, “Is
the difference (i.e. the amount of bias). . . clinically important?” We have shown that
the amount of bias depends on the number of competing events (i.e. the number of
patients who have died), compared to the number of events of interest (i.e. the number
of patients who have undergone revision surgery). However, why would one be willing
to accept any form of bias, especially when it is possible to eliminate such bias using
freely available tools? In the second place, the authors state that “The KM estimates
of implant failure are more clinically meaningful and straightforward to interpret for
clinicians and patients”. This argumentation is flawed, since both the KM estimator and
the cause-specific cumulative incidence estimator estimate the cumulative probability of
a certain event as a function of time. Thus, the clinical meaning of the KM estimator and
the cumulative incidence estimator is identical. The only difference is that the cumulative
probability of being event-free is presented by the KM estimator, while the cumulative
incidence estimator presents the cumulative probability of having the event of interest.
Surely, getting accustomed to this slightly different way of presenting the probability of re-
vision surgery is worthwhile, as it permits unbiased estimation of the outcome of interest.
Clinimetrics: In this thesis we have summarised the literature regarding MCIDs
in HRQoL after THR and TKR, we have estimated CIDs in HRQoL after THR and TKR
using an innovative approach and we have estimated PASS in Joint-specific Patient
Reported Outcome Measures.
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A number of issues remain to be addressed. To date, no CIDs have been established
for neither OHS nor OKS, two often used joint specific Patient Reported Outcome
Measures. In esstimating these CIDs, future studies could compare our innovative
approach to the approach of Chesworth et al.[203]
Questionnaire Mode Preference: In chapter 9 (p. 119), we found that the vast
majority of THR and TKR patients prefer pen-and-paper questionnaires, when partici-
pating in a cohort study on the improvement in Health-Related Quality of Life after THR
or TKR.
In the past few years, tablet computers have gained in popularity. Recent evidence sug-
gests that the acceptance and satisfaction rates of tablet computers are high amongst
senior users.[238] It would be interesting to see whether or not the rising popularity of
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233 Brandtzaeg PB, Heim J, Karahasanović A. Understanding the new digital divide: A
typology of Internet users in Europe. Int J Hum Comput Stud. 2011;69(3):123–138.
234 Lee SJ, Kavanaugh A, Lenert L. Electronic and computer-generated patient
questionnaires in standard care. Best Pract Res Clin Rheumatol. 2007;21(4):637–47.
235 Nieuwenhuijse MJ, Valstar ER, Kaptein BL, Nelissen RGHH. Good diagnostic
performance of early migration as a predictor of late aseptic loosening of acetabular
cups: results from ten years of follow-up with Roentgen stereophotogrammetric analysis
(RSA). J Bone Joint Surg Am. 2012;94(10):874–80.
155
236 Mancuso CA, Graziano S, Briskie LM, Peterson MGE, Pellicci PM, Salvati EA, Sculco
TP. Randomized trials to modify patients’ preoperative expectations of hip and knee
arthroplasties. Clin Orthop. 2008;466(2):424–31.
237 Ranstam J, Kärrholm J, Pulkkinen P, Mäkelä K, Espehaug B, Pedersen AB, Mehnert F,
Furnes O. Statistical analysis of arthroplasty data. II. Guidelines. Acta Orthop. 2011;
82(3):258–67.
238 Werner F, Werner K, Oberzaucher J. Tablets for Seniors: An Evaluation of a Current





In dit proefschrift werden voorspellers van de klinische uitkomst na een totale heup-
en knieprothese onderzocht. De klinische uitkomst kan op verschillende wijzen en van
verschillende perspectieven benaderd worden. Grofweg kan de volgende driedeling
worden gehanteerd: het medisch-technische perspectief, het patiëntperspectief en
het maatschappelijke perspectief. In het eerste deel (hoofdstuk 2) lag de nadruk op
het medisch-technische aspect. Het patiëntperspectief kwam aan bod in deel twee
(hoofdstuk 3 en 4). Tenslotte werden in het derde deel (hoofdstuk 5 – 9) methodologi-
sche aspecten behandeld, die ten grondslag liggen aan orthopaedisch onderzoek. Het
maatschappelijke aspect, welk beoordeeld kan worden binnen het raamwerk van de
International Classification of Functioning, Disability and Health, wordt in dit proefschrift
grotendeels buiten beschouwing gelaten.
Een belangrijke medisch-technische uitkomstmaat is de kans dat een patiënt binnen 10
jaar na plaatsing van de prothese een heringreep moet ondergaan wegens het falen
van het implantaat. Deze kans vormt de basis waarop de verschillende totale heup- en
knieprotheses onderling vergeleken worden. Over het algemeen geldt dat een goed
medisch-technisch resultaat een randvoorwaarde is voor een goede uitkomst, ook vanuit
het perspectief van de patiënt. Toch is 10–30% van de patiënten na een totale heup-
of knieprothese ontevreden met de uitkomst, ondanks een medisch-technisch goed
resultaat.
Om meer inzicht te krijgen in het perspectief van de patiënt, zoals de toename in kwaliteit
van leven en de tevredenheid met het operatieresultaat, wordt er gebruik gemaakt
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van vragenlijsten. Deze vragenlijsten, ook wel Patient Reported Outcome Measures
(PROMs) genoemd, worden door de patiënt zelf ingevuld. Dergelijke meetinstrumenten
kunnen in twee categorieën ingedeeld worden: generieke en ziektebeeld-specifieke
vragenlijsten. In dit proefschrift lag de nadruk op generieke vragenlijsten. Om onderzoek
te kunnen doen naar de toename in kwaliteit van leven na een heup- en knieprothese,
hebben we de Paprika Studie opgezet: Patiënten Prospectief gevolgd in het kader van
een totale knie- of heuparthoplastiek (CCMO-Nr: NL29018.058.09; MEC-Nr: P09.189;
Netherlands Trial Register: NTR2190). Patiënten die eerder deel hebben genomen
aan de Trigger Studie of de TOMaat Studie, werden benaderd om deel te nemen aan
een vragenlijstonderzoek en aan genetisch onderzoek, om een basis te vormen voor
associatiestudies tussen genotype en loslating van heup- en knieprothesen.
Samenvatting
In hoofdstuk 1 (p. 1) werd de epidemiologie van heup- en knieprothesen in Nederland
besproken. Daarnaast werd een kort overzicht gegeven van de opzet van de Paprika
Studie en een overzicht gegeven van de inhoud van dit proefschrift.
In hoofdstuk 2 (p. 9) hebben we een systematische literatuurstudie verricht naar de kans
op een heringreep binnen 10 jaar na implantatie voor elk type primaire heupimplantaat.
We vergeleken de uitkomsten van elk implantaat met de NICE benchmarks.[35] We
vonden 10-jaars resultaten van 34 verschillende typen acetabulaire cups en van 32
verschillende femorale stelen. De gepubliceerde resultaten van 8 acetabulaire cups
en 15 femorale stelen waren significant beter dan de NICE benchmarks; Van 16
acetabulaire cups en 6 femorale stelen waren de gepubliceerde resultaten significant
slechter dan de NICE benchmarks. De methodologische kwaliteit van de meeste
onderzoeken was laag. Dit betekent dat het risico op gebiasde resultaten hoog is. De
conclusies van de beoordeelde artikelen wordt hierdoor twijfelachtig.
In hoofdstuk 3 (p. 37) hebben we onderzocht of de socio-economische positie van de
patiënt van invloed is op de verbetering in kwaliteit van leven en de postoperatieve
patiënttevredenheid na een totale heup- of knieprothese. We hebben de deelnemers
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van de Paprika Studie in drie groepen onderverdeeld, op basis van de hoogst voltooide
opleiding, wat een goede indicator is van de socio-economische positie. We vonden een
vergelijkbare toename in kwaliteit van leven en een vergelijkbare patiënttevredenheid
voor elke groep na een totale heupprothese. Na een totale knieprothese vonden
we kleine verschillen in toename in kwaliteit van leven tussen de groepen, zonder
klinische relevantie. De patiënttevredenheid was vergelijkbaar voor elke groep. De
socio-economische positie van de patiënt is geen goede voorspeller voor de toename in
kwaliteit van leven en patiënttevredenheid na een heup- en knieprothese.
In hoofdstuk 4 (p. 55) hebben we onderzocht of de pre-operatieve radiologische gradatie
van artrose gerelateerd is aan de verbetering in kwaliteit van leven na een totale heup-
of knieprothese. De pre-operatieve radiologische artrose van deelnemers aan de
Paprika Studie werd beoordeeld volgens Kellgren en Lawrence[174] en ingedeeld in
twee groepen: patiënten met ernstige artrose (Kellgren en Lawrence graad 3 en 4)
en patiënten met milde artrose (Kellgren en Lawrence graad 0, 1 of 2). Patiënten met
een ernstige artrose verbeterden niet alleen meer, maar hadden ook een hogere kans
op een relevante verbetering van het fysieke functioneren na zowel een totale heup-
als knieprothese. De patiënttevredenheid was ook hoger na een totale knieprothese
bij patiënten met ernstige radiologische artrose. De pre-operatieve radiologische
artrose kan dus een nuttige variabele zijn om de toename in fysiek functioneren en
postoperatieve tevredenheid te voorspellen.
In hoofdstuk 5 (p. 71) hebben we onderzocht hoeveel bias er geïntroduceerd wordt
in de schatting van de kans op een heroperatie na een heupprothese, wanneer een
cruciale aanname van de Kaplan-Meier analyse wordt geschonden. In de Kaplan-Meier
analyse neemt men aan dat de tijd tot het event onafhankelijk is van het mechanisme
van censurering. Dit is een plausibele aanname in de oorspronkelijke toepassing
van de Kaplan-Meier analyse, namelijk het schatten van de cumulatieve kans om
nog in leven te zijn op elk willekeurig moment, in een populatie waarin niet iedereen
overleden is bij het einde van de follow-up van de studie (oftewel rechts-censurering).
Bij andere eindpunten, zoals de kans op een heroperatie, kunnen er competing events
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optreden: gebeurtenissen die ervoor zorgen dat het event niet meer plaats kan vinden.
In het geval van heupprothesen is het overlijden van de patiënt een treffend voorbeeld
van een competing event: de heupprothese van een overleden patiënt zal niet meer
gereviseerd worden. Wanneer er competing events optreden, wordt de aanname van
onafhankelijkheid van de tijd tot event en het mechanisme van censurering geschonden.
De Kaplan-Meier analyse leidt in aanwezigheid van competing events áltijd tot een
overschatting van de cumulatieve incidentie van het event.
In hoofdstuk 6 (p. 81) hebben we een systematische literatuurstudie verricht naar
Minimal Clinically Important Differences (MCIDs) in kwaliteit van leven scores (gemeten
middels Short-Form 36) na een totale heup- en knieprothese. Door middel van
meta-analyse hebben we getracht de precisie van MCIDs te vergroten. Helaas
bleek dit niet mogelijk: we vonden 3 schattingen van 3 verschillende populaties
(primaire totale heupprothese, primaire totale knieprothese, revisie totale heupprothese).
De gevonden MCID schattingen waren niet gevalideerd met behulp van externe
criteria, gerelateerd aan bijvoorbeeld patiënttevredenheid. Daarnaast hadden de
gevonden MCID schattingen een geringe precisie, wat herleidbaar was uit de
wijde betrouwbaarheidsintervallen. Tot op heden zijn dit echter de best bekende
schattingen. We adviseren enige terughoudendheid in het gebruik van deze MCIDs als
absolute drempelwaarden in de beoordeling of een patiënt al dan niet een minimaal
klinisch relevante toename in kwaliteit van leven heeft ondervonden na een heup- of
knieprothese.
In hoofdstuk 7 (p. 93) hebben we op een innovatieve wijze Clinically Important
Differences (CID) in kwaliteit van leven (gemeten middels SF36) geschat na een
totale heup- en knieprothese, gebruik makend van data van de Paprika Studie. CIDs
zijn drempelwaarden die een substantiële verbetering aangeven na een interventie.
Voor de kliniek zijn deze drempelwaarden relevanter dan MCIDs, aangezien men
ook een substantiële verbetering verwacht van een totale heup- of knieprothese.
CID schattingen van de subschalen Physical Functioning, Role Physical, Bodily Pain
en Social Functioning werden gevalideerd door de volgende validatievraag: “Zou u
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deze ingreep opnieuw willen ondergaan, nu u weet hoe de resultaten voor u zijn?”.
We adviseren enige terughoudendheid in het gebruik van de CIDs van de overige
subschalen als absolute drempelwaarden, omdat deze niet extern gevalideerd zijn.
In hoofdstuk 8 (p. 105) hebben we Patient Acceptable Symptom States (PASS) van
de Oxford Hip Score (OHS) en de Oxford Knee Score (OKS) geschat na een totale
heup- en knieprothese, gebruik makend van data van de Paprika Studie. PASS
zijn drempelwaarden, waarboven een patiënt een acceptabele uitkomst heeft bereikt.
Receiver Operating Characteristic curves identificeerden een optimale balans tussen
sensitiviteit en specificiteit bij een PASS drempel van 42 punten voor de OHS na een
totale heupprothese en 37 punten voor de OKS na TKR. Heupprothese patiënten met
een OHS ≥ 42 punten en knieprothese patiënten met een OKS ≥ 37 punten hadden
een hogere tevredenheidsscore en gaven vaker aan dat ze bereid waren de operatie
opnieuw te ondergaan, gegeven hun uitkomst. De PASS drempelwaarden verschilden
echter aanzienlijk tussen relevante subgroepen. In vergelijking met gepubliceerde
PASS drempelwaarden 6 maanden na de ingreep, lijken de PASS drempelwaarden na
gemiddeld 3 jaar na de operatie hoger. We adviseren deze PASS drempelwaarden
eerst te valideren in een externe populatie, alvorens ze te gebruiken in de praktijk bij het
bepalen of een patiënt een aanvaardbare uitkomst na een totale heup- of knieprothese
heeft bereikt.
In hoofdstuk 9 (p. 119) hebben we de voorkeur voor het gebruik van een type
vragenlijst geïnventariseerd van deelnemers aan de Paprika Studie: gebruik van
papieren vragenlijsten of vragenlijsten elektronisch invullen en per email terugsturen.
Een ruime meerderheid (>80%) van de patiënten gaf aan de papieren vragenlijst
te verkiezen boven een elektronische variant. Patiënten die de voorkeur gaven aan
een elektronische vragenlijst, waren gemiddeld jonger en hoger opgeleid. Onderzoek
doen naar kwaliteit van leven na heup- of knieprothesen met uitsluitend elektronische
vragenlijsten kan leiden tot selectie bias.
Tenslotte werden de bevindingen van dit proefschrift samengevat in hoofdstuk 10 en
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